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ABSTRACT 
 
Meckel-Gruber syndrome (MKS) is a recessive genetic disease that is 
uniformly lethal in affected children due to resultant developmental defects in 
the kidney and brain. 13 MKS genes have been identified, and further candidate 
genes have been linked to this disease, all encoding unrelated proteins. Their 
role is believed to be in generation and compartmentalisation of the primary 
cilium, a microtubule-based organelle that functions in signal transduction of 
developmentally-crucial pathways. However, recent evidence indicates that 
these proteins are also likely involved in regulation of the actin cytoskeleton. 
Furthermore, research is beginning to uncover roles of other ciliopathy proteins 
in regulation of additional subcellular structures, such as the microtubule 
cytoskeleton, focal adhesions and the Golgi. To begin to understand the roles of 
the MKS proteins beyond the cilium, I examined a number of cellular features of 
patient fibroblasts carrying mutations in TMEM216 (MKS2) and TMEM67 
(MKS3). In this thesis, I describe the temporal appearance and nature of 
prominent actin bundles observed in these cells, and analyse the dependency 
of these on the Rho/ROCK signalling pathway. Furthermore, I identify novel 
alterations to the microtubule cytoskeleton and organisation of the Golgi 
complex in MKS patient cells, and subsequently establish a temporal order of 
these phenotypes, demonstrating microtubule defects as the first to occur in 
these cells. Finally, I connect these phenotypic defects to Rho/ROCK signalling. 
In contrast to the prevailing view in the ciliopathy field, I believe that a diffusion 
barrier at the transition zone is not the primary role of MKS proteins. Instead I 
propose, supported by these data, that MKS protein complexes play a dual role 
as effectors of Rho signalling in addition to performing a structural role with 
particular importance in tethering the cytoskeleton to membranes. I therefore 
conclude that these, and other ciliopathy protein complexes, may act as 
important signal transduction and structural components at multiple locations 
throughout the cell.  
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CHAPTER I: INTRODUCTION 
 
1.1 Ciliopathies 
 
Diseases termed “ciliopathies” represent a spectrum of inherited, recessive 
human disorders associated with mutations in proteins that are structural or 
functional components of the primary cilium. The primary cilium is an organelle 
involved in mechanosensation, chemosensation, photoreception, olfaction and 
a plethora of other roles entailing signal transduction. Dysfunction of the primary 
cilium causes wide-ranging disease phenotypes, including severe 
developmental abnormalities such as polycystic kidneys, polydactyly and 
central nervous system (CNS) malformations (Sharma et al., 2008; Szymanska 
et al., 2014). The cause of a number of these defects remains unexplained, 
illustrating the importance of clarifying the molecular aetiology of these 
disorders. 
 The diseases typically associated with ciliary dysfunction include Joubert 
syndrome (JBTS), Senior-Løken syndrome (SLS), nephronophthisis (NPHP), 
Bardet-Biedl syndrome (BBS), orofaciodigital (OFD) syndrome, Jeune 
syndrome, polycystic kidney disease (PKD), Alström syndrome, and Meckel-
Gruber syndrome (MKS) (Sharma et al., 2008; Waters and Beales, 2011). 
Ciliopathies are relatively common, with estimated worldwide prevalence of 1 in 
2,000, based on the three typical disease traits of polydactyly, retinal 
degeneration, and renal cysts (Quinlan et al., 2008). These diseases are 
clinically distinct entities but have overlapping clinical presentation (Table 1.1). 
Simultaneous presentation of a number of these traits is often used as a 
predictive fingerprint of structural and/or functional ciliary abnormalities. Many 
ciliopathies also present with brain agenesis (such as of the corpus callosum, or 
encephalocele), situs inversus, and renal disease (Badano et al., 2006b). 
 In 2011, ciliopathic features were associated with mutations in over 40 
genes, and over 1,000 polypeptides were known to fall within the ciliary 
proteome (Waters and Beales, 2011), but this number has greatly increased in 
recent years. This is, in part, due to the increasing availability of next-generation 
methods for nucleic acid sequencing, which make mutation identification much 
less time-consuming. Presently, mutations in 27 genes have been described as 
JBTS-associated (Bachmann-Gagescu et al., 2015), and 13 as MKS-causative, 
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for instance (Shaheen et al., 2015; Szymanska et al., 2014); however, a few 
other likely candidates have also been identified (Shaheen et al., 2013; 
Szymanska et al., 2012). These display allelism with each other and with other 
ciliopathies.  
Ciliopathies are genetically and phenotypically heterogeneous, often 
demonstrating similar phenotypes in models with mutations in multiple loci as in 
models with mutations at a single locus. This has presented extreme difficulty in 
making genotype-phenotype correlations (Szymanska et al., 2014). These 
similarities have ethical implications: antenatal presentation of BBS appears like 
MKS, the former of which has a much lower fatality risk, meaning that 
termination could be inappropriately recommended (Karmous-Benailly et al., 
2005). 
 Although these “ciliopathic” diseases share a dysfunction of the primary 
cilium or associated structures, a number of other subcellular defects correlate 
in these diseases, which is the subject of this thesis. 
 
Clinical diagnosis 
 
There is a high degree of phenotypic overlap in clinical presentation of the 
ciliopathies (Table 1.1), and there are a few common features observed across 
multiple ciliopathies, such as hepatic and renal disease, retinal degeneration, 
laterality defects, and polydactyly. These defects occur at varying frequency in 
each disease, and certain ciliopathies are more severe than others. For 
example, in NPHP patients, childhood end-stage renal failure is estimated at 
only 5% prevalence in these patients; this is, however, the most common 
genetic cause of chronic kidney disease up to the third decade of life (Wolf and 
Hildebrandt, 2011). MKS – the subject of this thesis - is uniformly perinatal 
lethal (Waters and Beales, 2011; Wolf and Hildebrandt, 2011). As one of the 
most severe of the ciliopathies, and the most common syndromic cause of 
neural tube defects (Leitch et al., 2008), MKS is an important focus of 
investigation from which we may be able to deduce the underlying molecular 
foundations of ciliopathies. It is for this reason that I have chosen to study MKS 
as a model of the ciliopathies. 
  MKS was first reported in 1822 by Johann F. Meckel, and then by C.B. 
Gruber in 1934 (Salonen and Paavola, 1998). MKS is typically characterised by 
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TABLE 1.1: Clinical features associated with ciliopathies 
Feature MKS BBS JBTS NPHP SLS Jeune OFD Alström PKD 
Hepatic disease          
Renal disease          
Polydactyly      
Posterior fossa 
defects/encephalocele 
 
Laterality defects/situs 
inversus 
     
Skeletal dysplasia   
Craniofacial defects    
Retinal impairment ?       
Cognitive impairment ?    
Obesity ?   
Adapted from Waters and Beales (2011), Brugmann et al. (2010) and Quinlan et al. (2008). 
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renal cysts [estimated at a prevalence of 97.7% of cases (Barisic et al., 2015), 
making it the most frequent defect], variable CNS defects (particularly occipital 
encephalocele; 83.8% of cases), and polydactyly (87.3% of cases) (Barisic et 
al., 2015). It should be noted, however, that the diagnostic triad occasionally 
incorporates hepatic fibrosis in place of polydactyly, as this is also a common 
defect (65.5% of cases) (Barisic et al., 2015; Dawe et al., 2007b). These defects 
typically correlate with specific mutations, and phenotypes are often heritable.  
 MKS is also associated with a number of other defects, including skeletal 
changes and laterality defects (Alexiev et al., 2006; Salonen, 1984; Salonen 
and Paavola, 1998). Incidence is estimated to be between 1:13,250 and 
1:140,000 live births. Higher incidence is present in groups with higher rates of 
consanguineous relationships, such as the Gujarati Indians and the Finnish. In 
Finland, for instance, there is a genetic founder effect, meaning that the same 
MKS1 mutation (a deletion, 1408-35_1408-7del29; Szymanska et al., 2012) 
exists in many of the patients here (Chen, 2007). 
 Ultrasound diagnosis of the classical MKS presentation of CNS, renal and 
digital anomalies is typically made before 14 weeks gestation (Barisic et al., 
2015; Sepulveda et al., 1997; Tongsong et al., 1999). MKS is unavoidably lethal 
in utero or in the first hours of life (or, rarely, up to a few months), normally due 
to pulmonary hypoplasia (Ramadani and Nasrat, 1992). 
 Mutations at the MKS2 (occurring within the TMEM216 gene) and at 
MKS3/TMEM67 loci, the focus of this thesis, cause fairly typical MKS 
phenotypes. Mutations at the MKS2 locus, for instance, cause CNS defects 
(anencephaly, encephalocele or meningocele) and cystic kidneys, amongst 
other defects (including bile duct proliferation, polydactyly, cleft palate and 
bowing of long bones) in patients (Valente et al., 2010).  
 By contrast, mutations at the MKS3/TMEM67 locus appear to affect the 
liver in all patients, suggesting that liver disease is a key clinical result of this 
mutation (Otto et al., 2009). Mutations in TMEM67 are also the most common 
cause of COACH syndrome, a Joubert syndrome-related disorder presenting 
with liver fibrosis, supporting a marked association between this gene and liver 
involvement (Iannicelli et al., 2010; Szymanska et al., 2014). Notably, it has 
previously been reported that, compared with patients with mutations at MKS1 
loci, CNS malformations are less common and milder in MKS3 cases, and 
polydactyly is rarely present (Consugar et al., 2007; Morgan et al., 2002). Thus 
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far, a clear genotype-phenotype correlation from MKS2 and -3 loci to cause 
MKS has proven difficult to elucidate. However, based the severity of the 
disease, it is likely that these mutations have dramatic consequences on the 
MKS proteins. 
 
Animal models of MKS 
 
Mice carrying mutations in MKS1, TMEM67, CEP290, RPGRIP1L, 
CC2D2A, NPHP3, TCTN2, B9D1 and B9D2 have now been established, many 
of which closely mirror human disease (Chen et al., 2015; Norris and Grimes, 
2012; Stratigopoulos et al., 2014).  
No mouse models of MKS2 currently exist and animal studies beyond this 
are limited to investigation of TMEM216 (of which the MKS2 locus forms a 
smaller part) in two zebrafish models. The first was a knockdown of tmem216, 
causing gastrulation defects that are typical of Wnt/planar cell polarity defects, 
including misshapen somites, broad notochords, and a shortened body axis 
(Valente et al., 2010). Similar defects were previously demonstrated by a 
similar, morpholino-based approach in mks3 knockdown zebrafish, which 
revealed alterations to somite size, a kinked notochord and a shortened body 
axis (Leitch et al., 2008). Morpholino knockdown of tmem216 and tmem67 also 
caused defects in convergence to the midline and extension along the anterior-
posterior axis; it is of note that this was more pronounced in tmem67 
morphants, however (Valente et al., 2010). The second also used a morpholino 
knockdown of tmem216, revealing similar gastrulation defects; these morphants 
demonstrated hydrocephalus, left-right heart axis defects and a curved or 
kinked tail (Lee et al., 2012). These defects, particularly gastrulation defects, 
are of interest due to the established CNS malformations in MKS2 patients, 
supporting a necessity of MKS2 protein product TMEM216 in embryonic 
development. 
MKS3 models are better established, with several examples; these include 
Caenorhabditis elegans and Paramecium tetraurelia mutants, the Wpk (Wistar 
polycystic kidney) rat and the bpck (bilateral polycystic kidney) mouse. 
C. elegans mks-3 null mutants displayed reduced chemotaxis, indicative of 
impaired sensory function, but exhibited no obvious ciliogenesis defects 
(Williams et al., 2011). P. tetraurelia with RNAi knockdown of MKS3 developed 
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distortions in the cell and ciliary membranes and, in contrast with the C. elegans 
mutants, demonstrated absence or shortening of cilia (Picariello et al., 2014). 
The Wpk rat, originally established as a model of autosomal recessive 
polycystic kidney disease (Nauta et al., 2000), also displays CNS malformations 
such as severe hydrocephalus (Gauttone et al., 2004). The presence of severe 
CNS defects mirrors the zebrafish model, but does not reflect human disease – 
as mentioned previously, CNS defects are less common and typically milder in 
MKS3 (Consugar et al., 2007; Morgan et al., 2002). The bpck mouse, which is 
tmem67-null, has multiple tissue phenotypes reflective of human disease. 
These include cystic kidneys and a bowing of bones and a notable absence of 
polydactyly (Cook et al., 2009; Du et al., 2013). These mice also exhibit features 
not typically present in human MKS3 but present in multiple ciliopathies, 
including disorganised stereociliary bundles in the inner ear, retinal 
degeneration, (Leightner et al., 2013) neural tube defects (Abdelhamed et al., 
2013) and hydrocephalus (Cook et al., 2009). Variation in phenotypes is likely 
due to species differences; versions of human and rat meckelin, the MKS3 
protein have 91% similarity (Smith et al., 2006), for instance. For this reason, it 
is valuable to study MKS2 and -3 using in vitro, human cell models, to optimally 
recapitulate clinically observed features. However, these animal models can 
provide insight into how conserved, and crucial, these proteins are in correct 
embryonic development across multiple species, particularly during gastrulation. 
 
Molecular genetics 
  
The ciliopathies are genetically heterogeneous, and MKS has been 
associated with mutations at several of the same loci found to be affected in 
BBS, JBTS, SLS, LCA, OFD and NPHP (Baala et al., 2007; Delous et al., 2007; 
Edvardson et al., 2010; Gerdes et al., 2009; Gorden et al., 2008; Leitch et al., 
2008; Mougou-Zerelli et al., 2009; Online Mendelian Inheritance in Man, 2015; 
Quinlan et al., 2008; Valente et al., 2010; Valente et al., 2006).  
MKS is caused by mutations in 13 known genes, (Table 1.2) encoding 
proteins at numerous subcellular locations. These are present in most fetal and 
adult tissues, but are expressed at particularly high levels in ciliated tissues. 
TMEM216 (MKS2) mRNA, for instance, is abundantly expressed in the CNS, 
limb bud and kidney (Valente et al., 2010). Similarly, MKS3 transcripts are 
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TABLE 1.2: Table to summarise the known information about the MKS genes. 
 
Phenotype Gene 
locus 
Also known as Chromosome 
location (in 
humans) 
Corresponding 
protein length 
(amino acid 
residues) 
Meckel 
syndrome type 1 
MKS1  MKS, BBS13 17q23 559 a.a. 
Protein name and structural features: 
MKS1. 
Contains B9 domain. 
Meckel 
syndrome type 2 
MKS2 TMEM216, 
JBTS2, CORS2 
11q13 148 a.a. (longest 
splice isoform) 
Protein name and structural features:  
TMEM216. 
A tetraspan transmembrane protein with one intracellular and two extracellular loops. 
Forms a complex with TMEM67. 
Meckel 
syndrome type 3 
MKS3 TMEM67, JBTS6, 
NPHP11 
8q21.13-q22.1 995 a.a. 
Protein name and structural features: 
TMEM67 or Meckelin. 
Contains a cleavable signal peptide and extracellular region, followed by three to seven 
predicted transmembrane regions and a short cytoplasmic tail. 
Meckel 
syndrome type 4 
CEP290 KIAA0373, 
3H11AG, JBTS5, 
SLSN6, LCA10, 
BBS14 
12q21.32-
q21.33 
2479 a.a. 
Protein name and structural features: 
CEP290/Nephrocystin-6 (NPHP6). 
Contains 13 putative coiled-coil domains, a region with homology to SMC chromosome 
segregation ATPases, a bipartite NLS, 6 KID motifs, three tropomyosin homology domains, 
and an ATP/GTP binding site motif A, and has sites for N-glycosylation, tyrosine sulfation, 
phosphorylation, N-myristoylation, and amidation. 
Meckel 
syndrome type 5 
MKS5 RPGRIP1L, 
KIAA1005, JBTS7 
16q12.2 1315 a.a. 
Protein name and structural features: 
RPGRIP1L. 
Contains an N-terminal region comprising five coiled-coil domains, a C-terminal region 
homologous to the RPGR-interacting domain of RPGRIP1 and a central region containing 
two PKC C2 motifs. Interacts with nephrocystin-4. 
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Meckel 
syndrome type 6 
MKS6 CC2D2A, 
KIAA1345 
4p15.3 1561 a.a.
Protein name and structural features: 
CC2D2A. 
Contains C2 domain; likely to have three coiled-coils and CaM-binding site. Predicted to be 
mostly alpha helix and random coil structure. 
Meckel 
syndrome type 7 
MKS7 NPHP3, NPH3, 
RHPD1 
3q22 1330 a.a.
Protein name and structural features: 
Nephrocystin-3 (NPHP3). 
Contains an N-terminal coiled-coil, a C-terminal tetratrico peptide repeat and a tubulin-
tyrosine ligase domain.  
Interacts with nephrocystin-1 (NPHP1). 
Meckel 
syndrome type 8 
MKS8 TCTN2, TECT2 12q24.31 700 a.a. (in mouse) 
Protein name and structural features: 
Tectonic 2. 
Contains an N-terminal signal peptide. 
Meckel 
syndrome type 9 
MKS9 B9D1, MKSR1 17p11.2 115 a.a.
Protein name and structural features: 
B9 domain-containing protein 1 (B9D1). 
Meckel 
syndrome type 
10 
MKS10 B9D2, MKSR2 19q13.2 175 a.a.
Protein name and structural features: 
B9 domain-containing protein 2 (B9D2). 
Meckel 
syndrome type 
11 
MKS11 TMEM231, 
JBTS20, 
16q23.1 315 a.a.
Protein name and structural features: 
TMEM231. 
Contains both N-terminal and C-terminal transmembrane domains. 
Meckel 
syndrome type 
12 
MKS12 KIF14, KIAA0042 1q32.1  1648 aa. (longest 
splice isoform) 
Protein name and structural features: 
KIF14. 
Contains myosin- and kinesin-motor domain. 
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Information sources: Bialas et al., 2009; Chih et al., 2012; Delous et al., 2007; 
Edvardson et al., 2010; Filges et al., 2014; Frank et al., 2008; Kyttala et al., 2006; 
Nakagawa et al., 1997; Olbrich et al., 2003; Omran et al., 2000; Online Mendelian 
Inheritance in Man, 2015; Ota et al., 2004; Reiter and Skarnes, 2006; Sayer et al., 
2006; Shaheen et al., 2011; Shaheen et al., 2013a;  Shaheen et al., 2015; Smith et 
al., 2006; Tallila et al., 2008; Valente et al., 2010.
Abbreviations: SMC - structural maintenance of chromosomes; NLS – nuclear 
localisation signal; KID - kinase-inducible domain; PKC – protein kinase C; C2 – 
conserved region (Ca2+ dependent) 2; CaM - calmodulin
Meckel 
syndrome type 13  
MKS13 TMEM107  17p13.1 139 a.a. 
Protein name and structural features: 
TMEM107. 
Has 4 transmembrane domains. 
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expressed in agreement with tissue phenotypes observed in this disease, 
particularly in the hindbrain, the cartilage of developing limbs, the lung, the 
kidney and the developing retina (Dawe et al., 2007b). 
The type of mutation at these loci – i.e. frameshift deletions, splicing 
mutations, insertions, nonsense or missense mutations from transversion or 
transition, and from homozygous/heterozygous mutations, or (as “modifier 
genes”) having subsequent epistatic effects from any of these on other loci can 
cause alternative clinical outcomes from MKS (Arts et al., 2007; Baala et al., 
2007; Brancati et al., 2009; Delous et al., 2007; den Hollander et al., 2006; 
Doherty et al., 2010; Edvardson et al., 2010; Gorden et al., 2008; Leitch et al., 
2008; Noor et al., 2008; Otto et al., 2009; Sayer et al., 2006; Srour et al., 2012; 
Valente et al., 2010; Valente et al., 2006). 
The two genetic loci I have concentrated on in my research are MKS2 and 
MKS3, encoded for by genes TMEM216 and TMEM67 (respectively). These 
were chosen based on the availability of patient cells, and as TMEM67 is 
reported to be the most commonly mutated gene in MKS patients (29.8% of 
cases in the cohort analysed; Szymanska et al., 2012). Aside from causing 
MKS, mutations at both of these loci can cause Joubert syndrome (Baala et al., 
2007; Edvardson et al., 2010; Valente et al., 2010). TMEM67 mutations can 
additionally cause COACH syndrome (Brancati et al., 2009; Doherty et al., 
2010) or NPHP (Otto et al., 2009), or can have an epistatic effect, acting as a 
modifier at BBS-associated loci (Leitch et al., 2008).  
MKS2 cases are attributable to homozygous deleterious mutations to the 
TMEM216 gene on chromosome 11q13, and the MKS2 locus is proposed to 
have allelism with JBTS2 (Roume et al., 1998; Valente et al., 2010). Causative 
mutations include nonsense, splice site and, most commonly, missense 
mutations, which led to unstable protein production when transfected into 
heterologous cells (Valente et al., 2010). Mutations are reported throughout the 
gene, with no obvious correlation between mutation and clinical outcome. 
Confusingly, the same TMEM216 mutation (a homozygous 218G-A transition in 
exon 4, leading to the same arg73-to-his (R73H) substitution) has been noted in 
siblings with different disorders (one with JBTS, one with MKS) (Valente et al., 
2010). This is likely to be due to modifier genes also present in these patients 
having an epistatic effect on clinical outcomes. 
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MKS3 is caused by homozygous or compound heterozygous mutations to 
the TMEM67 gene on chromosome 8q21.13-q22.1, including frame-shift, 
splicing and missense mutations (Consugar et al., 2007; Smith et al., 2006). 
These mutations are hypothesised to lead to nonsense-mediated decay of 
transcripts in MKS3 patients (Smith et al., 2006).  
The most impactful MKS mutation is that of MKS4-associated gene 
CEP290, encoding nephrocystin-6 or CEP290 (Sayer et al., 2006); mutations at 
this locus are causative of phenotypes associated with SLS, JBTS, NPHP, BBS, 
LCA and MKS, with no obvious genotype-phenotype correlation (Coppieters et 
al., 2010; Frank et al., 2008). Mutations in CEP290 are also, after TMEM67 and 
MKS1, the third most frequent cause of MKS (Szymanska et al., 2012). Over 
100 unique CEP290 mutations are known to exist, affecting multiple organ 
systems; these include the eyes (as retinal dystrophy), nose (olfactory 
dysfunction), ears (particularly otitis media), kidneys, CNS (particularly occipital 
encephalocele), liver (elevated liver enzymes and abnormal structure are 
reported), heart (particularly septal defects), in addition to a plethora of other 
skeletal and other tissue patterning defects, such as diverse craniofacial defects 
and polydactyly (Coppieters et al., 2010). 
Most CEP290 mutations are nonsense, splice-site, or frameshift mutations, 
which cause loss of protein function (Frank et al., 2008; Waters and Beales, 
2011). It is proposed that the dramatic spectrum of phenotypic heterogeneity 
associated with these mutations is not due to the function of the CEP290 
proteins themselves, but rather disruption of their function as genetic modifiers, 
or their interaction with other proteins (Coppieters et al., 2010; Gorden et al., 
2008). This is the case for CEP290 and CC2D2A, in which the knockdown of 
each results in concomitant pronephric cyst phenotypes. CEP290 interacts with 
TCTN1, RPGR, CC2D2A and numerous other proteins at the transition zone 
(Chang et al., 2006; Garcia-Gonzalo et al., 2011; Gorden et al., 2008), the role 
of which will be described in a later section. 
Mutations in a number of MKS-associated genes, such as CC2D2A and 
RPGRIP1L, demonstrate a more obvious genotype-phenotype correlation; the 
more severe MKS phenotypes result from truncating and resultant loss-of-
function mutations at these loci, whilst patients with the milder JBTS tend to 
have at least one missense mutation (Delous et al., 2007; Mougou-Zerelli et al., 
2009). 
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In a study aiming to make a genotype-phenotype correlation in the 
ciliopathies, NPHP (with no brain anomaly) was demonstrated to correlate with 
a missense mutation affecting amino acids C615 or G821, and Joubert 
syndrome patients all had at least one missense allele but not truncating 
mutations (Otto et al., 2009). Heterozygous mutations in BBS-related genes and 
alterations to certain BBS-interacting proteins can modulate penetrance of the 
BBS phenotype (Badano et al., 2003; Badano et al., 2006a; Beales et al., 2003; 
Katsanis et al., 2001; Stoetzel et al., 2006). As a BBS-causative gene, MKS3 
mutations are thought to have an epistatic effect on BBS-associated loci (Leitch 
et al., 2008), i.e., whether BBS or another clinical outcome occurs is dependent 
on the genetic context of the mutation. It is apparent that making a genotype-
phenotype correlation is an incredibly complex issue, which cannot yet be 
resolved with the information currently available. 
 
The MKS2 and -3-encoded proteins 
 
The MKS2 locus is present within gene TMEM216 and and MKS3 is 
otherwise known as TMEM67, encoding TMEM216 and meckelin proteins, 
respectively (Smith et al., 2006; Valente et al., 2010). 
TMEM216 and meckelin are both considered to be transmembrane 
proteins. TMEM216 is a tetraspan transmembrane protein, a group of proteins 
characterised by four hydrophobic putative transmembrane domains (TM1 to 
TM4), forming two extracellular loops and one intracellular loop (Lee et al., 
2012; Valente et al., 2010), but this protein remains uncharacterised. Meckelin 
consists of a cleavable signal peptide, a 490-residue extracellular region 
followed by seven transmembrane regions, and a 30-residue cytoplasmic tail 
(Smith et al., 2006). The structure of the extracellular region and cytoplasmic tail 
are proposed to be likely indicators of a receptor function of this protein; 
however, despite topological similarity to the Frizzled receptors, there is limited 
sequence homology with this or any other proteins (Smith et al., 2006). 
Notably, TMEM216 and meckelin form a complex, as demonstrated by an 
immunoprecipitation study (Valente et al., 2010). This study revealed that 
TMEM216-GFP could be immunoprecipitated by meckelin antisera containing 
the N- and C-termini, and that anti-GFP could also pull down a C-terminus-
containing isoform of meckelin in a complex with TMEM216-GFP. These 
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proteins are now established to interact within a larger complex at the transition 
zone (Garcia-Gonzalo et al., 2011), which will be discussed in the next section.  
 
1.2 Building a cilium 
 
Ciliary structure – an overview 
 
Cilia are categorised as primary or motile, based on their structure and 
function. Cilia are sensory organelles, acting to detect the extracellular 
environment, participate in signal transduction to the inside of the cell and link 
diverse signalling pathways involved in cellular activities such as differentiation, 
migration and cell growth (Satir and Christensen, 2007; Satir et al., 2010). The 
primary cilium is presented on the outside of quiescent cells and resorbed 
during cell division. However, there is evidence that a transient cilium is re-
assembled and subsequently disassembled during G1/S-phase transition 
(Spalluto et al., 2013; Tucker et al., 1979a; Tucker et al., 1979b), but the exact 
nature of this cilium remains unknown. 
Motile cilia have additional roles in directing fluid flow. This is an important 
function, for instance, in developing left-right patterning at the embryonic node 
by generating leftward fluid flow to instigate signalling in primary cilia at the 
periphery of the node (Babu and Roy, 2013; Satir and Christensen, 2007), or 
lining the trachea, where they remove mucus from the lungs (Horvath and 
Sorscher, 2008; Jeffery and Reid, 1975; Sanderson and Sleigh, 1981; Shah et 
al., 2009). Multiple cilia are more likely to be present in higher numbers than 
flagella or primary cilia (Dawe et al., 2007a), at least in opisthokonts; the sperm 
of gymnosperm Ginkgo biloba, for instance, are multi-flagellated (Vaughn and 
Renzaglia, 2006). 
All cilia and flagella have a similar structure, consisting of a distinct, 
specialised membrane, the ciliary membrane, surrounding nine doublet 
microtubules (MTs). These extend from a centriole of nine triplet MTs, referred 
to as a basal body (Ishikawa and Marshall, 2011; Scholey, 2003).  
Figure 1.1 illustrates the structure of mammalian primary cilia in cross-
section, including the components of the transition zone, a region between the 
basal body and axoneme that is posited to act as a diffusion barrier (discussed 
later). Primary cilia have a 9+0 structure, meaning that they are lacking a 
24
FIGURE 1.1: Longitudinal and transverse structure of a human primary cilium. The 
cilium has a 9+0 microtubule-based axoneme, beginning as microtubule triplet 
pairs at the basal body (comprising mother and daughter centrioles), and tapering 
to microtubule singlets at the end of the axoneme. Separating the basal body from 
the transition zone are the transition fibres, which begin as distal appendages. 
Distal to this are the Y-links; these connect each microtubule doublet to the 
overlying membrane via the ciliary necklace, a set of intramembranous particles. 
The transition zone is proposed to enable selectivity of diffusion into the cilium, 
allowing the specialised ciliary membrane and axoneme to develop. Ciliary 
placement is demonstrated with respect to the ciliary pocket and plasma 
membrane (Adapted from Reiter et al., 2012).
Daughter
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Ciliary membrane
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central pair of MTs (i.e., not 9+2), and lack the dynein and nexin arms, radial 
spokes and central pair apparatus of motile cilia (Scholey, 2003). Figure 1.1 
also shows these structures in relation to the ciliary pocket, a region embedded 
within the plasma membrane. 
The basal body is, in the case of the primary cilium, derived from the 
mature centriole of the two, forming the microtubule organising centre (MTOC). 
Specifically, in the case of eukaryotic cells, this is referred to as the centrosome, 
and this is an important structure in cell division. When docked, the centrosome 
is known as a basal body, an analogous structure to the mother centriole 
(Chapman, 1998). Migration of the centrioles to the apical cell surface marks 
the start of ciliogenesis and is followed by association with vesicles (proposed 
to be post-Golgi) and acquisition of accessory structures. Abundant evidence 
implicates the actin-myosin network in this migration and docking (Dawe et al., 
2007a; Garcia-Gonzalo and Reiter, 2012). An MT axoneme is subsequently 
nucleated from the basal body then elongated to form a cilium through a 
process known as intraflagellar transport (IFT) (Ishikawa and Marshall, 2011; 
Rosenbaum and Witman, 2002), discussed later.  
 
Centriole migration 
 
The centriole is a 0.4-µm long, 0.2-µm diameter cylindrical arrangement of 
MT triplets arrayed with ninefold radial symmetry around a cylindrical core; 
these triplets consist of α– and β-tubulin heterodimers (Dawe et al., 2007a). An 
immature centriole, such as the daughter centriole, has a central rod linked to 
the inner tubule by spokes, referred to as the cartwheel (Vorobjev and 
Nadezhdina, 1987). The mature (mother) centriole acquires distal and subdistal 
appendages (Paintrand et al., 1992) with various cellular roles, including in 
docking the centrosome. The mother and daughter centriole, along with a 
surrounding dense mass of pericentriolar material (PCM) comprise the 
centrosome (Dawe et al., 2007a). 
Centrosome position is tightly regulated across multiple cellular contexts, 
based on polarity cues. These can be factors such as cell shape or extracellular 
signals, which are then transduced through the partitioning (Par) proteins and 
the Rho GTPases (Goldstein and Macara, 2007). Par proteins and the Rho 
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GTPases then interact with the cytoskeleton in order to effect this established 
cell polarity (Cowan and Hyman, 2007).  
To initiate cilium formation, the centrioles migrate to the plasma membrane, 
through a cytoskeleton-dependent mechanism; this movement also appears to 
be dependent on a number of centrosomal proteins, such as TALPID3 (Stephen 
et al., 2013). Notably, TMEM216 and meckelin are necessary for this stage of 
ciliogenesis. Cells with an siRNA knockdown of TMEM67 (Dawe et al., 2007b) 
and TMEM216, and two different patient fibroblast cell lines with mutations in 
TMEM216 (Valente et al., 2010) all display defects in ciliogenesis and, 
specifically, in centriole migration and docking at the apical cell surface. This 
process has a proposed link to the actin cytoskeleton, and these MKS proteins 
may be directly involved in centrosome migration during ciliogenesis via action 
on the cytoskeleton (Abdelhamed et al., 2015; Dawe et al., 2007b; Valente et 
al., 2010). Recent evidence also supports a role of meckelin in basal body 
positioning in Paramecium (Picariello et al., 2014), suggesting a conserved role 
of these proteins. 
Centriole repositioning is necessary not only for ciliogenesis, but also for 
cell motility; wounded monolayers of endothelial cells, for example, exhibit 
MTOC reorganisation between the nucleus and leading edge in 80% of cells 
within 4 hours of wound formation (Gotlieb et al., 1981). In migrating newt 
eosinophils, U2OS and PtK2 cells, irradiation-induced centrosome removal led 
to loss of cell polarisation during directed cell migration, likely linked to 
concurrent actin- and MT-based changes (Koonce et al., 1984; Wakida et al., 
2010). The MKS2 patient cells examined in this thesis demonstrate centrosome 
positioning defects (Valente et al., 2010), and siRNA knockdown of TMEM67 in 
IMCD3 cells inhibits the apical positioning of centrosomes (Dawe et al., 2007b), 
as previously mentioned.  This is of note as, in unpublished work, these patient 
lines have been shown to have motility defects; in a wound healing assay, 
MKS2- and MKS3-mutated patient cells demonstrated aberrant migratory 
capabilities through defects in speed and directionality (Barker and Dawe, 
unpublished). These data may implicate cell migratory defects underlying errors 
during embryonic development. Moreover, this implies that problems in 
centrosome positioning may precede or cause these, or a number of other 
defects. For additional information on centrosome repositioning, see 
Appendix 1: Centrosome positioning in non-dividing cells. 
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The cytoskeleton is involved during centrosome reorientation and docking. 
MTs are known to position the centrosome during interphase in a dynein-
dependent manner (Burakov et al., 2003) and centriole movement to the cell 
surface is accompanied by loss of radial MT organisation (Rieder et al., 2001). 
There is also substantial evidence implicating involvement of the actomyosin 
network; actin and myosin are known to be associated with the centrioles or 
centriolar material (Lemullois et al., 1988; Lemullois et al., 1987), and actin- or 
myosin-blocking drug treatments prevent centriole migration in ciliogenic 
oviducts (Boisvieux-Ulrich et al., 1987; Boisvieux-Ulrich et al., 1990). 
Furthermore, interrupting actin remodelling prevents basal body docking (Pan et 
al., 2007). Precise regulation of the actin cytoskeleton is critical to facilitate 
ciliogenesis, for instance through stabilisation of the pericentrosomal preciliary 
compartment by blocking actin assembly at specific subcellular locations (Kim 
et al., 2010).  
The underlying signalling pathways for centrosome reorientation during 
primary cilium development are slowly being revealed, principally in links to the 
cytoskeleton. Foxj1 appears to be involved; Foxj1-null mice display aberrant 
centriole migration (Brody et al., 2000), and Foxj1, dependent on the presence 
of a cilium, modulates the responsiveness of cells to Shh signalling (Cruz et al., 
2010).  
As previously mentioned, the Rho GTPases and Par proteins are necessary 
for centrosome repositioning during both migration and ciliogenesis. For 
example, in order for the centrosome to reposition in C. elegans, Rho1 
regulates actomyosin-dependent movement of the centrosome, while Cdc42 
enables interaction between the actin cortex and the Par proteins (Cowan and 
Hyman, 2007). In astrocytes, cell polarity determinants, including Cdc42 and the 
Par proteins, control centrosome and Golgi orientation in the direction of 
migration, organised in this way to ensure vesicular trafficking in the correct 
direction (Cau and Hall, 2005). This is known to occur via a complex consisting 
of Par6, Par3 and atypical protein kinase C (aPKC) (Etienne-Manneville and 
Hall, 2001). This aPKC complex also localises to cilia and participates in 
ciliogenesis by promoting ciliary membrane development (Krock and Perkins, 
2014), and intraflagellar transport (Rosenbaum and Witman, 2002; Scholey, 
2003), a process discussed in a subsequent section. Inhibition of the activity of 
this protein complex has been reported to cause a reduction in cilia number and 
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size in zebrafish photoreceptors, leading to left-right asymmetry defects (Krock 
and Perkins, 2014). Moreover, Par1 and aPKC have also been revealed to 
promote and inhibit ciliated cell fates in the developing Xenopus ectoderm, 
respectively (Ossipova et al., 2007), illustrating their powerful influence in cells.  
In fibroblasts, the centrosome must remain at the cell centre and the 
nucleus moves in a dynein-dependent manner (Dujardin et al., 2003; Gomes et 
al., 2005; Levy and Holzbaur, 2008); for additional details on the nucleus-
centrosome interaction, see Appendix 1. MTs anchored to the actin cortex are 
thought to be partially responsible for centrosome positioning by exerting pulling 
forces; myosin and moesin impart the necessary rigidity on the actin cortex for 
this to occur (Tang and Marshall, 2012), illustrating a necessity of cross-talk 
between the actin and MT cytoskeleton for centrosome repositioning. 
It is apparent that the cytoskeleton is necessary for centrosome movement 
during ciliogenesis and cell migration; however, it is unclear how the association 
of the centrosome with other organelles, such as the Golgi complex, relates to 
centrosome repositioning. The Golgi is necessarily positioned to enable 
appropriately directed vesicular trafficking; that is, at the minus ends of 
microtubules and typically surrounding the centrosome, as it is transported here 
via microtubule motor proteins (Ho et al., 1989; Thyberg and Moskalewski, 
1999). This is so organised in order that ciliary components are trafficked to the 
ciliary base and membrane during cilium biogenesis. In most cell types and 
contexts, microtubule cytoskeleton organisation, controlled by polarity 
determinants and centrosome position, is presumed to affect Golgi position. 
However, the Golgi complex is also known to nucleate a subset of microtubules 
used in migration (Chabin-Brion et al., 2001; Miller et al., 2009), and 
reorientation of the Golgi and centrosome can be independently controlled 
(Magdalena et al., 2003). Furthermore, it has been reported by a previous study 
that blocking Golgi reorientation can prevent centrosome reorientation (Bisel, 
2008), suggesting that movement of other organelles may be an overlooked 
factor in centrosome repositioning. 
 
Basal body docking 
 
In order to initiate axoneme MT polymerisation for ciliary elongation 
(Lemullois et al., 1988; Satir and Christensen, 2007), basal bodies must dock 
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either with the plasma membrane [in a number of epithelial cells (Sorokin, 
1962)], or with Golgi-derived ciliary vesicles [in smooth muscle and other 
epithelial cells (Sorokin, 1968; Sotelo and Trujillo-Cenoz, 1958)]. Docking is 
thought to be mediated by distal appendages, the precursors for transition fibres 
(Anderson, 1972), which are discussed later. Fusion of additional vesicles 
enables ciliary growth into the extracellular medium (Sorokin, 1962).  
Focal adhesion proteins FAK, Paxillin and Vinculin, interact in complexes 
with the actin cytoskeleton to enable cell migration. Furthermore, integrin, 
another focal adhesion component, interacts with the extracellular matrix during 
astrocyte cell migration to activate and effect the polarised recruitment of Cdc42 
(and thus the mPar6/PKC complex) at the leading edge (Etienne-Manneville 
and Hall, 2001). All of these proteins are additionally required for basal body 
migration, docking, and spacing, suggesting that focal adhesion complexes also 
participate in tethering the centrosome to the cortical actin cytoskeleton in a 
variety of cellular contexts (Antoniades et al., 2014).  
All cilia are extended from a single basal body, or numerous basal bodies in 
the case of multi-ciliated cells (Dawe et al., 2007a). Multi-ciliated cells do not 
use typical centriolar duplication; instead basal bodies develop from the pre-
existing progenitor daughter centrosome, which nucleates deuterosomes in a 
cartwheel-shaped structure. The resultant procentrioles grow synchronously 
before detaching from each other, following which they migrate and dock as 
usual (Al Jord et al., 2014). 
During migration and docking, basal bodies in primary cilia retain an 
associated procentriole daughter, and acquire a plethora of accessory 
structures. For instance, Cep164, a centrosomal protein that is required for 
vesicle docking, recruits and acts as a substrate of Tau tubulin kinase 2 (TTK2), 
an enzyme involved in distal appendage assembly during primary ciliogenesis 
(Cajanek and Nigg, 2014; Carvalho et al., Cilia 2014 conference (unpublished); 
Schmidt et al., 2012). This Cep164-TTK2 interaction, in addition to recruitment 
of proximal end centriolar satellites such as Cep135 and WDR8, are essential in 
removal of a proximal CP110 cap, a requirement for axoneme extension 
(Kurtulmus et al., 2015; Oda et al., 2014). 
Membrane trafficking to the primary cilium, inclusive of the ciliary vesicle, is 
crucial for basal body docking and ciliary elongation. A number of centriolar 
satellites, such as Cep164, Chibby and Talpid3 are recruited and form 
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structures at the distal end of the basal body, which then recruit and activate the 
Rab pathway components in order to form the ciliary vesicle (Burke et al., 2014; 
Kobayashi et al., 2014). Small GTPases, such as Rab8, are involved in sorting, 
docking and fusion of post-Golgi vesicles or recycling endosomes containing 
ciliary proteins at the periciliary membrane of the ciliary base (Li and Hu, 2011; 
Lim et al., 2011; Nachury et al., 2010; Pazour and Bloodgood, 2008; 
Rosenbaum and Witman, 2002; Wei et al., 2015).  
Defects in components involved in formation of the ciliary vesicle have also 
been connected to ciliopathy. CC2D2A, a protein altered in some forms of MKS 
and Joubert syndrome, functions with the centrosomal protein NINL in Rab8-
regulated ciliary vesicle docking; knockdown of cc2d2a or ninl in zebrafish leads 
to vesicular accumulation and mislocalisation of Rab8, in addition to retinal 
defects that are reminiscent of symptoms of Joubert syndrome (Bachmann-
Gagescu et al., 2015). Furthermore, EXOC8, a Joubert syndrome-causative 
gene, and EXOC4, a novel MKS candidate gene encoding Sec8, encode 
proteins involved in the exocyst, a structure involved in vesicular trafficking to 
the basal body (Dixon-Salazar et al., 2012; Shaheen et al., 2013). Deletion in 
zebrafish of the Joubert syndrome-contributory interactors of these, Sec10 and 
Arl13b, leads to the cystic kidney and decreased ciliogenesis phenotypes 
observed in ciliopathy patients (Seixas et al., 2016), illustrating the necessity of 
appropriate vesicular trafficking in ciliogenesis. 
A number of studies have been conducted regarding the signalling 
responsible for basal body docking and ciliary vesicle formation. Anchoring of 
the basal body at the plasma membrane has been linked to planar polarity 
pathway components inturned (Park et al., 1996) and fuzzy (Collier and Gubb, 
1997) through their control of the actin array. Similarly, cytoskeletal calpain, a 
protease appearing downstream of Foxj1 and acting on actin-plasma 
membrane linker protein ezrin, regulates basal body anchoring to the apical 
cytoskeleton (Gomperts et al., 2004). Cdc42, a downstream effector of the 
Ca2+-dependent Wnt signalling pathway, is reportedly required for exocyst 
fusion at the base of the primary cilium, effecting ciliogenesis (Zuo et al., 2011); 
notably, knockdown of Cdc42 attenuates vesicular trafficking to the primary 
cilia, leading to ciliogenesis defects and polycystic kidney disease (Choi et al., 
2013). 
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Mutation or loss of many ciliopathy-associated proteins therefore causes 
defects in the beginning stages of ciliogenesis (Reiter et al., 2012), such as in 
ciliary vesicular trafficking (Fan et al., 2004; Hsiao et al., 2009) and basal body 
anchoring (Huang et al., 2011; Valente et al., 2010; Williams et al., 2011), 
indicative of the importance of these stages in directing appropriate embryonic 
development.  
 
The basal body and the transition zone 
 
The structurally-unique region separating the basal body and the axoneme 
is called the transition zone (TZ). The TZ contains a number of important ciliary 
structures and proteins with vital roles in ciliary function, such as in recruiting 
IFT components and regulating ciliary composition (Christensen et al., 2012; 
Garcia-Gonzalo and Reiter, 2012).  
In mammalian cells, disruption of the TZ causes plasma membrane proteins 
GFP-CEACAM1 and GFP-GPI to aberrantly accumulate inside the cilium (Chih 
et al., 2012); this illustrates how crucial this structure is in maintaining a 
specialised region within the cilium. Furthermore, emerging bioinformatic 
evidence has demonstrated that TZ complex proteins are restricted to the 
proteomes of ciliated organisms (Barker et al., 2014a), implying a necessity of 
these proteins in ciliary function. The TZ is therefore the focus of a large 
proportion of research into ciliary function. The localisation of the TZ within the 
cilium is shown in Figure 1.1. 
Complicating the proposed role of the TZ, the primary cilium has no basal 
plate, meaning the boundaries of TZ are harder to define. In primary cilia, the Y-
links extend further into the cilium than in motile cilia, meaning the entire 
primary cilium has been proposed to be analogous to the transition zone of 
motile cilia (Rohlich, 1975). 
An important feature of primary cilia is compartmentalisation, which is 
achieved through its distinct membrane composition and regulated protein 
transport. The regulation of protein entry and exit is thought to be via a ‘ciliary 
gate’ which prevents non-specific movement of protein and allows it to remain a 
privileged domain for appropriate modulation of certain signalling pathways 
(Garcia-Gonzalo and Reiter, 2012; Hu et al., 2010; Reiter et al., 2012).  
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Various structures and systems are proposed to make up this ‘ciliary gate’, 
including the ciliary necklace and Y-links (in the TZ), transition fibres (displayed 
in Figure 1.1) and a septin ring (at the periciliary region) and nucleocytoplasmic 
transport machinery (Reiter et al., 2012).  
At the ciliary base, a “ciliary pore complex” is thought to be present, and is 
proposed to be analogous to the nuclear pore complex. The nuclear pore 
excludes passage of proteins greater than a certain size, unless bound to 
importins or exportins, which recognise their targets using nuclear localisation 
signals (NLSs) or export sequences (NESs) (Garcia-Gonzalo and Reiter, 2012). 
Similarly, importin binding to an NLS-like ciliary localisation sequence (CLS) is 
required for some proteins to accumulate inside cilia, such as the kinesin Kif17 
(Garcia-Gonzalo and Reiter, 2012).  
Transmembrane proteins, unlike peripheral membrane proteins, must enter 
ciliary membranes by moving laterally from the periciliary membrane; as 
diffusion barriers often separate these, it is suggested that machinery engaging 
CLSs in the cargo facilitates this process (Chih et al., 2012; Hu et al., 2010). 
The ciliary pore complex is mechanistically disparate from both the proximal 
(closest to the nucleus) axoneme and from the nuclear pore complex (Breslow 
et al., 2013). 
The most proximal accessory structures associated with the centriolar 
barrel are the subdistal appendages and basal foot, and the distal appendages 
beyond these (which mature into the transition fibres) (Reiter et al., 2012).  
Ninein is a component of the basal foot, which is recruited by Odf2. 
Together, these promote centrosomal MT docking and nucleation (Delgehyr et 
al., 2005; Ishikawa et al., 2005). Odf2 has multiple splicing variants which cause 
this protein to localise to a variety of points along the basal body and ciliary 
axoneme. One Odf2 splicing variant, Cenexin1, localises to the distal/subdistal 
appendages and is essential for ciliogenesis (Chang et al., 2013), indicative of 
the necessity of these structures in building a cilium. MKS6 protein product 
CC2D2A is also essential in the assembly of subdistal structures in a number of 
species; Cc2d2a -/- mouse embryonic fibroblasts lack cilia, Odf2 and 
(concordantly) ninein is reduced (Veleri et al., 2014), implying a structural or 
regulatory role of this MKS protein at the subdistal structures. However, mks-6 
mutant TZ ultrastructure appears normal in C. elegans, indicating that disruption 
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of specific components, such as the MKS proteins, at the base of the cilium 
does not necessarily lead to total loss of the TZ (Williams et al., 2011). 
The transition fibres (Figure 1.1) are located at the distal end of the basal 
body and serve as the main membrane attachment point for the basal body, as 
a site of protein target [including target by IFT particles (Deane et al., 2001) and 
septin, which functions in an actin-regulated diffusion barrier at the ciliary base 
proximally to the transition fibres (Francis et al., 2011; Hu et al., 2010)], and as 
a physical block to transport. Electron micrographs suggest that inter-fibre 
spaces are too small for vesicles to traverse - about 60 nm in diameter - which 
could fit large protein complexes, but not vesicles (Nachury et al., 2010; Reiter 
et al., 2012). Large proteins thus require active transport to enter the cilium, but 
not for movement around the cilium (Breslow et al., 2013; Takao et al., 2014). 
The TZ begins distally to the transition fibres (although certain definitions 
include these as a TZ constituent), characterised by Y-links connecting the 
doublet MTs to the overlying membrane at the ciliary necklace (Figure 1.1A) 
(Reiter et al., 2012). These are also structures believed to be involved in a 
permeability barrier or ‘smart filter’, restricting membrane and soluble proteins 
based on CLSs; Chlamydomonas reinhardtii and C. elegans mutants lacking Y-
links fail to accumulate proteins correctly in the ciliary membrane and MKS4-
encoded protein CEP290 is essential for Y-link formation in C. reinhardtii 
(Craige et al., 2010; Garcia-Gonzalo et al., 2011; Garcia-Gonzalo and Reiter, 
2012). However, the exact biochemical nature of Y-links is unknown. 
Genetic and biochemical analysis in C. elegans, mouse and human models 
have identified two major protein modules located within the TZ protein 
interaction network, as indicated in Figure 1.2. These are the NPHP module and 
the MKS module, predominantly comprising proteins established to contribute 
primarily to NPHP or MKS, respectively. MKS proteins have been indicated in 
yellow, for ease of analysis. Briefly, the NPHP module proteins are proposed to 
interact with the axonemal MTs, and MKS module proteins with the ciliary 
membrane. These modules are hypothesised to also interact with the Y-links at 
the TZ, but only CEP290 is confirmed to be a structural component of these. 
CEP290 also appears to be a vital protein in tethering the flagellar transition 
zone to the ciliary membrane (Craige et al., 2010; Yang et al., 2015). Notably, 
RPGRIP1L function is crucial for the integrity of the TZ, and is thought to 
promote its assembly (Blacque and Sanders, 2014; Garcia-Gonzalo and Reiter, 
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FIGURE 1.2: Proposed protein interaction network within the TZ, indicated by 
human gene names, and deduced through biochemical and genetic analysis in 
human, mouse and C.elegans models. The NPHP and MKS modules 
predominantly comprise NPHP- and Joubert syndrome-/MKS-associated proteins, 
respectively. Coded as follows: yellow, MKS-associated; blue, key components of 
the NPHP/MKS modules not associated with MKS; grey, MKS-associated but with 
unknown localisation/interactors; red outline, vital component for 
assembly/maintenance of TZ; and black lines, protein-protein interaction. The 
NPHP and MKS modules are proposed to interact with the MTs or staggered along 
the ciliary membrane, respectively. Proteins from both modules are proposed to 
interact with the Y-links, which may have CEP290 as a crucial component. 
RPGRIP1L is hypothesised to promote TZ assembly. TZ, transition zone; MT, 
microtubule. Sources: Blacque and Sanders, 2014; Jensen et al., 2015; 
Garcia-Gonzalo and Reiter, 2012; OMIM and UniProt, 2015; Yee et al., 2015.
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2012; Jensen et al., 2015; OMIM and UniProt, [accessed 2016]; Yee et al., 
2015). It is of note that the localisation of meckelin to the TZ is additionally 
supported by the presence of an X-box domain within this protein (Smith et al., 
2006), which is characteristic of a ciliary protein (Efimenko et al., 2005). 
The protein modules are proposed to be anchored together by MKS-
5/RPGRIP1L. Taken together with evidence that Y-links are lost in 
MKS/MKSR/NPHP double mutants, these data imply that a number of these 
proteins may represent elements of the Y-link/ciliary necklace structures 
anchoring axonemal MTs to the ciliary membrane and functioning as a ciliary 
gate (Williams et al., 2011). In support of this, bioinformatics have revealed a 
correlation between absence of TZ proteins and lack of Y-links, implicating the 
MKS proteins as structural components or regulators of Y-links (Barker et al., 
2014a). 
The separation into modules simplifies our understanding of associated 
ciliopathies; these are likely disorders of larger, synergistic molecular 
complexes with partial functional redundancy and a common biological function. 
In C. elegans, for instance, at least one protein from each complex must be 
abrogated in order to display a phenotype, except in the case of RPGRIP1L 
(Williams et al., 2011). However, in mammalian models, mutation of a single 
gene is sufficient (Barker et al., 2014b). 
TMEM216 and TMEM67 have been visualised at the basal body/TZ of the 
primary cilium (Abdelhamed et al., 2013; Adams et al., 2012; Valente et al., 
2010). However, aside from localising to the basal body and ciliary membrane, 
TMEM216 and TMEM67 also localise to the endoplasmic reticulum, Golgi and 
cytoplasmic vesicles (Lee et al., 2012; Wang et al., 2009), in addition to the 
actin cytoskeleton (Adams et al., 2012). This could simply represent production 
and transport within the cell, or may be indicative of alternative roles of these 
proteins or different isoforms of these proteins within the cell, such as in 
vesicular trafficking, signal transduction and/or cytoskeletal remodelling. 
In support of alternative cellular roles of ciliary proteins, several BBS 
proteins, including the basal body component BBS4, and OFD1 interact with 
proteasomal subunits (Gerdes et al., 2007; Liu et al., 2014). Moreover, BBS11 
mutation reportedly affects the B-box domain of TRIM32, a ubiquitin ligase 
involved in proteasomal degradation of actin through interaction with myosin 
(Kudryashova et al., 2005; Locke et al., 2009). It has been suggested that basal 
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body proteasomal regulation regulates certain paracrine signalling pathways 
(Liu et al., 2014), indicating possible extra-ciliary sources of unexplained 
signalling defects. 
 
Intraflagellar transport, trafficking into the cilium and ciliogenesis 
 
Subsequent to centrosomal docking, the ciliary axoneme extends using 
intraflagellar transport (IFT). IFT involves continuous, bidirectional movement of 
membrane-bound particles, driven by the MT motors cytoplasmic dynein and 
kinesin-2 associated with two subcomplexes, IFT-A and IFT-B. IFT-A is used in 
retrograde transport to the ciliary base and IFT-B is used in anterograde 
transport to the ciliary tip. IFT is also involved in ciliary maintenance, 
disassembly and signalling (Garcia-Gonzalo and Reiter, 2012; Ishikawa and 
Marshall, 2011). For instance, IFT20 is localised to the basal body and the 
ciliary axoneme however, this is also found at the Golgi complex. IFT20 
particles are vitally involved in ciliogenesis through appropriate delivery of ciliary 
membrane proteins via the Golgi (Follit et al., 2006), illustrating the necessity of 
appropriate trafficking in ciliogenesis. Loss of IFT proteins typically leads to 
ciliogenesis defects and, resultantly, ciliopathy phenotypes (Bhogaraju et al., 
2013; Bujakowska et al., 2015; Lee et al., 2015; Williams et al., 2014).  
Numerous immunofluorescence studies indicate that IFT proteins, such as 
IFT52 and IFT46, IFT-B protein complexes, are in two pools at the ciliary base, 
only one of which is involved in transport. These pools are below the TZ and at 
the juncture at which the ciliary membrane and periciliary membrane attach, 
particularly around the transition fibre attachment region (Buisson et al., 2013; 
Deane et al., 2001; Lee et al., 2015; Reiter et al., 2012; Sedmak and Wolfrum, 
2010; Sedmak and Wolfrum, 2011; Williams et al., 2011).  
The IFT complex is a large, multimeric complex, with a number of 
components greater than 100kDa. Many of its cargoes, such as dynein, are also 
large complexes. These are reported to be assembled prior to entering the 
ciliary axoneme and are thought to be actively transported into the cilium 
through the “ciliary pore complex” (Wei et al., 2015). IFT recruitment to basal 
bodies and entry of IFT particles into the flagella of Chlamydomonas are 
dependent both on correct actin organisation and myosin function, implicating 
the cytoskeleton in flagellum and, likely, cilium assembly (Avasthi et al., 2014).  
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IFT particle movement within the ciliary axoneme occurs on a restricted set 
of MTs – fast IFT particles observed in the ciliary axoneme have frequently 
been demonstrated to fuse with slower ones – and IFT particles are reused 
upon returning to the ciliary base (Buisson et al., 2013). 
When the final steady state of the cilium is reached, IFT machinery, 
powered by molecular motors, transports cargo, such as tubulin (Craft et al., 
2015), up and down the axoneme. IFT particles also turn over proteins, 
including signalling proteins, in a compartment at the distal tip (He et al., 2014; 
Ishikawa and Marshall, 2011; Pedersen and Rosenbaum, 2008; Rosenbaum 
and Witman, 2002). 
Ciliary import of membrane proteins is dependent on polarised exocytosis 
adjacent to the basal body (Nachury et al., 2010; Pazour and Bloodgood, 2008; 
Rosenbaum and Witman, 2002). The cilium itself has also been proposed to 
secrete ectosomes, vesicles containing proteolytic enzymes, and is thought to 
be a source of bioactive molecules (Wood et al., 2013). However, the 
significance of ectosomes in cellular behaviour, is a relatively unexplored area 
of research. 
Previous studies reported that six ESCRT proteins, involved in ubiquitinated 
protein transport, abscission of the midbody in cytokinesis and budding of 
vesicles from the cell surface, could be identified within the TZ proteome of 
Chlamydomonas. These data importantly imply an involvement of ESCRT 
proteins and membrane trafficking machinery in the function of TZ complex 
proteins or associated complexes (Diener et al., 2015). 
The role of the TZ complex proteins in ciliogenesis, inclusive of the MKS 
proteins, appears predominantly to be in regulating entry of appropriate proteins 
and lipids into the ciliary membrane through correct trafficking function of the 
ciliary gate (Aldahmesh et al., 2014; Chih et al., 2012; Garcia-Gonzalo et al., 
2011; Roberson et al., 2015; Szymanska et al., 2014). Rab8GTP, for instance, 
contacts the BBSome and promotes ciliary elongation, but inhibiting Rab8GTP 
leads to typical BBS phenotypes, suggesting that BBS may result from a 
vesicular trafficking defect (Nachury et al., 2007). This also begs the question of 
whether ciliary vesicular trafficking machinery is used beyond the cilium, as 
implied in the above evidence of IFT20 function in the cilium and at the Golgi. In 
additional support of this, partial knockdown of IFT27 in Chlamydomonas led to 
cytokinesis defects and knockout led to lethality (Qin et al., 2007). Similarly, in 
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vertebrates, IFT20, IFT88, and IFT57 form a complex in T cells, despite the fact 
that these cells do not build cilia (Finetti et al., 2009). Here, the IFT proteins are 
functioning at the immunological synapse. 
Forming an immunological synapse is a process considered to be 
analogous to ciliogenesis, similarly requiring centrosomal migration and docking 
at the plasma membrane, Golgi rearrangement and effective vesicular  
trafficking, and rearrangement of the actin and MT cytoskeletons (Appendix 1; 
Griffiths et al., 2010). At the immune synapse, IFT components, such as IFT20, 
used in ciliogenesis are also used to effect endocytosis and exocytosis (Finetti 
et al., 2009). Furthermore, Cdc42 and the Par proteins, previously discussed in 
the context of polarity determination, are also implicated in formation of this 
region (Ludford-Menting et al. 2005). The immunological synapse is thus a site 
of interest, particularly as centrosome docking appears to be concomitant with 
designating a specialised membrane in this region (Griffiths et al., 2010). A 
compartmentalised membrane is a crucial feature for proper ciliary function, 
also implying that centrosome migration and docking are of particular 
importance when studying ciliary dysfunction. 
 
Cellular phenotypes in animal models of MKS 
 
Multiple examples exist of animal models of MKS mimicking the cellular 
features observed in patient cells, such as the aberrant basal body migration 
reported in the Tmem67tm1Dgen/H1 knockout mouse (Abdelhamed et al., 2015). 
However, evidence has been reported of mouse/rat models with normal docking 
of the basal body in MKS1 mutants (Weatherbee et al., 2009) or shortened or 
over-abundant cilia in MKS1 and -3 mutants (Tammachote et al., 2009), and of 
C. elegans mks-3 null mutants with no obvious ciliogenesis defects (Williams et 
al., 2011). Furthermore, structurally normal cilia have been revealed in a B9D1-
null zebrafish mutant, although these cilia did not correctly signal or have 
correct protein localisation, implying a functional role of this gene in targeting 
proteins to the cilium or regulating their access (Dowdle et al., 2011). One study 
of zebrafish tmem67 morphants and tmem67-null (bpck) mice revealed 
developmental abnormalities (including renal, skeletal and eye abnormalities) 
associated with ciliopathy and dysfunctional cilia, but no global loss of 
ciliogenesis, basal body docking or Wnt/planar cell polarity signalling, indicating 
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that developmental abnormalities may be attributed to elevated proliferation 
(Leightner et al., 2013). Discrepancies have been ascribed to the use of 
different species as models, different types of mutation (as these may lead to 
phenotypes of varying severity) or the differences in tissue or cell type used 
(Norris and Grimes, 2012). 
It is possible that MKS proteins have a role in signalling. Based on the 
variability of effects of MKS mutations in animal models on ciliary structure, 
cilium-dependent signalling and disease-associated tissue defects, it is also 
possible that MKS mutations simultaneously lead to a number of subcellular 
changes. These may include failure to build a cilium, failure of the TZ to 
compartmentalise, or other alterations that result in global perturbation of signal 
transduction pathways. In support of a hypothesised role of MKS proteins 
beyond signalling alone, these are known to have evolved long before 
vertebrate developmental signalling (Barker et al., 2014a). Developmental 
signalling was not their earliest role, and is thus unlikely to be their only role 
now. 
There is also evidence of extra-ciliary roles of proteins associated with 
ciliopathy. For instance, mutations in Atmin, a DNA damage protein and 
transcription factor, lead to shortened cilia; mutant mice also develop defects in 
Wnt/PCP-modulated oriented cell division (Goggolidou et al., 2014b) and 
proteasomal degradation (Gerdes et al., 2007). Furthermore, meckelin at the 
endoplasmic reticulum participates alongside other cytosolic machinery in the 
degradation of surfactant protein SP-C proprotein (Wang et al., 2009), indicating 
the potential of additional, TZ-independent roles of MKS proteins. 
  
1.3 Cilium-dependent signalling 
 
Vesicular trafficking initially contributes transmembrane proteins and lipids 
to ciliogenesis, and is subsequently used for cilium maintenance and cilium-
dependent signalling (Nachury et al., 2010). Cilia are only able to effect their 
primary function, signalling, due to a selective, biochemically-specialised and 
segregated membrane (Wei et al., 2015).  
Signalling pathways underlying ciliogenesis are not fully understood, but it 
is known that components of the non-canonical Wnt/planar cell polarity (PCP) 
pathway modulate correct localisation and posterior tilting of cilia in zebrafish 
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(Borovina et al., 2010), Xenopus (Park et al., 2008) and mice (Hashimoto et al., 
2010). These processes are linked to developmental defects, such as aberrant 
neural tube closure (Gray et al., 2009; Park et al., 2006). 
MKS mutants display phenotypes indicative of alterations to developmental 
signalling pathways, including Hedgehog (Hh) and Wnt signalling. The role of 
cilia in Hh signalling is fairly well-accepted (Gerdes et al., 2009), whilst their role 
in the canonical and non-canonical Wnt signalling pathways remains 
controversial (Wallingford and Mitchell, 2011). 
 
Hedgehog signalling 
 
In mammals, there are three Hh signalling pathways, governed by three 
different ligands. These act as mitogens and as morphogens by determining 
whether Hh pathway genes are transcribed or repressed to effect downstream 
function, particularly during development. The best studied of these is Sonic 
hedgehog (Shh), which controls the number and identity of digits (Buxton et al., 
2004). The necessity of a cilium in regulating this signalling pathway, as 
detailed below, therefore means that the loss of a cilium has obvious 
implications in the development of the limb bud, and can easily be linked with 
the polydactyly observed in ciliopathies. 
Figure 1.3 illustrates how Hh signalling is transduced through the cilium. 
Briefly, in the absence of Hh ligand, transmembrane Patched (Ptch) receptor, 
prevents repressed seven transmembrane protein Smoothened (Smo) from 
entering the ciliary membrane. Glioma (Gli) proteins are proteolytically 
processed and Gli activator remains in the cilium, bound to Sufu, until it is 
proteasomally degraded. Simultaneously, Gli repressor enters the nucleus and 
prevents the transcription of Hh pathway genes (Berbari et al., 2009; Nozawa et 
al., 2013). 
Upon Hh binding, however, Ptch leaves the cilium and accumulates in 
vesicles in the cytosol. This allows the activation of Smo, causing its ciliary 
accumulation, and promotes cleavage of Gli proteins. Gli activators use IFT to 
translocate to the nucleus, activating target gene transcription (Berbari et al., 
2009; Gerdes et al., 2009; Nozawa et al., 2013).  
Hh signalling activity at the immunological synapse is another example of 
this behaving as a modified cilium. At the immunological synapse, Hh signalling 
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FIGURE 1.3: In vertebrates, components of the Hedgehog (Hh) pathway localise 
to the cilium. (A) In the absence of Hh ligand, Ptch receptor remains in the cilium 
and inhibits transmembrane protein Smo from accumulating on the ciliary 
membrane. Gli proteins are then proteolytically processed; Sufu binding prevents 
transcription by the activator form of Gli, whilst the repressor forms of Gli inhibit Hh 
target gene transcription in the nucleus. (B) Upon Hh binding, Ptch leaves the 
cilium, alleviating its inhibition of Smo. Activated Smo is recruited to the ciliary 
membrane, promoting cleavage of full-length Gli and producing Gli activators. 
Through intraflagellar transport, Gli activators translocate to the nucleus, activating 
Hh target gene expression. Adapted from Berbari et al., 2009; Nozawa et al., 2013. 
42
is activated upon T-cell receptor activation, triggering Rac1 synthesis and 
concomitant actin remodelling, centrosome reorientation and vesicular granule 
release (de la Roche et al., 2013) 
Components of this pathway localise to and are transduced through the 
cilium (Haycraft et al., 2005; May et al., 2005) (Figure 1.3). Ciliary accumulation 
of Hh components is not necessary for Hh pathway activation; however, 
transduction at the cilium is necessary for appropriate regulation of this pathway 
(Fan et al., 2014). A number of centrosomal and IFT proteins, in allowing 
appropriate transduction of this pathway, thus affect both ciliogenesis and Hh 
signalling; this has been demonstrated in studies of Talpid3 (Yin et al., 2009), 
OFD1 (Ferrante et al., 2006), Arl13b (Caspary et al., 2007), Kif3a and IFT172 
(Huangfu and Anderson, 2005), amongst many others. 
Certain MKS-related phenotypes are consistent with Hh pathway defects, 
such as neural tube dorsalisation, which is concordant with decreased Gli2 
activity (Dowdle et al., 2011). Analysis of developmental abnormalities in MKS1 
loss-of-function mouse mutants demonstrated that a number of these defects 
(for instance, patterning of the neural tube and limb) are in response to 
disrupted, cilium-dependent Shh signalling. Cells in the neural tube, for 
instance, have a reduced response to high levels of Shh. MKS1 acts 
downstream of Ptch1, through the Gli proteins, to regulate spatial patterning of 
the neural tube and limb bud (modulating ventral and posterior signalling, 
respectively). However, a number of defects (such as in the liver and kidney) 
cannot be attributed to altered Hh signalling (Weatherbee et al., 2009). 
A TMEM67 (MKS3) mouse model demonstrating variable neurological 
features associated with a loss of primary cilia also displayed diminished Shh 
signalling and perturbed canonical Wnt/β-catenin signalling, associated with 
hyperactive Dishevelled-1 (Dvl-1) at the basal body. This evidence supported 
an interaction between not only the Hh signalling pathway and TMEM67, but 
between Dvl and TMEM67 (Abdelhamed et al., 2013). 
 
Wnt signalling 
 
The Wnt signalling pathway is involved in cell growth, polarity and fate 
determination, enabled in part due to divergence into three different pathways, 
canonical/β-catenin dependent, and two non-canonical/β-catenin-independent 
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pathways: planar cell polarity (PCP) and Wnt/calcium (Kikuchi et al., 2009). It is 
also heavily implicated in the development of cystic kidney disease in a number 
of ciliopathies (Goggolidou et al., 2014a).  
Briefly, Wnt signalling, as detailed in Figure 1.4, initiates upon Wnt ligand 
binding and activating Frizzled receptors. In the canonical cascade, this leads to 
stabilisation and nuclear localisation of β-catenin (as opposed to its 
ubiquitination and proteasomal degradation), triggering activation of Wnt target 
genes. These target genes regulate, in particular, cell growth and differentiation 
(Lancaster and Gleeson, 2010; Lerner and Ohlsson, 2015; Kikuchi et al., 2009). 
PCP signalling controls the migration and polarity of cells relative to a plane of 
tissue, acting through Dvl to activate small GTPases RhoA and Rac, Rho-
associated kinase (ROCK) and Jun N-terminal kinase (JNK) (Lancaster and 
Gleeson, 2010; Lerner and Ohlsson, 2015; Kikuchi et al., 2009). Additional 
information about the Rho GTPases is included within the next section. 
Finally, the calcium-dependent Wnt pathway participates in a multitude of 
functions, including cell migration, cytoskeletal rearrangements, cell polarity and 
regulation of canonical Wnt signalling. This pathway also acts through Dvl and a 
small GTPase, Cdc42. Furthermore, it involves a number of other proteins such 
as filamin A, which interacts with meckelin (Adams et al., 2012), and mitogen 
activated protein kinase (MAP), which is inappropriately activated by TMEM67 
in polycystic kidney disease (Du et al., 2013; Lerner and Ohlsson, 2015; Kikuchi 
et al., 2009).  
Persistent β-catenin activation during development causes renal cysts 
(Saadi-Kheddouci et al., 2001), but so does downregulation of canonical Wnt 
signalling (Pinson et al., 2000), and loss of core PCP proteins (Cao et al., 
2010). This highlights how carefully these signals must be controlled, 
particularly for kidney homeostasis.  
Wnt signalling is involved in ciliogenesis: manipulation of Dvl and axin, 
components of non-canonical pathways, disrupts cell migration and randomises 
centrosome positioning (Schlessinger et al., 2007). Interestingly, the PCP 
effector proteins Fuzzy and Inturned are highly expressed in ciliated cells, and 
knockdown of these in Xenopus results in profound defects in ciliogenesis and 
(perhaps resultantly) Hh signalling (Park et al., 2006). Futhermore, Fuzzy may 
participate in vesicle trafficking (Gray et al., 2009), and Inturned is needed for 
actin assembly, possibly through Rho localisation, which impacts on basal body 
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FIGURE 1.4: Summary diagram showing the canonical and non-canonical Wnt 
signalling pathways, a number of the involved components and the major roles of 
each. (A) Canonical Wnt signalling. When Wnt signalling is inactive, β-catenin is 
targeted for proteosome-mediated degradation; however, in the presence of Wnt, 
the “destruction complex” is inhibited. β-catenin is then stabilised, enters the 
nucleus and  activates the transcription of Wnt target genes. (B) The 
non-canonical/planar cell polarity pathway. This pathway is associated with 
activation of small GTPases Rho and Rac, Rho kinase (ROCK) and JNK to effect 
cytoskeletal rearrangements. (C) The non-canonical/Ca2+ pathway. This is 
responsible for the Dvl-enabled activation of calcium/calmodulin-dependent kinase 
(CaMK) and PKC, appearing to inhibit the β-catenin pathway and altering cell 
migration. Wnt5a and Ror2 can, alternatively, act on filamin A or Cdc42 to regulate 
cell migration and polarity through cytoskeletal rearrangements. Fz, Frizzled; 
LRP5/6, lipoprotein receptor-related protein-5/6; APC, adenomatosis polyposis 
coli; GSK-3, glycogen synthase kinase-3; CK1α, casein kinase 1α; Dvl, 
Dishevelled; TCF/Lef, T-cell factor/lymphoid enhancing factor; Pk, Prickle; JNK, 
c-Jun N-terminal kinase; Daam1, Dishevelled-associated activator of 
morphogenesis 1; Fy, Fuzzy; Intu, Inturned; ROCK, Rho-associated kinase; PLC, 
phospholipase C; IP3, inositol trisphosphate; DAG, diacylglycerol; PKC, protein 
kinase C; MAPK, mitogen-activated protein kinase; Cdc42, cell division control 
protein 42 homolog; ATF2, activating transcription factor 2. Sources: Lancaster and 
Gleeson, 2010; Lerner and Ohlsson, 2015; Kikuchi et al., 2009. 
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docking at the apical surface (Park et al., 2008). Asymmetric localisation of PCP 
components regulating posterior displacement of centrioles has also been 
reported in numerous studies (Borovina et al., 2010; Guirao et al., 2010; 
Hashimoto et al., 2010). We can thus conclude that non-canonical Wnt, 
particularly PCP, signalling is vital for the initial stages of ciliogenesis (i.e. 
centriole reorientation and basal body docking). 
As with the Hh pathway, several Wnt pathway components have been 
localised to the cilia and/or basal body (e.g. APC and β-catenin) and loss of 
ciliary and basal body proteins causes hyper-responsiveness to β-catenin 
signalling at the expense of non-canonical Wnt signalling (Corbit et al., 2008; 
Oh and Katsanis, 2012), suggesting that the cilium might participate in Wnt 
signalling.  
In the case of BBS-depleted zebrafish embryos, upregulated canonical Wnt 
signalling resulted from defective proteasomal targeting of β-catenin (Gerdes et 
al., 2007). This may suggest that Wnt signalling is dependent on the cilium 
being fully functional, but that the Wnt defects may actually be cilium-
independent and secondary, unrelated functions of the basal body/axonemal 
proteins playing alternative roles within the cell (Oh and Katsanis, 2012). 
TMEM67 protein is essential for the phosphorylation of non-canonical Wnt 
receptor ROR2 upon Wnt5a stimulation, and interacts with both proteins at the 
ciliary TZ. In a recent study, TMEM67-mutant mice did not respond to Wnt5a, 
which is likely to inhibit Shh and canonical Wnt signalling; however, pulmonary 
defects, including cell polarity and epithelial branching defects, could be 
rescued by RhoA stimulation (Abdelhamed et al., 2015).  
This evidence is strongly indicative of MKS proteins having a key role in 
non-canonical Wnt signalling (with downstream effects on canonical Wnt and 
Shh signalling), whether as a receptor or another mediator of signal 
transduction. Whether this happens within the cilium or the cytosol, however, is 
unclear.  
The posited role of cilia in Wnt signalling is controversial, with certain 
groups arguing that there is no role for cilia in Wnt signalling (Huang and Schier, 
2009). Nonetheless, MKS1, TMEM67, CEP290 and RPGRIP1L mutant mice do 
commonly demonstrate alterations to Wnt signalling, whether in the canonical 
and/or PCP pathways (Abdelhamed et al., 2013; Lancaster et al., 2011; 
Mahuzier et al., 2012; Wheway et al., 2013), suggesting that this abstruse 
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connection requires additional investigation. It is possible, considering the 
localisation of many ciliopathy proteins, such as inversin (Mahuzier et al., 2012), 
to the basal body that the centrosome itself acts as a hub for Wnt signalling. 
 
The Rho GTPases 
 
The Rho GTPases are a subfamily of the Ras superfamily of small 
GTPases. These are molecular switches that are principally activated by 
Wnt/PCP signalling to control diverse signal transduction pathways, altering cell 
polarity, membrane transport, migration and transcription, chiefly through their 
effects on actin and MT dynamics (Ellenbroek and Collard, 2007; Etienne-
Manneville and Hall, 2002). 
These molecules switch between an “active” and “inactive” state through 
conformational changes associated with GTP or GDP binding, respectively. 
Numerous GTPase-activating proteins (GAPs) of varying specificity stimulate 
GTP hydrolysis to GDP using GTPases, promote GDP binding and bind effector 
proteins, thereby inactivating the GTPase. A similar number of guanine 
nucleotide exchange factors (GEFs) catalyse nucleotide exchange and mediate 
activation of the GTPase through a conformational change that increases the 
binding affinity toward effector proteins (Ellenbroek and Collard, 2007; Etienne-
Manneville and Hall, 2002).  
Rho GTPases can only bind effector proteins and transduce signals 
received from, for example, growth factor receptors, adhesion receptors, or G-
protein coupled receptors, when they are in an active state. Activation is strictly 
spatially and temporally regulated by GAPs and GEFs and by guanine 
nucleotide dissociation inhibitors (GDIs). GDIs bind inactive Rho GTPases into 
cytoplasmic complexes and prevent their translocation to, and thus activation at, 
the plasma membrane (Ellenbroek and Collard, 2007). Full activation of 
effectors downstream of the GTPases is thought to only occur upon fulfilment of 
certain criteria; for instance, full activation of Pkn requires RhoA binding, lipid 
association and autophosphorylation events (Bishop and Hall, 2000; Mukai et 
al., 1994). 
The best-characterised members of the Rho GTPases are Cdc42 (involved 
in filopodium formation), Rac1 (involved in lamellipodium formation) and RhoA 
(involved in stress fibre and focal adhesion formation), all of which impact upon 
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cell migration. However, there are 22 mammalian members in total, all of which 
are involved in generation of actin structures (Bishop and Hall, 2000; Ridley, 
2006). 
There are multiple effector proteins associated with the Rho GTPases. 
These include the p21-activated kinases (PAKs), serine/threonine kinases able 
to bind active Cdc, a number of of which can bind active Rac (Hofmann et al., 
2004); and Rho-associated coiled-coil-containing protein kinases (ROCK), 
which are serine/threonine kinases that bind active RhoA and regulate 
actomyosin-mediated cell migration and cell-substrate adhesion (Riento and 
Ridley, 2003). 
In further example of effectors, the actin depolymerising proteins 
ADF/cofilins are thought to be regulated downstream of small GTPases. Cofilin 
is phosphorylated at a serine near its N-terminus by LIM kinase in vivo and 
in vitro, it is believed, by upstream Rac activation (Arber et al., 1998; Pollard et 
al., 2000; Yang et al., 1998), regulated by Pak1 and ROCK (Edwards et al., 
1999; Maekawa et al., 1999). 
Rac1 and Cdc42 are established mediators of cell polarity (Pruyne and 
Bretscher, 2000; Schlessinger et al., 2007), hypothesised to operate through 
regulation of MT dynamics in the pericentrosomal region and cell apex. This 
activity is mediated using aPKC, Lis1 (Kirjavainen et al., 2015; Sipe et al., 2013) 
and PAR (partitioning-defective) proteins such as Par3 or Par6, which function 
as Cdc/Rac effector proteins and adaptor proteins, respectively (Joberty et al., 
2000). Through a similar mechanism, Rac1 and Cdc42 are also responsible for 
establishing cell shape through downstream action on the cytoskeleton, cell-cell 
junctions and membrane protrusion (Etienne-Manneville and Hall, 2002). 
Finally, the Rho GTPases promote endocytosis and exocytosis, for instance 
at the immune synapse following Hh-induced T-cell activation (de la Roche et 
al., 2013), by driving MTOC and Golgi reorientation and enabling spatially-
specific release of secretory granules, or the pinocytosis facilitated by 
Cdc42/Rac-dependent actin protrusions (Etienne-Manneville and Hall, 2002) 
Multiple ciliopathies display defects in the Rho GTPases, the actin 
cytoskeleton, and in functions associated with these, such as cell migration, 
polarity and focal adhesion development, leading me to examine the 
cytoskeleton and the Rho GTPases in the subsequent results chapters. 
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Other cilium-dependent signalling 
 
Several other crucial developmental signalling pathways have been linked 
to the cilium, such as platelet-derived growth factor (PDGF; Schneider et al., 
2005), fibroblast growth factor (FGF; Tanaka et al., 2005), receptor tyrosine 
kinase (Christensen et al., 2012) and Notch/Delta (Ezratty et al., 2011). 
However, investigation into the role of MKS genes in these pathways has been 
limited. 
Ciliary involvement in developmental signalling is conserved across 
numerous organisms, with evidence recently emerging of cilium-modulated Hh 
signalling extending even to the sea urchin (Warner et al., 2014) and Drosophila 
(Kuzhandaivel et al., 2014); however, dependence on cilia to regulate signalling 
appears species-dependent (Yamamoto et al., 2015). Together, these data 
imply that the cilium and associated proteins probably evolved with this function.  
 
1.4 The cytoskeleton 
 
The cytoskeleton underlies the minutiae of motility and cytoplasmic 
organisation in eukaryotic cells and is primarily responsible for maintenance of a 
stable - yet dynamic and adaptable - cell structure throughout cellular processes 
such as growth, division and movement. These cellular processes involve three 
types of filament - intermediate filaments, MTs and actin. I explore actin and 
MTs in this thesis, but will not cover intermediate filaments. Present 
understanding of the cytoskeleton often informs our knowledge of the aetiology 
of disease; genetic defects affecting the building or function of primary cilia, 
such as Meckel-Gruber syndrome, and their intersection with the cytoskeleton is 
the predominant focus of this thesis. 
 
The structure of actin filaments 
 
Actin is the major component of the thin filaments of muscle cells, and of 
the cytoskeletal system of non-muscle cells. It is involved in diverse cellular 
functions, such as effecting locomotion through the extension of pseudopods. 
Cellular movement is necessary in multicellular organisms during processes 
which include morphogenetic movement during embryonic development, 
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remodelling of the nervous system, chemotactic movements of immune cells 
and wound healing (Otterbein et al., 2001; Pollard et al., 2000). 
Monomeric, globular actin (G-actin) assembles to form polymers of 
filamentous actin (F-actin) (Otterbein et al., 2001). These filaments are 
polarised through arrangement of the globular subunits head-to-tail into a 
double helical polymer. Based on the arrowhead pattern formed when myosin 
binds actin filaments, the rapidly-growing end is referred to as the barbed end 
and the slowly-growing end is the pointed end (Pollard et al., 2000; Pollard and 
Borisy, 2003; Wegner, 1982). The barbed end is preferentially used for filament 
growth and actin filaments are largely oriented with their barbed ends in the 
direction of growth (Small et al., 1978), supported by experiments showing that 
permeabilised cells provided with fluorescent actin subunits add these to the 
barbed ends at the leading edge of the cell (Symons and Mitchison, 1991; 
Watanabe and Mitchison, 2002). 
 
Cell migration and focal adhesions 
   
Directional cellular movement is necessary for numerous critical processes 
across all domains of life; in eukaryotes, this includes a plethora of embryonic 
developmental systems, wound healing, tumour cell metastasis and immune 
responses (Mitchison and Cramer, 1996; Pollard and Borisy, 2003). For 
example, small, circular wounds can be healed by a contraction-based 
mechanism of the surrounding cells, in which an actomyosin cable lines the 
edge of the wound (Conrad et al., 1993) and, through generation of roughly 
equal force across the cells bordering the wound, “purse-string” closure 
involving inward migration occurs (Cramer, 1999).  
It is widely accepted, that animal cells use the actin cytoskeleton for 
crawling motility (Mitchison and Cramer, 1996), in addition to less common 
methods such as antigen-antibody binding (Pavalko et al., 1988).  
In order to migrate, cells must attain a spatial asymmetry, specifically a 
“leading edge” and a cell rear, in response to migratory stimuli (Lauffenburger 
and Horwitz, 1996). It is recognised that a cell must reorganise its actin 
cytoskeleton to effect lamellipodial protrusion at the leading edge, adhere, 
translocate the cell body and retract the tail at the rear (Cramer, 1999; Nobes 
and Hall, 1999) 
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The fibroblast cell regions (the lamellipodium, lamella, cell body and rear of 
the cell) all have characteristic properties which enable them to be tracked 
separately during cell locomotion by time-lapse microscopy. Through this, it has 
been determined that the lamellipodium, cell body and tail all appear to move 
forward roughly in the same direction, whereas the lamella appears to remain in 
the same place as the cell body proceeds (Cramer, 1999). 
Abercrombie et al. (1970) first introduced the term “lamellipodium”, 
describing  “thin, sheet-like, mobile, commonly transitory projections from the 
cell”, also noting their occurrence “particularly at and near the front end of a 
fibroblast.” Further, it was found by Euteneuer and Schliwa (1984) that even 
small fragments taken from these lamellipodia engaged in persistent, 
translocative behaviour. 
These lamellipodia lack nuclei or other organelles (Euteneuer and Schliwa, 
1984), primarily being made up of actin filaments and actin-associated proteins 
within a cross-linked meshwork (Lauffenburger and Horwitz, 1996). This is 
important as it suggests that protein synthesis is not necessary for motility in the 
short-term.  
Alternatively at the leading edge of the cell, the surface which forms the 
“front” of the migrating cell, are filopodia. These are thin, finger-like projections, 
formed of bundled actin filaments (Lauffenburger and Horwitz, 1996; Nobes and 
Hall, 1999). Lamellipodia and filopodia both consist of polarised F-actin, but 
these different conformations are achieved through use of different actin-binding 
proteins (Small et al., 2002). 
Lamellipodial protrusion is induced by Rac (Ridley et al., 1992) and, through 
appropriate assembly or disassembly and organisation of actin filaments, cell 
motility is controlled by a cascade of intracellular signalling (Lauffenburger and 
Horwitz, 1996; Nobes and Hall, 1999). Lamellipodia are responsible for 
directional protrusion of the front of the cell, enabled by dynamic actin 
cytoskeleton re-organisation, and for the development of adhesions to attach 
the cell to the underlying substrate (Abercrombie, 1980; Nobes and Hall, 1999; 
Small et al., 2002). Lamellipodia and focal adhesions are both vital during 
migration. 
Adhesion occurs when cells are plated in vitro, and is considered to be the 
next stage in cell migration. As mentioned, the leading edge is considered to be 
the preferential locus where adhesions form. These persist and mature, fixed on 
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the substratum as the cell regions migrate over them, thereby moving 
centripetally, before finally detaching when they reach the cell rear (Couchman 
and Rees, 1979; Lauffenburger and Horwitz, 1996). These have a vital role in 
cell migration; mean size of focal adhesions precisely predicts cell speed, for 
instance (Kim and Wirtz, 2013). 
Focal adhesions are organised aggregates of specialised proteins with 
diverse functions, including structural, signalling and mechanosensing proteins. 
These aggregates include proteins such as integrin, fibronectin and focal 
adhesion kinase. Focal adhesions are distributed over the basal surface of 
adherent cells, providing a structural intermediate and a signalling site between 
the actin cytoskeleton and the extracellular matrix (ECM) (Geiger et al., 2009; 
Patla et al., 2010; Prager-Khoutorsky et al., 2011).  
Transient adhesions, often called focal contacts or focal complexes, appear 
initially as submicron-sized vinculin-, alpha-actinin- or paxillin-positive dots, 
before maturing into more stable structures, called focal or fibrillar adhesions. 
These focal adhesions, unlike the focal contacts, are elongated structures 
associated with the actin filament bundles of the cytoskeleton (Bershadsky et 
al., 1985; Wolfenson et al., 2009). This elongation and maturation is enabled by 
the exertion of tension in specific actin filament bundles - stress fibres - 
extending from the rudimentary focal contacts towards the cell body (Couchman 
and Rees, 1979; Wolfenson et al., 2009). Formation of focal adhesions is 
therefore affected by the rigidity of the ECM (Zamir et al., 2000) as this will 
affect the potential tensile strength of the stress fibres. 
Dysfunction of focal adhesion components is observed in a few ciliopathy 
models. In one example, RPGR-deficient cells demonstrated dysregulation of 
focal adhesion kinase, a 20% reduction in plasma membrane β1-integrin 
receptors, and inhibition of fibronectin-induced signalling. These cells also 
displayed dense actin bundles and reduced numbers of cilia (Gakovic et al., 
2011). Notably, multiple focal adhesion proteins, including vinculin, paxillin and 
focal adhesion kinase, also localise to the basal bodies of multiciliated cells, 
forming complexes that interact with actin. Furthermore, disruption of focal 
adhesion kinase leads to defects in basal body migration and docking 
(Antoniades et al., 2014), cellular defects observed in MKS models, indicating 
that these complexes may have undiscovered cellular roles which may inform 
our knowledge of ciliopathies 
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Focal adhesions in the lamella eventually mature and stop growing, 
remaining in this region in stationary cells or ending in the posterior lamella in 
motile cells, before gradually disassembling (Wolfenson et al., 2009). The cell 
body must advance over these focal adhesions in order to move. It is the 
subject of debate as to how this translocation occurs, however. The two current 
key models explain migration in terms of contraction of acto-myosin fibres, or in 
terms of actin polymerisation balanced with membrane tension (Fournier et al., 
2010). 
In the presence of active myosin II, strong adhesions to the extracellular 
substrate form and subsequent actomyosin contraction leads to a tension 
between the actin filaments at the leading edge and the cell body. Tension force 
can then be transmitted as a strong, propulsive traction force to the cell 
adhesions, allowing cellular movement through use of the cytoskeletal actin 
filaments (Fournier et al., 2010). 
The role of myosin II is controversial; it has long been argued that myosin 
filaments interact with actin filaments, providing a contractile force to move the 
cell body forward by pulling the cell substrate over the focal adhesions in a 
similar way to skeletal muscle contraction (Abercrombie, 1980). More recently, 
myosin has been assigned a lesser role, and is now associated with 
organisation of the direction of force as opposed to directly generating motile 
force (Lo et al., 2004). Furthermore, it was demonstrated by Lo et al. (2004) that 
myosin IIB null fibroblasts still migrate, and did so faster than control cells; 
however, the resultant polarity of migration was unstable, suggesting that 
myosin II has more of a regulatory role in cell migration. 
Several studies have reported that migration involves myosin-independent 
forces, namely attributing traction force to actin filament assembly (Fournier et 
al., 2010). It has been hypothesised that actin filament assembly provides a 
structure, which the myosin II then uses to pull the cell body and that the 
plasma membrane transmits this force from the front to the back of the cell 
(Fournier et al., 2010).  
Finally, retraction of the tail end of the cell is required to complete a 
migratory movement. Myosin-powered contraction is responsible for unsticking 
of the focal adhesions at the back and sides of the cell, causing the tail end to 
be pulled by the rest of the cell (Fournier et al., 2010). In the absence of myosin, 
the tail end moves through actin depolymerisation (Mseka and Cramer, 2011). 
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Microtubule structure and organisation 
 
Microtubules (MTs) are the other major constituent of the cytoskeleton, 
functioning predominantly as tracks for motor proteins carrying varied cargoes. 
MTs are essential for numerous cellular functions, such as motility, intracellular 
transport/vesicular trafficking and cell division, in addition to acting as the 
principal component of the axoneme in cilia and flagella (Amos and 
Schlieper, 2005). 
These structures are tubular polymers of α- and β-tubulin heterodimers 
(which have 50% amino acid similarity), arranged head-to-tail in 13 staggered 
protofilaments to make up a ~24 nm-wide hollow cylinder. This structure can be 
elongated by the addition of more tubulin dimers and, like actin, these are polar 
structures, a feature key to their function. Tubulin heterodimers are 
preferentially added to the plus end, which is characterised by its exposure of β-
tubulin subunits, in contrast to the minus end, which has exposed α-tubulin 
subunits (Amos and Schlieper, 2005; Desai and Mitchison, 1997; Evans et al., 
1985; Walker et al., 1988; Weisenberg, 1972). 
MTs run straight, which enables MT-associated motor proteins such as 
dynein (a plus end-directed motor) and kinesin (a minus end-directed motor) to 
travel for long distances, carrying cargo including vesicles or organelles. The 
orientation of MTs (and thus the direction of transport) is cell type-dependent; 
for example, nerve axons are arranged with the plus ends of longitudinally-
placed MTs pointing away from the cell body, epithelia orient plus ends towards 
the basement membrane, and fibroblasts typically display MTs radiating from 
the cell centre with the plus ends at the periphery (Hirokawa, 1998).  
Nucleation and organisation of MTs can occur from multiple sites, known as 
microtubule organising centres (MTOCs). These contain γ-tubulin, which 
nucleates the formation of new MTs from large complexes referred to as the γ-
tubulin small complex (γ-TuSC) in nearly all eukaryotes. These γ-TuSCs form 
part of the γ-tubulin ring complex (γ-TuRC) in many eukaryotes, but constituents 
of this complex vary (Kollman et al., 2011). Furthermore, these also act as a 
minus end cap (Keating and Borisy, 2000). 
The centrosome is the main MTOC in most animal cells and, as 
discussed previously, becomes the basal body of primary cilia. However, many 
MTs have acentrosomal origins (Kollman et al., 2011), including the Golgi 
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complex (Chabin-Brion et al., 2001; Efimov et al., 2007) or the outer nuclear 
envelope (Bugnard et al., 2005). These alternative, acentrosomal origin points 
also contain centrosomal proteins ninein, pericentrin and γ-tubulin (Bugnard et 
al., 2005; Mogensen et al., 2000). MTs can be severed and stabilised by 
association with other factors, but they can also be released, then transported 
using molecular motors and tethered at alternate, acentrosomal sites, such as 
the adherens junctions (Bellett et al., 2009; Keating and Borisy, 1999; Meng et 
al., 2008).  
Cytoplasmic conditions ultimately determine the source of MTs. In 
fibroblasts (and most other proliferating and migrating animal cells), free MT 
minus ends become destabilised, leading to centrosomally-focused MTs.  
Contrastingly, epithelial cells (and most differentiated animal and fungal cells) 
have stable, free MT minus ends stabilised by, for instance, ninein-containing 
complexes, leading to frequent acentrosomal MT foci (Bartolini and Gundersen, 
2006; Keating and Borisy, 1999). 
 
1.5 Research questions and aims 
 
The research problem 
 
The major obstacles currently impeding research into ciliopathies are the 
inability to make genotype-phenotype correlations between mutations and the 
spectrum of disease phenotypes – this is a convoluted problem, dependent on 
genetic context, the type of mutation, the subsequent protein structure, and so 
on – and the exact subcellular roles of the proteins involved. 
The role of the “ciliopathy” proteins in building and maintaining a functional 
cilium is a hotly-investigated topic in ciliary research. A role of these proteins in 
a “ciliary gate” at the transition zone appears almost certain. However, evidence 
for additional extra-ciliary roles of these proteins is rapidly accumulating. These 
extra-ciliary roles have common themes: many of these proteins are involved in 
processes or protein complexes associated with the cytoskeleton. 
The pertinent question for ciliopathy research is thus whether the alternate 
functions that these proteins appear to have are a result of the loss of a cilium, 
whether these proteins have a primary role beyond the cilium which 
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subsequently impacts on ciliogenesis and ciliary function, or whether the 
proteins have multiple, independent roles in the cell. 
The MKS proteins have been linked to actin-mediated centriole migration 
and docking (Abdelhamed et al., 2015; Dawe et al., 2007b; Valente et al., 
2010), to Y-link/ciliary necklace formation (Williams et al., 2011) and, likely 
associated with this, regulation of ciliary membrane composition (Roberson et 
al., 2015) and Hedgehog signalling (Dowdle et al., 2011). 
Other associated defects are not as easily explained by ciliary loss or 
dysfunction, however. The role of cilia in Wnt signalling remains enigmatic, but 
many of the consequences of dysregulation of this pathway correlate with loss 
of a cilium. Ciliopathy proteins, such as TMEM67, have proven involvement in 
the Wnt signalling pathway – this protein is involved in Wnt5a transduction 
(Abdelhamed et al., 2015) - and MKS mutant mice commonly show alterations 
to Wnt signalling pathways (Abdelhamed et al., 2013; Lancaster et al., 2011; 
Mahuzier et al., 2012; Wheway et al., 2013). Elucidating this obscure 
connection between Wnt signalling and the cilium remains of vital importance 
for the field, and may be resolved if the roles of these proteins can be 
ascertained. 
Aside from a possible signalling role, emerging evidence for cilium-
independent functions of MKS proteins indicate these may act in regulation of 
actin networks, as indicated by their interaction with filamin A (Adams et al., 
2012) and localisation along actin fibres (Dawe et al., 2009), but evidence from 
research into other ciliopathies suggest these proteins may have more diverse 
extra-ciliary roles than these (Vertii et al., 2015). These roles include, but are 
not limited to: vesicular trafficking; centrosome cohesion; proteasomal 
degradation of cytoskeletal components; cytoskeletal links; focal adhesions; 
polarity; and migration, which will be discussed throughout this thesis. The 
currently established locations of TMEM216 and TMEM67 in the cell are 
depicted in Figure 1.5. However, understanding of their function at these 
locations, and whether they function beyond these locations, remains limited. 
 
Aims and hypotheses 
 
The aim of this thesis is to elucidate the cellular roles of the MKS proteins 
beyond the cilium, in order to formulate a more accurate model of how these 
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FIGURE 1.5: Model to demonstrate established MKS protein localisation. 
MKS proteins have been established to localise to the nuclear envelope, actin 
(which may or may not occur via other proteins), focal adhesion complexes and 
the ciliary transition zone; however, any additional sites of MKS proteins and their 
function at these subcellular locations have yet to be elucidated. Identification of 
their localisation and function is, therefore, to form the subject of this thesis.
Migrating 
fibroblasts
Epithelial cells
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proteins might function in the cell, with a view to advise future pursuance of 
appropriate therapeutic treatment (in the case of the milder diseases) or genetic 
counselling (in the case of the severe diseases) with regard to this spectrum of 
disorders. 
 
The hypotheses tested in this thesis are as follows: 
 
Chapter III: Actin in MKS2 and MKS3 patient cells changes temporally, and 
is structurally altered compared with control fibroblasts 
 
Chapter IV: Abnormal Rho/ROCK pathway activity is associated with the 
abnormal cellular phenotypes observed in MKS patient cells 
 
Chapter V: MTs are organised differently and are structurally altered in 
MKS patient cells. 
 
Chapter VI: Defects observed in MKS patient cells occur in a specific 
order, not simultaneously; defects are linked to Rho pathway activity. 
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CHAPTER II: MATERIALS AND METHODS 
 
2.1 Cell culture, drug treatments and transfection 
 
hTERT immortalised MKS3/TMEM67 [c.653G>T p.R217X]+[c.785T>C 
p.M261T] and MKS2/TMEM216 c.253C>T p.R85X neonatal patient fibroblasts, 
as used by Valente et al. (2010) were obtained from Colin Johnson (Leeds 
Institute for Molecular Medicine) together with age-matched hTERT-
immortalised controls (or wild-type) and cultured in DMEM/F-12 + GlutaMAX 
(Gibco) supplemented with 20% Fibroblast Growth Medium (FGM) (AMS 
Biotech) 10% foetal calf serum at 37°C/5% CO2, and split at roughly 70% 
confluency in TrypLE Express (Gibco) to sub-passage. All cells were used for 
experiments at passage 11-21. 
For micropattern experiments, cells were plated onto medium crossbow 
fibronectin micropatterns (Cytoo) according to the manufacturer’s instructions.  
The jasplakinolide-treatment experiment involved fibroblasts plated for 24 
hours on glass coverslips before addition of 10 nM jasplakinolide in fresh 
medium. They were incubated, as above, for 3 days before being fixed and 
stained. 
In acute drug treatment experiments, fibroblasts were plated onto collagen-
coated coverslips for 20 minutes. A number of extracellular matrices were 
trialled for this, but collagen I was selected as the most appropriate as cells 
from wild-type and MKS2 lines adhered fastest to this substrate. Following this, 
media was removed and appropriate concentrations of drug in medium (or fresh 
medium for the control) were applied for 40 minutes before fixing. These 
concentrations were: C3 transferase, 2.5µg/µL; Y27632, 5µM; H1152, 5µM; and 
blebbistatin, 50µM. Drug concentrations were selected based on working 
concentrations suggested by the suppliers, on previous studies using similar 
cell lines, and on an empirical determination of the effective and lethal dosages 
of the inhibitor; drugs were used at a concentration that did not cause >30% of 
the cells to die, but one at which alterations to the cytoskeleton could be seen 
upon microscopic examination. 
In prolonged drug treatment experiments, fibroblasts were plated onto 
collagen-coated coverslips for 1 day, media was removed and appropriate 
concentrations of drug (or corresponding control) in FGM were applied for 3 
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days before fixing. These concentrations were: C3 transferase, 1µg/µL; 
Y27632, 1µM; H1152, 1 µM; and blebbistatin, 5nM.  
For plasmid transfection experiments, cells were trypsinised and 
resuspended in 80 µL transfection medium per transfection (14.4 µL 
Supplement 1 and 65.6 µL Cell Line Nucleofector Solution R from Lonza Amaxa 
Cell Line Nucleofector Kit R), electroporated using a Lonza Nucleofector device 
with 1 µg of the relevant plasmid, resuspended in fresh medium and plated at 
appropriate density onto glass coverslips; cells were fixed and stained as 
normal after 4 days. 
Plasmids used for transfection were wild-type, constitutively active and 
dominant negative Rho (pcDNA3-EGFP-RhoA-wt, Addgene Plasmid 12965, G. 
Bokoch; pcDNA3-EGFP-RhoA-Q63L, Addgene Plasmid 12968, G. Bokoch; and 
pcDNA3-EGFP-RhoA-T19N, Addgene Plasmid 12967, G. Bokoch), and Rho 
kinase ∆3 – a constitutively active plasmid with a C-terminal truncation, but 
containing the kinase domain and coiled-coil region, shown to induce actin 
polymerisation and focal adhesion formation (Ishizaki et al., 1997). 
For siRNA transfection, IMCD3 cells (ATCC CRL-2123) were plated onto 
glass coverslips overnight. 1 µL lipofectamine (Invitrogen Lipofectamine 3000 
transfection kit) was added to every 1000 µL OptiMEM (Gibco). Separately, the 
appropriate siRNA [100 pmol of non-targeting (negative control), 100 pmol each 
of three MKS1 siRNAs (positive control) (all Invitrogen Stealth RNAi) or 100 
pmol of Coronin 7 SMARTpool siRNA (Dharmacon)] was added to 50 µL 
OptiMEM and 1.5 µL P3000. Next, 600 µL of transfection medium was added to 
each siRNA tube, and these were incubated at room temperature for 5 minutes. 
This solution (150 µL per coverslip) was added to the centre of the IMCD3 
coverslips; these were incubated (37°C/5% CO2) for 4 days, then fixed and 
stained. 
For nocodazole treatment of microtubules, fibroblasts were plated on 
coverslips for at least 24 hours, then were treated with 10 µM nocodazole 
(Sigma) in pre-warmed medium for 45 minutes. Cells were fixed (0 minute time 
point) or fresh, warm media replaced the nocodazole for 2 minutes before fixing 
and staining for centrosomes and microtubules. 
For temporal dependency experiments, cells were simultaneously plated, 
then fixed every 5 minutes and stained for the relevant structures. 
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Temporal dependency drug treatment experiments involved treating 
fibroblasts with actin stabilising (jasplakinolide - CalBioChem) and disassembly 
(latrunculin B – provided by M. Schrader) drugs (30 minutes after plating), 
microtubule stabilising (taxol – provided by J. Wakefield) and disassembly 
(nocodazole - Sigma) drugs, or DMSO (Sigma) (5 minutes after plating) – all at 
10 µM in medium, apart from DMSO, which was at 0.1%. These were then fixed 
and stained for actin and microtubules 1 hour after plating. 
Serum-starvation involved replacing medium with serum-free medium twice 
over 24 hours, then fixing and staining 2 days after the second medium change. 
 
2.2 Fixation and immunofluorescence 
 
Glass coverslips were coated with enough collagen I to cover the coverslip, 
left overnight at 4°C, then washed with PBS, prior to use in all experiments 
lasting 2 hours and under; experiments longer than this used untreated glass 
coverslips. Cells were plated at appropriate density and left to adhere at 
37°C/5% CO2 prior to fixing.  
To label actin, cells were fixed in 4% formaldehyde, 0.1% gluaraldehyde in 
cytoskeleton buffer (10mM MES pH 6.1, 138 mM KCl, 3mM MgCl, 10mM EGTA 
pH 7.0) with sucrose for 20 minutes, washed with PBS-0.1% Triton, then left to 
permeabilise in PBS-0.5% Triton for 10-15 minutes. Cells were blocked in AbDil 
(2% BSA in PBS-0.1% Triton) for over 15 minutes before labelling with Alexa-
Fluor 594 phalloidin to stain F-actin (1:100, Invitrogen) or AlexaFluor488 
deoxyribonuclease 1 (DNase 1) to stain G-actin (1:500, Invitrogen), washed off 
with PBS-0.1% Triton after 25-40 minutes.  
Immunofluorescence was used to label the remaining subcellular structures, 
as follows.  
For ROCK-1 and phosphomyosin labelling, cells were fixed in 4% 
formaldehyde in cytoskeleton buffer (10mM MES pH 6.1, 138 mM KCl, 3mM 
MgCl, 10mM EGTA pH 7.0) with sucrose for 20 minutes, washed with PBS-
0.1% Triton, then left to permeabilise in PBS-0.5% Triton for 10-15 minutes. 
Cells were blocked in AbDil (2% BSA in PBS-0.1% Triton) for over 15 minutes 
before labelling with primary antibody for 1 hour (Table 2.1), washed with PBS-
0.1% Triton, then treated with1:1000 Alexa-Fluor 488 goat anti-mouse or anti-
rabbit for 45 minutes. 
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TABLE 2.1: Details of primary (upper) and secondary (lower) antibodies 
used in immunofluorescence
Antibody Stains Concentration Source
ROCK-1 (Rabbit) Rho-associated 
coiled-coil-containing 
protein kinase1 
1:100 Chemicon (AB3885)
Phosphomyosin 
light chain (Mouse) 
Phosphomyosin 1:200 Cell Signalling 
(3675S) 
Myosin (Rabbit) Myosin 1:100 AbD Serotec (6490-
1004) 
GM130 Cis-Golgi 1:500 BD Biosciences
(610822) 
γ-tubulin (Rabbit) Centrosome 1:500 Sigma (T3559) 
Acetylated α-
tubulin (Mouse) 
Cilia/acetylated 
tubulin 
1:500 Sigma (T7451)
ZO-1 (Rat) Tight zunctions 1:500 Chemicon 
(MAB1520) 
α-tubulin (Mouse) Microtubules 1:500 Sigma (T9026)
Pericentrin (Rabbit) Pericentriolar material 1:500 Abcam (ab4448) 
YL1/2 (Rat) Tyrosinated tubulin 1:200 Provided by J. 
Salisbury 
AlexaFluor 488/594 
goat anti-mouse  
Mouse primaries 1:1000 Invitrogen (A11001/ 
A11005) 
AlexaFluor 488/594 
goat anti-rabbit 
Rabbit primaries 1:1000 Invitrogen (A11008/ 
A11012) 
Alexa-Fluor 488 
donkey anti-rat 
Rat primary 1:1000 Invitrogen (A21208) 
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For myosin, Golgi, centrosome/PCM, cilia, microtubules tyrosinated tubulin, 
and tight junction staining, cells were fixed in -20°C methanol (45 seconds for 
pericentrin, 3 min for Golgi, 5 mins for all others), washed with PBS and blocked 
as above, followed by 1 hour incubation with the relevant primary antibodies 
(Table 2.1), and 45 minute incubation with secondary antibodies (Table 2.1).  
In all experiments, the nucleus was stained using 1µg/ml 4',6-diamidino-2-
phenylindole (DAPI) for 1 minute, then washed with PBS-0.1% Triton prior to 
mounting in Vectashield (Vector Laboratories). 
 
2.3 Microscopy and image acquisition 
 
Samples were visualised using a Zeiss Axio Observer Z1 inverted 
microscope and 40x 1.2NA or 100x 1.4 NA oil objective, controlled by 
AxioVision software (Carl Zeiss). Images were captured using a CoolSnap HQ2 
camera (Photometrics) and processed in AxioVision and ImageJ.  
For cell volume analysis, samples were viewed using a 63x 1.4NA objective 
on a Zeiss LSM510 confocal microscope controlled by LSM examiner software. 
Constant exposure settings and pinhole size were used for all samples and 
cells imaged were randomly selected across the coverslips. Cell height was 
analysed in 15 randomly-selected cells from each cell line. 
 
2.4 Image analysis and statistical analysis 
 
Cell area was calculated from phase contrast images (n = at least 13 cells 
per cell line) using MetaMorph software, then mean cell area was calculated 
from these. The Kruskal-Wallis test was then used to compare differences in 
mean area ± standard error between the cell lines. 
Quantification of the progression of actin organisation was performed by 
identifying five stages of actin phenotypes; these were rounded, blebbing, 
showing protrusions, showing intracellular actin, and elongated. At each time 
point, 3 repeats were performed, categorising 100 cells on each coverslip. The 
percentage of cells showing each phenotype was plotted as a box plot, 
separated by cell line, displaying mean, standard deviation (SD) and range of 
the data at each time point and colours to indicate the phenotype. 
64
Line scan analyses to initially compare the prominent actin bundles were 
performed on 1000 actin bundles from at least 100-150 micrographs of each 
cell line, taken at 100x magnification. MetaMorph software was used to examine 
pixel intensity across each actin bundle, which was then exported into a 
Microsoft Excel spreadsheet. Each actin bundle was manually assessed to 
determine the beginning and end of the bundle across a series of pixel 
measurements; this was performed by subtracting the background of each 
series of measurements (determined to be a figure just greater than the bottom 
two values of each series of measurements) from each pixel intensity value 
individually, and considering an increase of ≥1000 from the background to 
define an actin bundle. These defined actin bundles were next exported to 
GraphPad software. Actin bundle line width was calculated as the mean number 
of values defining an actin bundle in each cell line. Mean pixel intensity – a 
measure of brightness – was calculated by working out the mean intensity of 
each actin bundle, then averaging this in each cell line. Graphs were drawn of 
the mean pixel intensity and line width of each actin bundle (1000 data points 
per cell line), and mean pixel intensity and line width ± SD in each cell line using 
GraphPad software. These data were analysed for difference using a χ2 test (as 
they were not normally distributed) within the same software. Subsequent line 
scan analyses used at least 50 lines, sourced from at least 10 cells, to gauge 
thickness of lines. 
For fluorescence intensity measurements, MetaMorph software was used to 
ascertain fluorescence intensity of each channel in each of 300 cells (100 cells 
in 3 repeats) from all cell lines. A line was drawn around the cell perimeter and 
average fluorescence intensity of each channel within this perimeter was 
calculated using the software to attain separate mean G- and F-actin 
fluorescence intensity per cell. G- and F-actin fluorescence intensity of each cell 
line was calculated by averaging these measurements across the cell 
population. Mean G:F-actin ratios were calculated by totalling the G:F-actin 
intensity of each cell and dividing this by the number of cells (i.e., 300 cells in 
each cell line). Graphs of mean F-actin fluorescence intensity ± SEM, mean G-
actin fluorescence intensity, and mean ratio of G-actin fluorescence intensity:F-
actin fluorescence intensity were plotted using GraphPad. A two-tailed Mann-
Whitney (U) test was used to determine statistical difference between the cell 
lines. 
65
Normality was tested using a D'Agostino & Pearson omnibus normality test 
in GraphPad Prism. 
In experiments determining temporal appearance of phenotypes, 
assessment of number of cells showing phenotypes such as prominent bundles, 
0-2 microtubule foci and dispersed Golgi were counted by eye in multiple, 
randomly-selected fields of view. At least 100 cells were counted per coverslip, 
and three repeats were performed of each of these experiments.  
To determine temporal difference in microtubule, actin and Golgi 
phenotypes, mean number of cells showing each phenotype was calculated ± 
SD, and a χ2 test was used to determine difference between each patient cell 
line and control cells over the first hour after plating in regard to mean 
proportion of cells displaying each phenotype. 
 
2.5 Reverse Transcription Polymerase Chain Reaction 
 
Fibroblasts (5-10 x 105) were pelleted and total RNA extracted using the 
High Pure RNA Isolation kit (Roche) according to the manufacturer’s 
instructions. RNA concentration was measured using a Biophotometer 
(Eppendorf). Equal RNA concentrations for each sample were reverse-
transcribed using the OmniScript kit (Qiagen) according to the manufacturer’s 
instructions and touchdown PCR (Table 2.2) was performed with resulting 
cDNA and appropriate primers (Tables 2.3 and 2.4), designed using Primer3, 
Eurofins to verify melting temperature and MAFFTT when aligning isoforms. 
Negative control experiments were run of each primer set by running through 
the whole process using 1 µL of water in place of reverse transcriptase; GAPDH 
primers acted as a positive control, confirming roughly equal RNA presence 
across all three cell lines. 
Pooled products from three repeats were run on an ethidium bromide-
containing 2% agarose-TAE gel at 100V for 30 minutes alongside HyperLadder 
I (BioLine) and products visualised using a UVP UV transilluminator. 
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TABLE 2.2: Touchdown PCR programme used for polymerase chain 
reaction.
Initial denaturation: 94°C 5 min 
Then 20 cycles (30 seconds per stage): 
Denaturation: 94°C 
Annealing: Progressive decrease from 60°C to 50°C throughout the cycles 
Extension: 72°C  
Then 15 cycles: 
Denaturation: 94°C 30 seconds 
Annealing: 55°C 30 seconds 
Extension: 72°C 1 minute 
Final Extension: 72°C 5 minutes 
Held at 10°C until removed and used 
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TABLE 2.3: Primers designed against each of the actin isoforms and DNA 
melting temperature
L- Left, R – Right. ACTA1 – Actin alpha 1,skeletal mucle.  ACTA2 –Actin alpha 2, 
smooth muscle, aorta. ACTC1 – Actin alpha, cardiac muscle 1. ACTB – Actin, 
beta. ACTG1 – Actin gamma 1. ACTG2 – Actin gamma 2, smooth muscle, enteric.  
Primer 
name Primer Sequence Tm 
ACTA1 L AGAGCTACGAGCTGCCAGAC 61.4 
ACTA1R GGCATACAGGTCCTTCCTGA 59.4 
ACTA2 L TCATCACCAACTGGGACGAC 59.4 
ACTA2 R CGCCTGGATAGCCACATACA 59.4 
ACTC1 L TGTCACCACTGCTGAACGTG 59.4 
ACTC1 R CAATGAAGGAGGGCTGGAAG 59.4 
ACTB L TGAGCGCAAGTACTCCGTGT 59.4 
ACTB R TGTCACCTTCACCGTTCCAG 59.4 
ACTG1 L TGTCAGGGCTGAGTGTTCTG 59.4 
ACTG1 R AGTAACAGCCCACGGTGTTC 59.4 
ACTG2 L CCCTCTTCCAGCCTTCCTTT 59.4 
ACTG2 R GTCAGCAATGCCAGGGTACA 59.4 
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TABLE 2.4: Primers designed against actin-binding proteins involved in (A) 
stress fibres and (B) lamellipodial structures and DNA melting temperature 
of each.
A
Name Primer Sequence Tm Primer 
length (bp) 
Product 
size 
ARPC2L GAAAACAATCACGGGGAAGA 55.3 20 158 
ARPC2R TGGAACCAAAACGGAGAATC 55.3 20 
ARPC3L GAAAGTTTTCGACCCTCAGAATG 58.9 23 284 
ARPC3R CAAATCACCCTTGATAACCCACT 58.9 23 
CAPZA1L CCGACTTCGATGATCGTGTGT 59.8 21 189 
CAPZA1R CAGGCGTGAACTGATCCATGT 59.8 21 
CAPZA2L  TTCAATGATGTTCGGTTACTGCT 57.1 23 149 
CAPZA2R  AAGTCGCCATGTTCTGTTATCAA 57.1 23 
CFL1 GGAGGGCAAGCCTTTGTGA 58.8 19 229 
CFL1 GCAGTTTGGGAAGGCCAGA 58.8 19 
CFL2 ATGGTTTGGGATCTTTTTGCAC 56.5 22 177 
CFL2 GAAAAATTCCATGGTGCCAAGT 56.5 22 
CTTNL GACCGACCCTGATTTTGTGA 57.3 20 219 
CTTNR TCCATTCGGTCTTGTTCCAC 57.3 20 
DSTNL GCAAAGAGATCTTGGTTGGAGAT 58.9 23 275 
DSTNR GAGATCTTCTGGTCCATTTGCTT 58.9 23 
EVLL TGCAGGATCAGCAGGTTGTG 59.4 20 277 
EVLR TGGTGCTGCTCCATCACTTG 59.4 20 
PFN1L  AGGAGGAGTCATCCCGTTTA 57.3 20 108 
PFN1R GAGCCAGAAGAAGGAAGGAA 57.3 20 
PFN2L TATTGTGGACTTGGCTGTCTTG 58.4 22 254 
PFN2R TCCCAGATGTAACAAAGTGCAG 58.4 22 
PFN3L ACTCGGAGCGCGATGG 56.9 16 142 
PFN3R AGATGGCCGCCAGCAG 56.9 16 
PFN4L CCAAATCACTGGAAGGCAGT 57.3 20 112 
PFN4R ACATGCTTGGTTCCCAAGAG 57.3 20 
WASF1L AAAGTGCCAAGAGCACCTCA 57.3 20 195 
WASF1R TGGCAAGGCAGAAAGTGAGT 57.3 20 
WASF2L TGCTGCCCACCTTCTTTTTC 57.3 20 129 
WASF2R TTGGTTGCTTCAGGGAAAGC 57.3 20 
WASF3L CACAAACTGCCTTCGTCAGC 59.4 20 179 
WASF3R AAGAGAAGACCCGGGACCA 58.8 19 
TMSB4XL TGCAAAGAGGTTGGATCAAGTTT 57.1 23 138 
TMSB4XR CCAACATGCAAGTTCTTTCCTTC 58.9 23 
WASLL ACCTCCACCACCATCAAGG 58.8 19 270 
WASLR ACCCCCAACACAGATGGAG 58.8 19 
L
L
R
R
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B 
 
Name  
Primer Sequence 
 
Tm 
 
Product 
size 
ACTN1 L AGAAGCATGAGGCCTTCGAG 59.4 
ACTN1R CCAGATTGTCCCACTGGTCA 59.4 156 
ACTN2 L GGGGTGAAACTGGTGTCCAT 59.4 
ACTN2 R GTCCAAGGCCATCTTTCCAG 59.4 226 
ACTN3 L CATGCAGCGCAAACTAGAGG 59.4 
ACTN3 R ATCTCCGAGAGCAGCCAGTC 61.4 234 
ACTN4 L GGAAGGGCTCCTTCTCTGGT 61.4 
ACTN4 R CCTCTGCATCCAGCATCTTG 59.4 236 
CORO1A L CTCACAGACCACCTGGGACA 61.4 
CORO1A R CAGGCGATGTCTAGCACAGG 61.4 177 
CORO1B L ACAGAGCCGGTGGTGGTACT 61.4 
CORO1B R GCTCTTGTCCTTGCATGCTG 59.4 234 
CORO1C L TGCCTCTCCATCTCTCACCA 59.4 
CORO1C R CAGCCCTTCCAAAACAGAGG 59.4 185 
CORO2A L CACGGCCTACAGGAAGGAAC 61.4 
CORO2A R CGTACTCATGGGGCTTGTGA 59.4 163 
CORO2B L GACCAGGGTCTGATGGCTTC 61.4 
CORO2B R GTGACCTTGGGCCACTTCTC 61.4 215 
CORO6 L ACTATACCCCCATGCGCAAC 59.4 
CORO6 R TGCTGTTCCAGCACACACTG 59.4 219 
CORO7 L GGCAGCTGTGACTGATCTGG 61.4 
CORO7 R ATCTTCTCCGTGTGGCCTGT 59.4 159 
FSCN1 L GCAAGTACTGGACGCTGACG 61.4 
FSCN1 R GCTGCCCATTCTTCTTGGAG 59.4 153 
FLNA L TCACCATCGATGCAAAGGAC 57.3 
FLNA R AGAAGGGGATCTCGTCACCA 59.4 186 
FLNB L AAGTGGGGTCTCTGGGGTTT 59.4 
FLNB R ACGGGCTGTCCTTGATGTCT 59.4 162 
PLS1 L AAGGTGGGGAAGATGGACCT 59.4 
PLS1 R GCAGGCACGGGTATGTGTTA 59.4 204 
PLS2 L GCACTCTCACACTGGCCTTG 61.4 
PLS2 R TGAGGTCCAGAACAGGCAGA 59.4 204 
PLS3 L GGGAGCCAACATGAAAAAGC 57.3 
PLS3 R CGTCATTGGCTTTCTGACCA 57.3 206 
TAGLN L AAGCGCAGGAGCATAAGAGG 59.4 
TAGLN R GCCCTCTCCGCTCTAACTGA 61.4 155 
TAGLN2 L TGGCAGTAGCCCGAGATGAT 59.4 
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TAGLN2 R TTGCAGCTGGTTATCCGAGA 57.3 101 
IQGAP1 L GGATGGGATGAACCTCCAAA 57.3 
IQGAP1 R GGTGATGGCAGGGATTTGTT 57.3 225 
IQGAP2 L CGAGAATACGCTGCTTGCAC 59.4 
IQGAP2 R CGGGGCTTCTGAGTTGATTC 59.4 236 
IQGAP3 L ACCTCCTCGCCATGACTGAT 59.4 
IQGAP3 R TGGGTTCAGGAAGCGGTAGT 59.4 185 
MACF1 L TCACGCGCCTTTCATAGAGA 57.3 
MACF1 R TGCTAACAGCCACACCTGCT 59.4 154 
MYH2 L CCAACTTCCAGAAGCCCAAG 59.4 
MYH2 R TTTGAGCCCCAGAGAAGAGC 59.4 195 
MYH10 L CGACACGCGGACCAGTATAA 59.4 
MYH10 R ATCGGCTGGAAGAGAAGCTG 59.4 235 
PALLD L GTCGCTATGCAGCACTTTCG 59.4 
PALLD R CAAGGCAATGGCTGTTTCAG 57.3 163 
VIL1 L GGGCAAGAGGAACGTGGTAG 61.4 
VIL1 R CTGGTCTCGGATCTCCTTGG 61.4 172 
CNN2 L AGTGAGGGCCGTACAAGGAA 59.4 
CNN2 R AGGCTGGAGAATCGCTTGAG 59.4 197 
CNN3 L GGGCGGCAAGTATATGATCC 59.4 
CNN3 R CATCCTGGTACTCGCCATGA 59.4 154 
TPM1 L GCTGAGAAGGCAGCAGATGA 59.4 
TPM1 R CCAGGTCGCTCTCAATGATG 59.4 184 
TPM2 L TACAAGGTTTGGGCCGAGGT 59.4 
TPM2 R TCCAGCTTCAGCATCTGCAT 57.3 243 
TPM3 L TGCTTTTGAGACGCCAGTGT 57.3 
TPM3 R TTGGTCCATGCCTATCAACG 57.3 153 
TPM4 L TAGAAAACCGGGCCATGAAG 57.3 
TPM4 R TTTCAGATGCAGCCTCCAGA 57.3 249 
FHOD1 L AGCTGTCCCTGGAAGAGCAG 61.4 
FHOD1 R GGCACCAGGTCTTTGTCCTC 61.4 208 
ZYX L CTGCGAGGGCTGTTACACTG 61.4 
ZYX R TGTGGTAGTCGGGGACACAG 61.4 197 
CRP1 L CCTGGGATCTGACACCATCA 59.4 
CRP1 R GGTGCCAAGATGTGTCCTCA 59.4 164 
VASP L GACCACTTCCGAGACCCAAC 61.4 
VASP R GGAAAGGAGAAGCGGGTCTT 59.4 200 
L- Left, R – Right. (A) also shows primer size; primers in (B) are all 20 bp. Full
names of DNA each primer sequence is designed against are also described.
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2.6 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
 
Cells grown in culture flasks for ≥4 days were trypsinised, centrifuged, and 
chilled lysis buffer (20mM Tris-HCl pH 7.4, 150mM NaCl, 1mM EDTA, 0.5% 
Triton X-100, 0.5% NP-40; 1mM PMSF and protease inhibitor cocktail added 
just before use) was immediately applied to the pellet. This was incubated at 
4°C for 15 minutes. Lysates were sheared with a 1ml syringe and 25 gauge 
needle and frozen at -20°C until needed. A Bradford assay (BioRad) was used 
to check the protein concentration using a UV spectrophotometer (Eppendorf 
Biophotometer Plus), ensuring that equal total protein was loaded (about 30 µg 
per lane). 
SDS 10% polyacrylamide gels were used to separate proteins by gel 
electrophoresis. Samples were denatured at 100°C for 5 minutes in 4x sample 
buffer (0.125M Tris pH 6.8, 2% SDS, 40% glycerol, roughly 0.015% 
Bromophenol Blue powder and 10% β-mercaptoethanol) prior to loading. 15 µL 
of sample-buffer mix per lane was run alongside Color Plus Prestained Protein 
Marker (BioLabs).  
Two identical gels were simultaneously run. One was stained with 
Coomassie Blue stain to visualise the protein on the gel. The other was used for 
a Western blot – it was electrotransferred onto PVDF membrane in transfer 
buffer (48mM Tris, 39mM glycine, 0.037% SDS, 20% methanol) at 220mA at 
room temperature for 90 mins using 1:750 primary (rabbit anti-myosin and 
rabbit anti-ROCK (as before, Table 2.1), with rabbit anti-VDAC1/2/3 (Abcam, 
Cat No. ab15895, used at 1:200), a protein in mitochondrial ion channels, as a 
loading control) and secondary antibody (goat anti -rabbit IgG-peroxidase - 
Sigma, Cat. No. A3687 - used at 1:10000). ECL reaction mixture (PerkinElmer) 
was added and chemiluminescence visualised by exposure to X-ray film 
(Fujifilm). 
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CHAPTER III: MKS patient cells display characteristic 
prominent actin bundles due to filament turnover defects 
 
3.1 Introduction 
 
Ciliopathy research is only just beginning to explore wider subcellular issues 
associated with the ciliopathies, and there seems to be remarkable correlation 
in cellular phenotypes amongst this spectrum of disorders. For instance, similar 
increases in actin stress fibre prominence are observed upon alteration to 
genes involved in Joubert syndrome (Huang et al., 2011), Bardet-Biedl 
syndrome (Hernandez-Hernandez et al., 2013) and nephronophthisis (Veland et 
al., 2013). 
Previous studies have connected alterations to MKS proteins to 
morphologically-similar defects in the actin cytoskeleton. MKS1 and meckelin, 
the TMEM67 (MKS3) protein product, interact with actin-binding isoforms of 
nesprin-2; this is one of a group of scaffolding proteins involved in maintenance 
of the actin cytoskeleton and nuclear positioning. Notably, nesprin-2 is also 
necessary for centrosome migration during ciliogenesis, potentially through its 
effects on actin (Dawe et al., 2009). Furthermore, meckelin localises to 
basolateral actin fibres and its loss triggers remodelling of the actin cytoskeleton 
into prominent bundles and hyperactivation of RhoA signalling (Valente et al., 
2010). Mutations in TMEM216 and TMEM67 are both reported to cause 
prominent actin bundles to form (Dawe et al., 2009; Valente et al., 2010), 
possibly due to this RhoA hyperactivation. 
The actin bundling and cross-linking protein Filamin A also interacts with 
meckelin, and loss of either protein results in similar cellular phenotypes; these 
include defects in basal body positioning, RhoA hyperactivation and 
dysregulation of the canonical Wnt pathway (Adams et al., 2011). Finally, 
knockdown of RPGR, the best studied binding partner of the MKS5 paralogue 
RPGRIP1L (Khanna et al., 2009), leads to more prominent actin bundles, 
impaired ciliogenesis and cell-substrate attachment (Gakovic et al., 2011). 
Taken together, these data indicate that MKS proteins have important functions 
in actin cytoskeletal organisation and regulation; however, their precise role and 
the underlying molecular mechanism involved remains unknown. 
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The current chapter tests the hypothesis that actin in MKS2 and MKS3 
patient cells changes temporally and is structurally altered compared with 
control fibroblasts.  
In the present chapter, I describe the temporal effects of mutations at the 
MKS2 and -3 loci upon actin organisation, affecting TMEM216 and meckelin, 
respectively. I report that actin levels are modified in patient cells, and trace this 
to defects in turnover of existing filaments, not in transcription or in generating 
new filaments.  
The data reported in the current chapter replicate the previous studies 
demonstrating that mutations in TMEM216 (MKS2) and TMEM67 (MKS3) lead 
to structural alterations to the actin cytoskeleton, but additionally indicate that 
these genes affect the spatiotemporally-appropriate maintenance and turnover, 
not the initial generation, of actin filaments. This is the first instance of study into 
the temporal appearance of these defects, and of whether these develop from 
existing stuctures or de novo. 
 
3.2 Results 
 
Actin organisation is altered in MKS patient cells 
  
 In order to first ascertain whether any gross morphological changes exist, I 
plated control and MKS patient fibroblasts on glass coverslips, fixed and took 
phase contrast images of these cells. MKS2 patient cells demonstrated 
significantly increased spreading and more variable size when compared with 
wild-type cells; mean area (± SEM) of these cell lines was 5,526±432 and 
1,708±80 µm2, respectively (n=13 and 14 cells, respectively; Kruskal-Wallis test, 
p<0.001). However, MKS3 patient cells were more variable but not significantly 
different in size from control cells, demonstrating a mean area of 2,570±380 
µm2 (n=15 cells) (Figure 3.1). This suggests that there may be an underlying 
problem with the actin cytoskeleton, as one of the key regulators of cell shape. 
 In order to improve the current characterisation of actin organisational 
defects in MKS patient cells (Dawe et al., 2009; Valente et al., 2010), I plated 
wild-type and MKS patient fibroblasts onto crossbow-shaped micropatterned 
coverslips and fixed and stained them with fluorescently-labelled phalloidin to 
highlight filamentous actin. Micropatterned coverslips were used due to their 
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FIGURE 3.1: MKS2 patient cells exhibit increased cell spreading
Phase contrast images showing cell morphology in wild-type, MKS2 and MKS3 
patient cells. MKS2 patient cells appear larger than controls, while MKS3 cells are 
more variable in size. Scale bars represent 40 µm.
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ability to fix cell shape, a feature which may affect actin organisation. MKS2 
patient fibroblasts formed prominent cell body actin bundles (Figure 3.2, red 
arrowhead), as previously reported (Valente et al., 2010). MKS3 patient 
fibroblasts generated highly ruffled lamellipodia but no prominent actin bundles, 
in contrast to previous results (Figure 3.2, yellow arrowhead) (Adams et al., 
2011; Dawe et al., 2009). Cells had only been allowed to settle for an hour 
before fixing; however, in published data, these defects were reported after an 
undisclosed number of days. This raised the possibility that actin defects in the 
patient cells vary over time. 
 To determine how actin organisation temporally develops in MKS patient 
cells, I plated wild-type and MKS patient fibroblasts onto collagen I-coated 
coverslips, then fixed and stained cells with fluorescently-labelled phalloidin 
every 10 minutes for an hour, then again at 2 hours after plating. Actin 
organisation was described during cell spreading (over the 2 hours after 
plating), and during cell growth and division (over the 7 days after plating). Wild-
type and MKS3 patient cells developed actin-rich blebs, which were not 
apparent in MKS2 patient cells, within 10-20 minutes of plating (red 
arrowheads, Figure 3.3); these cells then formed protrusive structures 
(microspikes, lamellipodia and, less commonly, filopodia). Fibroblasts carrying 
the MKS2 mutation formed prominent cell body actin ~40 minutes after plating 
on collagen I-coated coverslips, in contrast to the less-prominent cell body actin 
observed in wild-type and MKS3 patient cells (yellow arrowheads, Figure 3.3), 
following which the cell elongated. Similar prominent actin bundles develop in 
MKS3 patient cells 4 days after plating (yellow arrowheads, Figure 3.4). These 
results indicate that mutations in MKS2 and MKS3 act differently upon the actin 
cytoskeletal regulatory machinery. 
 In order to disentangle the subtleties of these actin organisational defects, I 
quantified the progression of actin organisation in these cell lines. I identified 
five stages of actin organisation and reported the percentage of cells 
demonstrating each of these phenotypes every 10 minutes for the first hour 
after plating, then at 2 hours after plating (Figure 3.5). These stages were 
rounded (Figure 3.5a), blebbing (Figure 3.5b), showing protrusions (Figure 
3.5c), showing intracellular actin (Figure 3.5d), and elongated (Figure 3.5e). 
MKS2 and MKS3 patient cells progressed more rapidly through the initial stages 
of actin organisation (Figure 3.5a and b), but progression slowed down in these 
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WT MKS3MKS2
FIGURE 3.2: Actin organisation is aberrant in MKS patient cells. 
Cells were grown on crossbow-shaped fibronectin-coated micropatterned 
coverslips and fixed and stained with fluorescently-labelled phalloidin. Note the 
presence of prominent actin bundles in MKS2 patient cells (red arrowhead) and 
highly ruffled lamellipodia in MKS3 patient cells (yellow arrowhead). Scale bar 
represents 20 µm.
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20 min 
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50 min 
60 min 
120 min 
Wild-type MKS2 MKS3 
FIGURE 3.3: Aberrant actin organisation develops rapidly after plating in 
MKS2 patient cells. 
Fibroblasts were plated on collagen I-coated coverslips, fixed and stained with 
fluorescently-labelled phalloidin in order to visualise actin phenotype progression 
over time. Actin blebbing (red arrowheads) is followed by formation of microspikes, 
filopodia and lamellipodia. Intracellular actin bundles (yellow arrowheads) form, and 
the cell extends. Scale bar represents 20 µm.
78
 Wild-type MKS2 MKS3 
FIGURE 3.4: Prominent bundles develop in MKS3 cells 4 days after plating.
Fibroblasts were fixed and stained with fluorescently-labelled phalloidin every 24 
hours after plating on coverslips, in order to visualise actin phenotype progression 
over time. In the first 7 days after plating, MKS2 patient cells present prominent 
actin bundles; ~4 days after plating MKS3 patient cells also begin to present 
prominent actin bundles. Yellow arrowheads indicate some of these prominent actin 
bundles in MKS patient cells. Scale bar represents 40 µm.
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FIGURE 3.5: Aberrant actin organisation develops rapidly after plating in 
MKS patient cells. 
Quantification of the progression of actin organisation in each cell line. Five stages 
of actin organisation were identified (a-e); image outline colour corresponds to bar 
colour in the graphs. Scale bar represents 10 µm. Graphs are plotted as mean 
percentage of cells with a phenotype (horizontal line on bar) ± S.D. (top and 
bottom of coloured bar) and range (whiskers). n=200-300 cells per time-point per 
cell line. MKS2 and MKS3 patient fibroblasts demonstrate faster progression 
through stages a and b than control cells, but at 60-120 minutes after plating, fewer 
cells are at stages c-e vs. control cells. 
a
b
c
d
e
Wild-type
MKS2
MKS3
Time after plating (mins)
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cell lines. At 60 and 120 minutes after plating, fewer MKS patient cells are 
displaying the more advanced actin organisation phenotypes (Figure 3.5d and 
e) when compared with wild-type cells. The absence of actin-rich blebs in MKS2 
patient cells and the rapid formation of cell body bundles but failure to progress 
beyond this stage may be indicative of a problem in recycling actin to or in using 
cytoskeletal components (such as actin-binding proteins) at the leading edge. 
 To verify that these prominent actin bundles in MKS patient cells differed 
from actin bundles in wild-type cells, I quantified pixel intensity and bundle width 
using line scan analyses, performed to temporally coincide with prominent 
bundle development (MKS2, 1 hour after plating; MKS3, 4 days after plating). At 
least 1,000 bundles were analysed from images of at least 100 cells per cell 
line, taken under identical exposures. 
 Actin bundles in MKS2 and MKS3 patient fibroblasts (red, Figure 3.6) had a 
higher mean and median pixel intensity; the prominent actin bundles in MKS2 
patient fibroblasts had a mean pixel intensity of 3,973±1498, compared with a 
mean pixel intensity of 2,302±1139 in wild-type cells (χ2 test, p<0.001). The 
corresponding median values were 3,667 and 2,015, respectively. Prominent 
actin bundles in MKS3 patient fibroblasts, similarly, had a mean pixel intensity 
of 5,898±2,633, compared with a mean intensity of 3,011±1,145 in wild-type 
fibroblasts (p<0.001). The equivalent median intensity values were 5,246 and 
2,849, respectively.  
 Actin bundles are also thicker in MKS patient cells; MKS2 patient cells had 
actin bundles with a mean width of 11±3 pixels, compared with a mean width of 
6±2 in wild-type cells; the corresponding median bundle widths were 11 and 5 
pixels, respectively. Actin bundles in MKS3 patient cells had a mean width of 
6±2 pixels, compared with a mean width of 4±1 pixels in wild-type cells, with 
equivalent median values of 6 and 4 pixels-wide, respectively. Both MKS2 
bundles and MKS3 bundles were thus highly significantly brighter and thicker 
(χ2 test, p<0.001) (Figure 3.6) than their wild-type counterparts. 
 I next evaluated whether the increased cell spreading observed in these 
cells was associated with increased cell volume, or with changes to the actin 
cytoskeleton. I constrained fibroblasts on micropatterned coverslips, which were 
then fixed and visualised after an hour. Confocal imaging was used to make XY, 
XZ and YZ projections of these cells in order to approximate their three-
dimensional structure. From these, I was able to measure cell height when cell 
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FIGURE 3.6: Actin bundles in MKS patient cells are brighter and thicker. 
Line scan analyses of actin bundles in control and MKS patient fibroblasts (n=1,000 
lines from at least 100 cells per cell line). Line scans were performed to temporally 
coincide with the appearance of prominent bundles (MKS2, 1 hour; MKS3, 4 days). 
Graphs show mean pixel intensity or line width of bundles ± SD, indicating *** 
statistical significance of p<0.001 (χ² test). Corresponding median pixel intensity for 
these data are as follows: WT vs. MKS2, 2,015 and 3,667, respectively; WT vs. 
MKS3, 2,849 and 5,246, respectively. Median bundle widths are as follows: WT vs. 
MKS2, 5 and 11 pixels, respectively; WT vs. MKS3, 4 and 6 pixels, respectively.
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shape was restricted, enabling me to use a single measurement to deduce 
whether increased cell volume was responsible for the increased cell spreading 
observed in MKS fibroblasts (Figure 3.7). 
 Cell height was approximately equal in wild-type and MKS patient cells 
(8.5 µm average, n=15 cells per cell line), but that MKS2 patient cells had 
increased actin blebbing protruding from their apical surface, presumably 
underlying membrane; these cells also contained intense G-actin staining 
(green, Figure 3.7). These results indicate that cell spreading is not due to 
increased cytoplasmic volume, but may be due to altered cytoskeletal 
properties; these abundant, non-polarised protrusions (actin bleb-like, as 
opposed to lamellipodia or filopodia) may be indicative of altered cortical F-actin 
levels. The increased G-actin intensity reported additionally led me to 
investigate levels of G- and F-actin in MKS patient cells. 
 
G- and F-actin levels are perturbed in MKS patient cells 
 
 In order to examine relative G- to F-actin levels, I plated wild-type and MKS 
patient cells on crossbow-shaped micropatterned coverslips, then fixed and 
stained the cells with fluorescently-labelled DNase1 to label actin monomer and 
fluorescently-labelled phalloidin to label actin filaments. 
 The cells (n=300 cells per cell line) were imaged under identical conditions. 
G-:F-actin ratios were calculated per cell by dividing mean G-actin fluorescence 
intensity by mean F-actin fluorescence intensity, from which mean G-:F-actin 
ratio for the population was calculated. G- and F-actin levels significantly 
increased in MKS2 patient cells [p<0.001 using a Mann-Whitney (U) test], and 
G-actin levels significantly decreased in MKS3 patient cells [p<0.001, Mann-
Whitney (U) test], (Figure 3.8). Mean G-:F-actin ratio significantly increased in 
MKS2 and decreased in MKS3 patient cells [p<0.001, Mann-Whitney (U) test] 
(Figure 3.8), revealing a perturbation in G-:F-actin balance.  
 These results imply that actin transcription, stabilisation or degradation are 
dysregulated in MKS2 and MKS3 patient cells; I therefore examined actin in 
within these contexts. 
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FIGURE 3.7: MKS patient cell volume is normal, but MKS2 patient cells 
demonstrate more actin blebbing.
Maximum intensity projections of confocal XYZ images (coloured panels), 
demonstrating cell height when cell shape is constrained by growth on 
micropatterned coverslips. Cells were stained with fluorescently-labelled 
phalloidin to mark F-actin (red), DNase1 to label G-actin (green) and DAPI to label 
DNA (blue). Yellow asterisks indicate protrusions on the apical surface of MKS2 
cells. Note that cell height is approximately equal in all cell lines.
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FIGURE 3.8: G- to F-actin balance is perturbed in MKS patient cells.
(A) Widefield images of G- (green) and F-actin (red) labelled in fibroblasts grown on 
micropatterned coverslips. (B) Mean fluorescence intensity of G-actin and of 
F-actin were calculated for each cell individually, and a mean of the population 
calculated from this. G-:F-actin ratios were calculated by dividing mean 
fluorescence intensity of G-actin in each cell by mean fluorescence intensity of 
F-actin in the cell and a mean figure was calculated from the cell population. G- and 
F-actin levels and mean G-:F-actin ratio were significantly increased in MKS2 
patient cells, whilst G-actin levels and mean G-:F-actin ratio were significantly 
decreased in MKS3 patient cells.
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Actin filament turnover is dysregulated in MKS patient cells 
 
 To investigate whether actin levels are altered at a transcriptional level, I 
assessed comparative levels of actin mRNA. I used RT-PCR and primers 
specific to each known actin isoform to compare the three cell lines, showing 
that actin mRNA levels did not appear to differ between MKS patient cell lines 
when compared with wild-type cells (Figure 3.9). Whilst this technique is only 
semi-quantitative, these data indicate that actin defects likely occur post-
transcriptionally in MKS patient cells.  
 I next aimed to establish whether aberrant actin organisation occurs 
through spatially- or temporally-inappropriate formation of prominent bundles 
using the G-actin pool, or turnover (remodelling or stabilisation) of existing actin 
filaments. I treated cells with 10nM jasplakinolide for 3 days, stabilising existing 
filaments and preventing turnover into new actin structures in a concentration 
and time-dependent manner (Cramer, 1999), then fixed and highlighted actin 
with fluorescently-labelled phalloidin. The prominent actin bundles present in 
untreated cells (yellow arrowheads, Figure 3.10) no longer formed in any of the 
MKS patient cells following jasplakinoide treatment (n>100 cells across 3 
repeats); however, actin filaments were still apparent in the cell body of wild-
type and MKS patient cells (Figure 3.10), suggesting that these structures 
develop from existing filaments and indicating a defect in filament turnover. 
 
3.3 Discussion 
 
 I have demonstrated that the previously reported defects (Adams et al., 
2011; Dawe et al., 2009; Valente et al., 2010) in actin organisation displayed in 
fibroblasts carrying a mutation in TMEM216 (MKS2) or TMEM67 (MKS3) occur 
in a temporally-distinct manner, indicating that these mutations influence 
cytoskeletal machinery in different ways. I confirmed that the prominent actin 
bundles of MKS patient cells are morphologically-distinct from wild-type actin 
bundles, and revealed that they may be connected to an imbalance in G-:F-
actin levels in these cells.  
 Altered G- and F-actin levels may be either causative or symptomatic of the 
prominent actin bundles observed in MKS2 and -3 patient fibroblasts; increased 
amounts of G-actin and increased numbers of actin filaments in these cells may 
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FIGURE 3.9: Actin mRNA levels remain unaltered in MKS patient cells.
RT-PCR was performed using RNA extracted from each cell line and primers 
specific to 6 actin isoforms, revealing no difference in mRNA levels of any actin 
isoform.
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FIGURE 3.10: Jasplakinolide treatment induces prominent actin bundle 
disassembly in MKS patient cells.
Fibroblasts were plated for 24 hours, then treated with 10 nM jasplakinolide for 3 
days, fixed and stained with fluorescently-labelled phalloidin to label actin 
structures. Drug-treated cells continued to form actin structures in all cell lines, but 
not stress fibres and not the prominent actin bundles of the MKS patient cells 
(indicated by yellow arrowheads). Scale bar represents 40 µm. 
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induce more filament nucleation (de novo or from existing filaments, 
respectively). However, greater F-actin levels are likely reflective of the 
presence of these prominent actin bundles. The demonstrably increased G-
actin levels in MKS2 patient fibroblasts may be due to concomitant disassembly 
of a proportion of these prominent bundles as they are being built, and 
decreased G-actin levels in MKS3 patient fibroblasts may be indicative of 
increased monomer incorporation into filaments. 
 Establishing why and how these prominent actin bundles are 
inappropriately built is an important avenue of investigation as it may provide 
clues to the roles of MKS proteins in cells, and thus the molecular aetiology of 
Meckel-Gruber Syndrome and of the other ciliopathies.  
 
Actin defects associated with the MKS2 and MKS3 loci 
 
 Actin has not been thoroughly investigated in cells with mutations at the 
MKS2 and -3 loci. Only one study has examined the effects of MKS2 mutations 
on the actin cytoskeleton (Valente et al., 2010) and, only 2 prior studies have 
examined the effects of MKS3 mutations (Adams et al., 2011; Dawe et al., 
2009). Two of these previous studies (Dawe et al., 2009; Valente et al., 2010) 
used patient cell lines with the same mutations as those of the current project 
and these reported the same prominent actin bundles. The other of these 
studies used an MKS3 siRNA knockdown in IMCD3 cells and demonstrated 
loss of basal and basolateral actin when compared with scrambled siRNA-
treated cells (Adams et al., 2011), strongly implicating these proteins in an actin 
organisational or regulatory function. 
 Meckelin, the MKS3 protein product interacts with actin-binding isoforms of 
nuclear envelope protein nesprin-2 (Dawe et al., 2009), and with actin cross-
linking protein filamin A (Adams et al., 2011). The latter of these interactions 
appears, in addition to preventing aberrant actin structures from forming, to 
maintain normal RhoA activity (Adams et al., 2011). Furthermore, 
hyperactivation of RhoA and Dishevelled, non-canonical/PCP Wnt signalling 
pathway components has been demonstrated in the current MKS2 and MKS3 
patient cells, in Tmem216 siRNA-knockdown IMCD3 cells, and in HEK293 cells 
transfected with meckelin deletion constructs (Adams et al., 2011; Dawe et al., 
2009; Valente et al., 2010).  
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RhoA signalling is established to effect stress fibre formation (Bishop and 
Hall, 2000; Ridley, 2006) and filamin A is an actin cross-linking protein that is 
used during migration (Janmey et al., 1990), and the prominent actin bundles 
could feasibly be stress fibres or cross-linked bundles. Furthermore, an aberrant 
interaction of nesprin-2 with actin filaments and with the nuclear envelope may 
be affecting the actin structures formed in these cells.  It is also of note that 
Rho-generated stress fibres (Cowan and Hyman, 2007), filamin A cross-linked 
F-actin (Li et al., 1999) and the nuclear positioning effected by nesprin-2 (Chang 
et al., 2015) are all structures that influence cell migration, a process which has 
been revealed in unpublished work by our group to be disrupted in these patient 
cells (Barker and Dawe, unpublished). Together these data imply that Dvl/RhoA 
signalling and/or actin-binding proteins may be responsible for the prominent 
actin bundles generated in these cells.  
 
Actin defects in other ciliopathies 
 
 Emerging evidence has reported mutations to a number of “ciliary” genes 
resulting in actin defects. Aberrant actin organisation (Gakovic et al., 2011; 
Hernandez-Hernandez et al., 2013; Ravanelli and Klingensmith, 2011; Werner 
et al., 2013; Yin et al., 2009), dynamics (Cao et al., 2012; Kim et al., 2010) or 
actin-related functions, particularly in cell migration [such as cell spreading, cell 
shape (Pitaval et al., 2010), or membrane retraction (Gilden et al., 2012)] all 
appear as common features of ciliopathy mutants. However, beyond the 
aforementioned MKS2 and MKS3 associations, the actin cytoskeleton has not 
been widely investigated in MKS. 
 A number of ciliary proteins, such as Bbs proteins, localise to filamentous 
actin – for instance, in the actin-based stereocilia of hair cells (May-Simera et 
al., 2015) – and to actin-rich focal adhesions where they modulate the actin 
cytoskeleton (Hernandez-Hernandez et al., 2013), which may be indicative of a 
cilium-independent, actin regulatory role of other ciliary proteins, including the 
MKS proteins. 
A hypothetical influence of the ciliopathy genes in actin remodelling is 
supported by evidence that TRIM32, a gene encoding an E3 ubiquitin ligase 
involved in the ubiquitination of actin, is also a BBS gene, revealing 
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proteasomal degradation of actin as a key feature of this ciliopathy (Chiang et 
al., 2006). 
 Furthermore, when BBS genes Bbs4, Bbs6, and Bbs8 are disrupted, 
abnormal stress fibre aggregates form (Hernandez-Hernandez et al., 2013). 
These structures are not like the prominent bundles that I observe in regard to 
their length, but also have measurably increased thickness. However, like those 
seen in the Dawe (2009), Valente (2010) and Adams (2011) studies, these also 
appear to be Rho pathway-dependent; in the absence of Bbs proteins, RhoA-
GTP levels were highly upregulated, but subsequent RhoA inhibitor treatment 
rescued BBS-associated phenotypes, such as cilia length and number, and 
actin cytoskeleton integrity. These findings imply that the Bbs proteins regulate 
ciliary length and the actin cytoskeleton through alteration of RhoA signalling 
(Hernandez-Hernandez et al., 2013). Importantly, this study also indicates that 
drug treatment can reverse a number of cellular features of BBS, supporting the 
possibility of associated therapeutic development. Furthermore, the potential of 
reversal of cellular phenotypes with such drugs stimulated the subsequent 
chapter investigating the Rho-dependency of these actin defects. 
 Inversin, the ciliary protein integral to nephronophthisis, has also been 
associated with the actin cytoskeleton – inv-/- MEFs demonstrate compromised 
migration, cytoskeletal rearrangements (such as distorted lamellipodia and 
extensive filopodia formation) (Veland et al., 2013; Werner et al., 2013). 
Notably, however, these altered lamellipodia and supernumerary filopodia are 
not like the actin structures observed in the current MKS patient cells. 
Nonetheless, inversin-null MEFs also demonstrate elevated canonical Wnt 
signalling – like the mouse model of MKS3 (Abdelhamed et al., 2013) – and 
dramatically altered activity and localisation of non-canonical/PCP Wnt 
signalling pathway components (Veland et al., 2013; Werner et al., 2013), like 
the MKS patient cells (Dawe et al., 2009; Valente et al., 2010). This indicates 
that the ciliopathies could still be affecting similar pathways, and further 
supporting a link between ciliary components and RhoA activity or regulation.  
 
Molecular mechanisms behind aberrant actin phenotypes 
 
 To commence investigation into a molecular explanation for the actin 
phenotype, I revealed that the prominent actin bundles occurred post-
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transcriptionally, and from existing filaments. These features remain unreported 
in prior research into the aberrant actin structures observed in other ciliopathies.  
The implication of the current data, in addition to the above discussed 
similarities with the other ciliopathies, was that the aetiology of the MKS actin 
defects may be within a branch of the Wnt signalling pathways.  
Canonical Wnt signalling affects transcription, as opposed to having a direct 
effect on actin and, given the short time frame of defect generation, this was 
unlikely to be the cause. Contrastingly, the non-canonical Wnt/PCP pathway 
signals, in part, via the Rho GTPases - including Rho, Rac and Cdc42 - to effect 
changes to the actin cytoskeleton and control cell polarity. Loss of components 
of this pathway are known to lead to cystogenesis (Cao et al., 2010; Werner et 
al., 2013), either through defective proliferation or polarisation, making such 
signalling in the ciliopathies of interest. 
 Various branches of the Wnt/PCP pathway are involved in actin 
cytoskeletal organisation and developmental phenotypes (renal cyst formation, 
and convergent extension and neural crest migration defects). Furthermore, a 
number of components of Wnt/PCP signalling pathways have been commonly 
associated with the other ciliopathies [particularly BBS (Gerdes et al., 2007; 
Hernandez-Hernandez et al., 2013; Ross et al., 2005) and NPHP (Simons et al., 
2005; Veland et al., 2013)], meaning that investigation into a subset of these 
pathways were an obvious topic of investigation.  
 RhoA appears to be upregulated in the current MKS patient cells (Dawe et 
al., 2009; Valente et al., 2010), so I next aimed to manipulate the Rho GTPases 
in these cells to examine their role in generating the prominent actin bundles. 
Chapter IV therefore addresses the hypothesis that abnormal ROCK pathway 
activity is responsible for actin structures observed in MKS patient cells. 
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CHAPTER IV: Cellular phenotypes in MKS patient cells are 
ROCK-dependent 
 
4.1 Introduction 
 
Investigation into the influence of signalling pathways in ciliopathies has 
accrued variable amounts of evidence, dependent on the signalling pathway in 
question. Research into Hedgehog (Hh) signalling in vertebrate cells supports a 
definite role of ciliogenesis upstream of Hh pathway defects – if a cilium is not 
correctly built, Hh signalling cannot occur within it (Corbit et al., 2005; 
Eggenschwiler and Anderson, 2007; Huangfu et al., 2003). Investigation into the 
multiple branches of Wnt signalling in relation to cilia, however, is far more 
confusing and often appears contradictory. This investigation is an important 
topic of research; understanding the molecular aetiology of the ciliopathies – 
such as the signalling pathways which appear to be acting upstream of 
developmental defects – would not only allow us to deduce other possible 
downstream effects of these diseases, but would enable us to devise 
appropriate therapeutic targets. 
Wnt signalling is not reportedly transduced through the cilium (Huang and 
Schier, 2009; Leightner et al., 2013), but loss or dysfunction of proteins involved 
in cilia or ciliogenesis often have downstream consequences reminiscent, 
particularly, defects in the Wnt/PCP signalling pathway. Equally, alterations to 
Wnt signalling often mimic cellular features associated with ciliopathies (Cui et 
al., 2013; Hernandez-Hernandez et al., 2013; Park et al., 2006; Veland et al., 
2013). For example, mice deficient in Wdpcp, a transition zone protein, exhibit 
cellular defects such as an altered actin cytoskeleton, including decreased 
membrane ruffling. Furthermore, these mutant mice demonstrate concomitant 
developmental defects, including aberrant convergent extension cell movement, 
and cardiac outflow tract and cochlea defects. These are phenotypes typically 
associated with Wnt/PCP perturbation and, in fact, these mice also display 
differences in canonical and Wnt/PCP pathway components at an mRNA level 
(Cui et al., 2013).  
Through the Rho GTPases, Wnt/PCP signalling is well-established as a 
modulator of actin dynamics (Etienne-Manneville and Hall, 2002), but evidence 
is increasingly finding Rho pathway activation upstream of aberrant actin 
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structure formation in the ciliopathies. The integrity of the actin cytoskeleton and 
ciliary length are both defective in Bbs4-deficient cells, which could be rescued 
by Rho inhibitor treatment (Hernandez-Hernandez et al., 2013), suggesting 
Rho-dependency of these phenotypes.  
RhoA is reportedly upregulated in the current MKS patient cells (Dawe et 
al., 2009; Valente et al., 2010), and transition zone proteins are known to form 
multi-protein complexes; it is therefore possible that TMEM216 and meckelin 
also participate, directly or as part of a complex, in a similar, modulatory role 
within this pathway. 
I therefore aimed to determine whether aberrant Rho/Rho kinase (ROCK) 
signalling influences the abnormal cellular phenotypes observed in MKS patient 
cells. To this end, I investigated the involvement of the ROCK/myosin II 
pathway in forming prominent actin bundles of MKS2 and MKS3 patient cells, 
and in other atypical structures – such as dispersed Golgi – that I revealed in 
these cells in the present chapter. These data indicate that ROCK is likely to act 
upstream of a number of cellular defects reported in MKS2 and MKS3 patient 
cells. 
  
4.2 Results 
 
Rho kinase/myosin II signalling is required for actin abnormalities in MKS 
patient cells 
 
To test whether the prominent actin bundles observed in MKS2 patient 
fibroblasts are generated in a Rho signalling pathway-dependent manner, I 
plated MKS patient cells for 20 minutes, i.e. just prior to prominent actin bundle 
formation (Chapter III), then treated them with no drug (untreated control; Figure 
4.1A), or inhibitors of Rho (2.5 µg/µL; Figure 4.1B), Rho-kinase (ROCK) (5 µM 
for both; Figure 4.1C and D) or myosin II (50 µM; Figure 4.1E) for 40 minutes, 
then visualised actin using fluorescently-labelled phalloidin to determine the 
effect of these drugs on actin organisation (n=3 experiments). Drug 
concentrations were selected as detailed in Chapter II. Two different ROCK 
inhibitors – both with equal ROCK1 and ROCK2 affinity – were used to enhance 
the validity of these results. 
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FIGURE 4.1: Prominent bundles do not form in MKS2 patient cells following 
acute treatment with ROCK-pathway inhibitors.
Fibroblasts were plated for 20 minutes, drug-treated with compounds to inhibit Rho 
(B), Rho-kinase (C, D), or myosin II (E) for 40 minutes, then fixed with 
fluorescently-labelled phalloidin to reveal F-actin organisation. Prominent bundles in 
MKS2 patient cells (yellow arrowheads) in control conditions (A) disassemble upon 
Rho pathway inhibitor treatment (B-E). Scale bar = 20 µm.
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I revealed that treatment with any of these Rho/ROCK/myosin pathway 
inhibitors prevented the prominent bundle formation typically observed in MKS2 
patient cells; Figure 4.1A illustrates the prominent bundles normally present in 
MKS2 patient cells, but not the other cell lines (yellow arrow). However, Figure 
4.1B-E demonstrates that neither prominent bundles nor notable cell body actin 
structures are apparent in any cell line following drug treatment. Fibroblasts in 
all lines do, however, adopt an altered morphology following Rho pathway 
inhibitor treatment: there are more actin-based extensions with no obvious 
polarity. Generation of prominent actin bundles is therefore likely to be 
ROCK/myosin II pathway-dependent. However, the marked response of these 
cells to experimental perturbation of the Rho signalling pathway indicates that 
this aberrant actin organisation is not caused by insensitivity to Rho activation 
and a subsequent failure to generate negative feedback in these cells. 
To determine whether the prominent actin bundles in MKS3 patient cells are 
also Rho pathway-dependent, I plated control and MKS3 patient cells for 3 
days. This time period was selected as this was a day prior to prominent bundle 
formation in these cells, as demonstrated in Chapter III. I then either changed 
the medium (untreated control; Figure 4.2A) or drug-treated the cells for 1 day 
with inhibitors of Rho (1 µg/µL, Figure 4.2B), ROCK (5 µM, Figure 4.2C, D) or 
myosin II (10 µM, Figure 4.2E), then visualised the filamentous actin 
cytoskeleton with fluorescently-labelled phalloidin (n=3 experiments). 
Prominent bundles did not form in MKS3 patient cells upon prolonged 
treatment (Figure 4.2B-E), as they did in untreated MKS3 cells (Figure 4.2A). 
These data suggest that actin defect generation, and possibly persistence, may 
be associated with the Rho pathway hyperactivity demonstrated in these cells 
(Dawe et al., 2009; Valente et al., 2010). 
To establish whether the prominent bundles observed in MKS patient cells 
could be mimicked in control cells, the control cells were transfected with a 
RhoA GFP-tagged construct which was either normal or had a mutation (Q63L) 
to induce constitutive activation. Cells were fixed after 4 days, reflective of time 
taken for prominent bundles to develop in MKS3 patient cells, and actin was 
visualised at this time point. Constitutive activation of Rho induced control cells 
to display thicker prominent actin bundles (n=3 experiments; Figure 4.3). 
Prominent bundles following constitutive Rho activation had a mean thickness 
of 9.75 pixels; compared with the normal 5.767 pixel-thick bundles, these were 
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FIGURE 4.2: Prominent bundles do not form following prolonged treatment 
with ROCK-pathway inhibitors.
Fibroblasts were plated for 1 day, drug-treated with compounds to inhibit Rho (B), 
Rho-kinase (C, D), or myosin II (E) for 3 days, then fixed with fluorescently-labelled 
phalloidin to reveal F-actin organisation. Prominent bundles in MKS3 patient cells 
(yellow arrowhead) under control conditions (A) disassemble upon Rho pathway 
inhibitor treatment. Rho inhibition (B) led to an increase in cortical actin in wild-type 
and MKS3 cells. Scale bar represents 20 µm.
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FIGURE 4.3: Transfection with constitutively-active Rho leads to thicker actin 
bundles in wild-type fibroblasts, but not MKS3 patient fibroblasts.
Fibroblasts were electroporated with a GFP-tagged RhoA construct or constitutively 
active RhoA construct (Q63L) and, after 4 days, fixed and stained with 
fluorescently-labelled phalloidin. Q63L RhoA caused wild-type cells to present more 
prominent bundles, but had no effect on MKS3 patient cells. In overlay images, red 
corresponds to actin, green to Rho-GFP and blue to DAPI (nucleus). Scale bar 
represents 40 µm.
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significantly thicker (n=20 bundles measured from each; χ² test; p<0.01); 
however, Q63L RhoA transfection caused no significant alteration to MKS3 
actin bundle thickness, in which 6.129 pixel-thick bundles became 7.6 pixel-
thick bundles (n=20 bundles; χ² test; p>0.05). MKS2 patient cells did not 
typically survive this transfection, so equivalent results are not shown. This 
result supports a hypothesis that the actin defects are caused by 
hyperactivation of the RhoA pathway, and suggests that MKS patient cells 
demonstrate relatively uncontrolled RhoA activity. 
To ascertain whether RhoA signalling could be inactivated in MKS patient 
cells, and whether this would ameliorate the actin phenotype, I transfected 
control and MKS patient cells with a dominant negative RhoA construct (T19N) 
in order to inactivate RhoA, then examined actin in after 4 days (n=3 
experiments).  
RhoA inactivation prevented all but small intracellular actin bundles from 
developing in MKS patient cells, and prevented the cell spreading observed in 
untreated cells (Figure 4.4). This implies that the prominent actin bundles and 
the cell spreading of MKS patient cells develop due to RhoA activation. 
To determine whether the actin defects observed were also associated with 
ROCK activation downstream of this, as opposed to through other signalling 
pathways, cells were transfected with a constitutively active Rho-kinase 
[ROCK∆3 - a plasmid with a C-terminal truncation, but containing the kinase 
domain and coiled-coil region (Ishizaki et al., 1997)], and actin was visualised. 
ROCK∆3 transfection significantly increased the thickness of actin bundles 
in control cells from 5.767 pixels to 11.84 pixels (χ² test; p<0.01), but had no 
effect in MKS2 (11.25 pixels to 9.63 pixels; χ² test; p>0.05) or MKS3 patient 
cells (6.129 pixels to 9.25 pixels; χ² test; p>0.05) (n=20 bundles examined from 
each cell line; Figure 4.5). ROCK∆3 had no statistically significant effect (χ2 test; 
p>0.05) on the proportion of cells displaying prominent bundles in control or 
MKS patient cell populations (n=3 experiments). This supports a conclusion that 
Rho/ROCK dysregulation in MKS patient cells is responsible for the formation 
and/or maintenance of the prominent actin bundles observed. 
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FIGURE 4.4: Transfection with dominant-negative Rho abolishes prominent 
bundle formation in MKS patient cells.
Fibroblasts were electroporated with a GFP-tagged dominant negative RhoA 
construct (T19N) or plated without treatment (UT), and fixed and stained with 
fluorescently-labelled phalloidin after 4 days. T19N RhoA prevented development of 
the prominent bundles of untreated MKS cells, and ameliorated the cell spreading 
typically observed in these cells. Scale bar represents 40 µm on the large images, 
and 10 µm on the small images.
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FIGURE 4.5: ROCK∆3 transfection increases the prominence of actin 
bundles in wild-type cells, but not MKS patient cells.
Fibroblasts were electroporated with ROCK∆3 construct or no construct, plated for 
4 days, fixed and stained for actin with fluorescently-labelled phalloidin. Bundle 
thickness (upper panels), increased in control populations but not in MKS patient 
cell lines, but percentage of cells demonstrating prominent actin bundles did not 
change (table). Lower panels show magnified actin bundles. Scale bars represent 
40 μm.
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ROCK and myosin behaviour are altered in MKS patient cells 
 
To test whether the localisation of ROCK or myosin was also affected in 
MKS patient cells, I plated these and control cells for 4 days. 
Immunofluorescence was then used to examine localisation of these proteins 
(n=3 experiments). ROCK localisation was perinuclear/ nuclear across all cell 
lines (Figure 4.6). Myosin localisation was not observably altered in MKS3 
patient fibroblasts, but displayed fibrillar patterning in MKS2 patient cells, 
presumably along the prominent actin bundles (Figure 4.6A).  
To resolve whether the prominent bundles were decorated with active 
myosin, indicative of contractility, phosphomyosin was also visualised in these 
cell lines 4 days after plating. Actin and phosophomyosin frequently co-localised 
(Figure 4.6B), suggesting that these prominent bundles are likely to be 
contractile actin structures [such as stress fibres or graded polarity bundles 
(Cramer et al., 1997)], which would also support ROCK-dependency of their 
development. 
As RhoA is known to be hyperactivated in MKS patient cells (Adams et al., 
2011; Dawe et al., 2009; Valente et al., 2010), and I postulate that the actin 
defects are Rho/ROCK pathway-dependent, I examined ROCK-1 and myosin 
levels in whole cell lysates of control and MKS3 patient cells via Western blot 
(n=3 experiments).  
As a semi-quantitative method, levels of these proteins could not be very 
accurately determined, but myosin levels appeared unaltered in MKS3 patient 
cells, but ROCK-1 levels appeared to be increased in MKS3 patient cells 
(Figure 4.7).  
An increase in ROCK levels is likely concomitant with the observed 
increase in MKS2 and MKS3 patient cells of RhoA activity (Dawe et al., 2009; 
Valente et al., 2010), which occurs upstream of ROCK, as this pathway is 
known to modulate actin cytoskeletal changes (Kikuchi et al., 2009). It is, thus, 
probable that MKS2 and -3 mutations are causing these actin defects through 
hyperactivation of the Rho/ROCK signalling pathway. 
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FIGURE 4.6: Myosin localisation differs in MKS2, but is unaltered in MKS3; 
ROCK localisation is unaltered in MKS patient fibroblasts; and 
phosphomyosin localises to MKS2 prominent actin bundles.
Fibroblasts were plated, fixed and stained to visualise myosin, ROCK, actin and 
phosphomyosin. There were no differences in ROCK localisation in MKS patient 
cells, but MKS2 patient cells demonstrate fibrillar patterning of myosin (A). 
Phosphomyosin staining localises to prominent actin bundles in MKS2 (B). 
Scale bar represents 40 µm. (Phosphomyosin experiment performed and 
visualised by Amy Barker).
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FIGURE 4.7: ROCK-1 levels are increased in MKS3 patient cells, but myosin 
levels are not altered.
Western blotting indicated that more ROCK-1 may be expressed in MKS3 patient 
fibroblasts, but there was no difference in myosin levels between control and MKS3 
patient cells.
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Actin defects are accompanied by modified actin binding protein 
transcription and Golgi defects  
 
The mechanism by which Rho and ROCK amplify actin bundle formation in 
MKS cells is unknown, but I posited that this may be linked to alterations to 
actin-binding protein (ABP) behaviour. Myosin, as such an ABP, may be 
responsible. Although the level of myosin protein in MKS patient cells appears 
not to be altered, TMEM216 and meckelin may induce myosin to effect an 
enhanced function through increased activation; this hypothesis is supported by 
the phosphomyosin observed associated with MKS prominent actin bundles 
(Figure 4.6). 
To determine whether other likely candidate ABP behaviours were modified, 
such as those involved in actin bundling function or lamellipodial ruffling, I 
examined 55 ABPs at the transcript level. These ABPs were selected based on 
their involvement in stress fibre and lamellipodium formation, and levels of 
these were evaluated, alongside the positive and negative controls GAPDH, 
and RNase-free water in place of reverse transcriptase, respectively. These 
ABP RNA transcript levels were examined in control and MKS patient cells 
using RT-PCR with primers specific to these ABPs. These RT-PCR reactions 
were repeated 3 times, and agarose gels reported in Figure 4.8 represent 
typical results. 
Amongst all of the ABPs investigated, profilin 3 and coronin 7 were the only 
proteins to be altered at a transcript level (red and yellow stars respectively, 
Figure 4.8). Both were downregulated in MKS patient cells, and profilin 3 was 
predominantly found as an isoform with a higher molecular weight in MKS3 cells 
(Figure 4.8). Profilin 3 is a relatively unknown protein, but is proposed to interact 
with mDia3 and phosphoinositides (Behnen et al., 2009). It is hypothesised that 
profilin 3 is principally expressed in the kidney and testis, which is functionally 
relevant to the present study. However, in polycystic kidney disease cases, this 
transcript is found to be elevated, contrasting with our results (Hu et al., 2001). 
As very little is known about this protein, and as no siRNA or antibodies are 
available which are specific to this transcript/protein, this result was not pursued 
any further. 
Coronin 7 is a protein known to function in maintenance of Golgi 
morphology and membrane trafficking (Rybakin et al., 2006; Rybakin et al., 
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FIGURE 4.8: Coronin 7 and profilin 3 transcript are altered in MKS patient 
fibroblasts.
RT-PCR was performed using RNA from each cell line and primers specific to a 
number of actin-binding proteins. Gels pictured are representative of 3 repeats. 
Note that coronin 7 transcript (red asterisk) and profilin 3 transcript (yellow asterisk) 
are different in patient cells compared with wild-type cells. GAPDH acts as a loading 
control, and the ‘-RT’ represents the negative control of GAPDH containing no 
reverse transcriptase during reverse transcription. Cell lines are wild-type (1), MKS2 
(2) and MKS3 (3).
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2004), and in protecting actin filaments from depolymerisation (Shina et al., 
2010). For these reasons, I next inspected Golgi morphology and localisation in 
MKS patient cells using anti-GM130 to visualise the cis-Golgi and anti-γ-tubulin 
to visualise the centrosome (n=3 experiments). 
An hour after plating, the Golgi was perinuclear in control and MKS3 patient 
cells, but dispersed in MKS2 patient cells, although the Golgi was still partially 
associated with the centrosome in these cells (Figure 4.9). This dispersal was 
then mimicked at 4 days in MKS3 patient cells, but not in control cells (Figure 
4.9). As these results are concordant with the vesicular trafficking defects 
observed in other ciliopathy models [such as BBS (Blacque et al., 2004; 
Nachury et al., 2007)], this indicates that ciliary proteins may be involved in 
other subcellular structures besides the cytoskeleton, or that Golgi defects may 
occur downstream of cytoskeletal or ciliary defects.  
In order to elucidate the role of ROCK in Golgi dispersal – or, indeed, 
whether it has any responsibility for this phenotype – I examined Golgi 
dispersal, using anti-GM130 to highlight cis-Golgi and anti-γ-tubulin to highlight 
the centrosome, in MKS patient cells upon transfection with ROCK∆3 (n=3 
experiments). 
Following constitutive ROCK activation, the proportion of cells 
demonstrating dispersed Golgi (white arrowheads, Figure 4.10) significantly 
increased in wild-type cells (χ2 test; p<0.001), but not in MKS patient cells (χ2 
test; p>0.05 in both cell lines). This provides additional evidence of ROCK 
dysregulation in these cells although, notably, fewer MKS3 patient cells 
revealed Golgi dispersal (table, Figure 4.10). These data indicate that ROCK 
activation may not be at its maximum in these cells, but may be less regulated 
than in control fibroblasts. 
 
4.3 Discussion 
 
In the current series of experiments, I evaluated the involvement of Rho and 
its downstream effectors in the development of prominent actin bundles in MKS 
patient cells. I revealed that these actin bundles are likely generated, and 
possibly maintained, by dysregulation of Rho kinase signalling. I also observed 
morphological modifications to the Golgi apparatus in these cells, which may 
also be associated with inappropriate ROCK pathway activation.  
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FIGURE 4.9: Golgi organisation is altered in MKS2 patient fibroblasts within 
an hour after plating.
Immunofluorescence using anti-GM130 (red) to visualise cis-Golgi, and γ-tubulin  
to visualise the centrosome (1 hour, green) or fluorescently-labelled DNase 1 (4 
day, green), fixed an hour or 4 days after plating. MKS2 patient cells reveal 
dispersed Golgi at 1 hour, and MKS3 patient cells at 4 days. DAPI (blue) was used 
to indicate the nucleus. Scale bar represents 20 μm (1 hour) or 40 μm (4 day).
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FIGURE 4.10: ROCK∆3 transfection causes Golgi to disperse in more 
wild-type cells, but does not affect Golgi dispersal in MKS patient cells.
Fibroblasts were electroporated with ROCK∆3 construct or no construct, plated for 
4 days, fixed and cis-Golgi (red - anti-GM130), centrosomes (green - γ tubulin) and 
nuclei (DAPI - blue) were visualised. The number of cells demonstrating dispersed 
Golgi (white arrowheads) increased in control populations but not in MKS patient 
cell lines (table, graph - mean ±SD). ***P<0.001; N.S., not significant, P>0.05. Scale 
bars represent 40 μm. 
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This was the first research to reveal alterations to coronin 7 transcription, 
and to the Golgi apparatus in this disease (although, unfortunately, antibodies 
are not available against coronin 7, so protein localisation and levels could not 
be determined). This was also amongst the first evidence of Rho/ROCK 
signalling prompting cellular defects in cells with alterations to MKS proteins, as 
opposed to these occurring as a consequence of cilium loss. These results are 
important as they indicate that the MKS proteins may directly or indirectly 
interact with the Rho signalling pathway, and this may happen upstream of the 
failure to build a cilium. These data provide valuable clues as to the function of 
these, and possibly other ciliopathy proteins. 
 
How does Rho signalling trigger ciliopathies? 
 
My results have illustrated a model in which hyperactive Rho induces 
prominent actin bundle formation over 40 minutes and, simultaneously, the 
Golgi disperses in MKS2 patient cells; this is likely before the basal body would 
dock, or a cilium would be generated in cilium-forming cells. The present results 
therefore suggest that Rho GTPase-induced cytoskeletal remodelling may 
preclude effectual vesicular trafficking and, either subsequently or concurrently, 
basal body migration and docking. 
Previous models have posited a system in which Dvl (a generalised Wnt 
pathway transduction component) and Rho mediate actin network-regulated 
basal body docking. This is proposed to occur at an appropriate location, 
established through an existing anteroposterior axis and, subsequently, Dvl and 
Rho establish ciliary planar polarity. This hypothesis is based on the 
observation that the direction of ciliary beating is refined following basal body 
docking and axonemal extension, in a positive feedback loop (Boisvieux-Ulrich 
et al., 1990; Mitchell et al., 2007).  
Initial cell polarity could be set by any number of factors, including PCP 
effectors (which may include “ciliary” proteins); appointing initial polarity would 
be followed or accompanied by directional protein trafficking, basal body 
migration and docking, and axonemal extension and, according to this model, 
polarity would be subsequently refined and maintained by ciliary signal 
transduction.  
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The above evidence suggests that MKS proteins likely function during or 
prior to basal body docking. It would be most parsimonious to presume that 
these proteins act early following plating, and thereby exert a number of 
downstream effects; for instance, by altering the activity of Rho signalling 
pathways. Rho GTPases are known to affect polarity establishment (Gao et al., 
2011; Kirjavainen et al., 2015), polarised membrane trafficking (Park et al., 
2008), basal body docking (Pan et al., 2007; Park et al., 2008), axonemal 
extension (Hernandez-Hernandez et al., 2013), actin cytoskeleton 
rearrangements (Etienne-Manneville and Hall, 2002), centrosome amplification 
and splitting (Chevrier et al., 2002; Ling et al., 2015), and cell migration (Veland 
et al., 2013), and defects are observed in all of these processes in MKS patient 
cells, supporting an interaction with Rho signalling.  
Furthermore, a number of the ciliopathies have diverse alterations to the 
actin cytoskeleton, indicating an involvement of Rho GTPase cross-talk; these 
include distorted lamellipodia and extensive filopodia in (the NPHP-causative) 
inversin-null mutants (Veland et al., 2013; Werner et al., 2013) and prominent 
actin stress fibres in Joubert syndrome (Huang et al., 2011), NPHP (Veland et 
al., 2013) and BBS (Hernandez-Hernandez et al., 2013). If these defects are, in 
fact, caused primarily by alterations to Rho signalling, compounds to regulate 
these pathways could have markedly effective therapeutic potential.  
 
Polarity determination in MKS 
 
It should be noted that multiple signalling pathways converge on Rho/ROCK 
signalling; these include transforming growth factor (TGF)β (Zhang, 2009) and 
vascular endothelial growth factor (VEGF; van der Meel et al., 2011). However, 
there is evidence to suggest that these defects occur in the Wnt/PCP signalling 
pathway, as discussed in Chapter I and the subsequent sections. The signalling 
upstream of the Rho/ROCK defects is not investigated in the current thesis, but 
should be evaluated in future experiments, for instance, by examination of the 
effects of inhibitors of the candidate upstream pathways upon the cellular 
defects. 
A number of Wnt/PCP pathway components influence cell polarity and 
directional protein trafficking – processes important to ciliogenesis – and in the 
effective polarised protrusion and consequential migration required for 
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convergent extension in vertebrates (Heisenberg et al., 2000; Wallingford et al., 
2000; Wang et al., 2006). The present results regarding morphological 
alterations to the Golgi beg the question of whether directional protein 
trafficking, a function of cell polarity, has also been perturbed. Is loss of polarity, 
directional protein trafficking, ROCK pathway dysregulation, or another factor 
the primary defect? As disruption to PCP results in neural tube closure defects 
(Jessen et al., 2002) comparable those seen in ciliopathies (Badano et al., 
2006b), this pathway may be a pertinent subsequent avenue of investigation.  
We have found defects in polarised migration in MKS patient cells (Barker 
et al., unpublished data), which is a phenotype also observed in inversin 
mutants (Veland et al., 2013). Inversin is a ciliary protein and the gene product 
mutated in NPHP2, a form of nephronophthisis; it also functions as a molecular 
switch between Wnt signalling pathways during renal development in zebrafish 
and convergent extension movements in gastrulating Xenopus laevis embryos 
(Simons et al., 2005).  
In establishing cell polarity, a global directional cue is required to orient a 
field of cells. Wnt is thought to function as such a polarity cue in vertebrates, 
using a signalling gradient. For instance, in mouse and chick limb bud, Wnt5a 
gradients are translated into directional information using variable 
phosphorylation of Vangl2 (a Wnt/PCP pathway component) in a Wnt-receptor 
complex. The most highly phosphorylated Vangl2, corresponding to highest 
Wnt5a expression, is located at the most distal processes and the least 
phosphorylated at the proximal processes (Gao et al., 2011), causing 
asymmetric limb outgrowth. Vangl2 is also enriched at the basal body (Ross et 
al., 2005). Wnt11 released from the neural tube, similarly, acts through the 
Wnt/PCP pathway as a necessary directional cue for myocytes, enabling 
muscle fibre organisation in the chick embryo (Gros et al., 2009). 
The mechanistic link between PCP signalling and the cilia is not precisely 
known, although some components localise to the cilium and are required for 
ciliogenesis (e.g. Fuzzy localises to cilia in multiciliated cells (Gray et al., 2009)). 
Wdpcp, a PCP effector, has recently been demonstrated to be required in 
ciliogenesis in addition to its role in noncanonical Wnt/PCP signalling; Wdpcp-
deficient mice showed actin cytoskeletal defects (namely reduced membrane 
ruffling), smaller focal adhesions, and the disruption in cell polarity and directed 
cell migration typically associated with ciliopathies. Wdpcp-deficient cells were 
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not able to recruit necessary ciliary proteins (such as Mks1 and Sept2) to the 
transition zone, disrupting ciliogenesis (Cui et al., 2013). The authors suggest a 
separable role of Wdpcp in ciliogenesis and in actin dynamics, but it is more 
probable that one engenders the other. In light of the present results, I propose 
that ROCK pathway-induced actin cytoskeletal changes precede ciliogenesis 
defects. 
 
Protein trafficking in MKS 
 
Wnt/PCP effectors, such as Fuzzy and Inturned, are vital to membrane 
trafficking; this includes exocytosis in secretory cells (probably during tethering 
or fusion), trafficking to basal bodies and to the apical tips of cilia (Gray et al., 
2009), and is key in ciliogenesis. Ciliopathy phenotypes such as polydactyly 
occur in the absence of these factors, which likely results from the absence of a 
cilium (and thus dysregulated Hedgehog signalling) and impaired secretion 
(Gray et al., 2009). Relatedly, Cdc42, an effector of Ca2+-dependent non-
canonical Wnt signalling, is used for fusion of the exocyst to form a ciliary 
vesicle at the base of the primary cilium in order to enable ciliogenesis (Zuo et 
al., 2011); perturbation of this process would clearly have detrimental defects on 
ciliary membrane extension. 
I have demonstrated in the current chapter that the structure of the Golgi 
apparatus is perturbed in MKS patient cells in a similar fashion to constitutively 
active ROCK-induced Golgi dispersal in control cells. Such an effect on the 
Golgi is unsurprising as previous evidence indicates that Rho signalling is 
essential for Golgi biogenesis (Quassollo et al., 2015), and Rho signalling is 
known to be dysregulated in these cells. Furthermore, nesprin-2 interacts with 
meckelin to mediate actin cytoskeletal changes (Dawe et al., 2009), but this 
nuclear envelope protein is also an essential determinant of Golgi organisation 
and cell polarisation (Schneider et al., 2011); it may be that failure of meckelin 
to interact with nesprin-2 prompts Golgi dispersal. However, no conclusions 
may be drawn about Golgi function in these cells from the present results alone.  
It is possible that the Rho hyperactivity induced by MKS protein mutations 
also provokes vesicular trafficking defects; ciliogenesis and Golgi organisation, 
which both require appropriate protein trafficking, may be perturbed directly by 
dysregulation of Rho signalling. However, these trafficking defects may, 
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alternatively, occur through an intermediary action, such as alteration to the 
organisation or function of the cytoskeleton.  
 
Rho in vesicular trafficking during ciliogenesis 
 
Vesicular trafficking is crucial for ciliogenesis; molecules to be transported 
into the cilium must first be transported to the basal body, signals transduced 
through the cilium must be transported via intraflagellar transport and, to initiate 
ciliogenesis, the basal body associates with membrane-bound vesicles in order 
to dock at the apical plasma membrane. Association of the basal body with 
membrane-bound vesicles is dependent on Rho GTPase activation (specifically 
at the basal body), and is Inturned- and Dvl-mediated (Park et al., 2008).  
Immune synapses are a focal point of endocytosis and exocytosis, directed 
by centrosomal docking, and are believed to represent a “frustrated cilium” (de 
la Roche et al., 2013; Griffiths et al., 2010). Notably, Dvl regulates distribution of 
presynaptic markers and function of the immune synapse (Ahmad-Annuar et al., 
2006), implying that Dvl may have a similar function to facilitate vesicular 
trafficking to, from and within the cilium, potentially in basal body docking.  
Failure of the basal body to dock is an established PCP defect in Mks-
knockdown and the current patient cells (Adams et al., 2011; Dawe et al., 2007; 
Mahuzier et al., 2012) and is associated, crucially, with the marked actin 
cytoskeletal remodelling observed in MKS patient cells (Dawe et al., 2009; Pan 
et al., 2007; Valente et al., 2010). However, these are not the only examples in 
which PCP-dependent actin remodelling has been demonstrated as essential 
for basal body docking during ciliogenesis. For instance, Foxj1 is a vital 
transcription factor responsible for increasing RhoA activation during 
ciliogenesis, causing apical actin network development, and thus promoting 
basal body docking (Pan et al., 2007), illustrating the necessity of both PCP 
signal transduction and actin remodelling during the initial stages of 
ciliogenesis. This provides support for a hypothesised role of the MKS proteins 
in Rho signal pathway transduction or regulation. 
However, it is necessary to note that cell shape affects actin network 
contractility and resultant basal body positioning and ciliogenesis. When 
compared with cells with a greater area (as these patient cells possess), 
spatially-confined cells develop contractile actin on their ventral surface, 
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protrusive actin structures on their dorsal surface; furthermore, cilia, which tend 
to be longer, are more frequently generated. It should also be noted that cells 
with a greater area also are more likely to develop contractile cortical actin 
bundles (Pitaval et al., 2010).  
Appropriate ROCK activity is required for centriole migration and docking at 
the apical surface; however, elongated cells display cilia protruding from ventral 
basal bodies following ROCK inhibition, suggesting that cell contractility and 
Rho signalling independently act upon basal body docking and axoneme 
extension (Pitaval et al., 2010).  
Not only does the centrosome fail to dock in multiple ciliopathies, but many 
of these exhibit other centrosomal defects, including centrosomal amplification. 
A previous study of MKS models, including MKS1 and -3 patient cells and 
shRNA knockdown of Mks1 and Mks3 in IMCD3 cells reported cilia and 
centrosome over-duplication (Tammachote et al., 2009). Centrosome 
amplification is known to be ROCK-dependent (Ling et al., 2015), and inhibition 
of p160ROCK (ROCK1) causes centrosomes to split and microtubule-
dependent docking defects (Chevrier et al., 2002), so this is a subset of 
phenotypes of interest to us. 
Finally, multiple phenotypes correlating with this proposed role of MKS 
proteins upstream of other cellular defects are observed in other ciliopathies. 
BBS proteins interact with Wnt signalling pathways (canonical and 
noncanonical) (Corbit et al., 2008; Hernandez-Hernandez et al., 2013), are 
found at the cilium and participate in ciliogenesis (Kim et al., 2004; Nachury et 
al., 2007), interact with multiple facets of the actin cytoskeleton (Hernandez-
Hernandez et al., 2013; May-Simera et al., 2015), and facilitate membrane 
delivery to the primary cilium (Kim et al., 2004; Nachury et al., 2007).  The ways 
in which these protein complexes and behaviours work together in normal cells, 
and in ciliopathies, remain to be elucidated, but a Rho pathway-effected series 
of cellular phenotypes, such as ciliogenesis and cytoskeletal defects, is 
plausible considering the present results and previous ciliopathy research. 
 
Alternate roles of MKS proteins 
 
The present chapter aimed to address the hypothesis that aberrant 
Rho/Rho kinase (ROCK) signalling is responsible for the abnormal cellular 
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phenotypes observed in MKS patient cells. The current results indicate that Rho 
signalling is associated with the actin and Golgi defects observed in these cells, 
whether directly or through other downstream effects. The most likely 
alternative roles for MKS proteins besides directly regulating Rho/ROCK 
signalling are in centrosome cohesion, and in tethering the cytoskeleton to 
membranes.  
Rho/ROCK signalling does not require cilia, but may be dependent on basal 
body integrity (Huang and Schier, 2009); in a model in which MKS proteins had 
a centrosome cohesion role, Rho signalling might be affected by the 
perturbation to basal body structure caused by their mutation. Other cellular 
defects, such as prominent actin bundle development, may then result from this 
Rho perturbation. 
MKS proteins may alternatively be a cytoskeleton-membrane tether; BBS4, 
another ciliopathy protein, is required for the anchoring of microtubules at the 
centrosome (Kim et al., 2004), leaving the possibility that the “ciliopathy” 
proteins function in a complex in a cytoskeletal organisation capacity. The 
microtubule cytoskeleton is an unexplored but potentially key feature of these 
cells, so I next examined the organisation and post-translational modification of 
microtubules and their attachment to centrosomes in MKS patient cells. 
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CHAPTER V: MKS patient cells show defects in microtubule 
organisation 
 
5.1 Introduction 
 
 The microtubule (MT) cytoskeleton has diverse transport roles within cells, 
from protein trafficking to chromosome segregation, regulating cell shape, 
polarity and cell division. These functions, similarly to the actin cytoskeleton, are 
achieved through rapid reorganisation of MTs, necessitating the use of binding 
proteins. However, in the MTs, post-translational modifications are additionally 
used to impart changes in stability (Li and Gundersen, 2008). As a key 
structural component of the ciliary and flagellar axoneme (Borisy and Taylor, 
1967; Kozminski et al., 1995; Kozminski et al., 1993) – first described as 
“longitudinal filaments” within the 9+2 axoneme in 1954 (Fawcett), and 
subsequently identified as having tubulin subunits in sperm flagella (Mohri, 
1968; Shelanski and Taylor, 1967) - and of multiple vital cellular functions, MTs 
are an important focus of ciliopathy study. 
Research into MT structure, organisation and function in the field of 
ciliopathies has predominantly concerned interactions of the ciliary axoneme 
with the centrosome (as the basal body), a structure involved in MT minus end 
nucleation and tethering (Bialas et al., 2009; Delous et al., 2007; Drivas et al., 
2013; Valente et al., 2006).  
Limited research has investigated the properties of cytoplasmic MTs 
amongst ciliopathies. A previous study revealed that depletion of a BBSome 
subunit, BBIP10, leads to split centrosomes and to defects in MT polymerisation 
and acetylation that may be abrogated by inhibiting the BBIP10-interactor 
HDAC6, the histone deacetylase (Loktev et al., 2008). Furthermore, BBS4 is 
required for MTs to anchor to pericentriolar material; truncated versions of this 
protein cause defective targeting and anchoring of pericentriolar proteins and 
MT disorganisation (Kim et al., 2004).  
Similarly, emerging evidence suggests that overexpression of Arl13b – 
mutations in which cause Joubert syndrome – impairs α-tubulin acetylation, 
implicating  Arl13b in cilium length regulation through its effects on MT 
dynamics (Pintado et al., Cilia 2014 Conference (unpublished)). There has been 
very little previous study into the properties and regulation of MTs in the 
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ciliopathies in general, and none in MKS, meaning that this is a novel field of 
ciliopathy research. 
Previous studies (Dawe et al., 2009; Valente et al., 2010) have revealed 
actin defects in the present MKS patient cells, but currently no such information 
regarding the MT cytoskeleton exists. The MT and actin cytoskeleton are well-
established to interact in numerous ways, including via proteins such as MACF 
at stress fibres (Leung et al., 1999) and formins at the cell cortex (Heil-
Chapdelaine et al., 1999). Together with the emerging evidence reporting 
alterations to microtubule stability in other ciliopathies, it was therefore pertinent 
to next examine the properties of the cytoplasmic MT cytoskeleton in MKS 
patient cells. I therefore aimed to address the hypotheses that, in MKS patient 
cells, MTs are organised differently, and that they are structurally altered. 
 
5.2 Results 
 
Microtubules emanate from multiple, non-centrosomal foci 
 
I examined the microtubule cytoskeleton in MKS patient cells by fixing these 
and visualising α-tubulin. Microtubules in MKS patient fibroblasts appeared less 
radially organised, and to emanate from more than one focus more frequently 
than in wild-type cells (Figure 5.1). This was particularly pronounced in MKS2 
patient cells, so I investigated this phenotype in more depth in these cells. 
At higher magnification, it was apparent that single foci from which 
microtubules emanate were never observed in MKS2 patient cells [<1% 
compared to ~90% in control cells, n=300 cells across 3 experiments (red 
arrowhead, Figure 5.2)]; instead MTs radiate from no obvious source (Figure 
5.2, demonstrating representative focal planes) or multiple sites (Figure 5.3) in 
MKS2 patient cells. This suggests that MTs in MKS2 patient cells are 
emanating from non-centrosomal sources or from multiple centrosomal sites of 
nucleation, or that MTs are tethering at multiple locations throughout the cells. 
These data led me to question the nature of the foci that microtubules were 
emanating from. 
To test whether MTs were radiating from multiple spots of centriolar 
material (whether multiple centrosomes, or multiple centrosomal fragments), or 
from acentriolar sources, I fixed and co-stained these MTs and pericentrin to 
118
W
ild
-ty
pe
M
K
S2
M
K
S3
FIGURE 5.1: MKS patient cells exhibit a different microtubule organisation.
Microtubules were visualised using anti-α-tubulin. These appear radially 
organised and  emanate from a single, brighter focus (indicated with red arrows) 
more frequently in control than in MKS patient cells. Scale bar represents 40 μm.
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FIGURE 5.2: Single MT foci are not observed in MKS2 patient cells.
Microtubules were visualised using anti-α-tubulin. These emanate from a single 
focus in wild-type cells (red arrowhead), but multiple sites (not shown) or no 
obvious site in MKS2 patient cells. Images used are single-plane, single-channel 
images that are representative of microtubules on all planes throughout these 
cells. Scale bar represents 20 μm.
120
visualise the pericentiolar material (PCM). The MTs in control cells radiate out 
from a single region of pericentrin staining (Figure 5.3), but MTs in MKS2 
patient cells emanate from multiple regions, a number of which may be 
associated with pericentrin and a number of which are not (yellow arrowheads, 
Figure 5.3), implying that at least a proportion of the microtubules are nucleated 
or tethered at non-centrosomal sites. These results caused me to examine the 
degree to which MT minus ends associate with this pericentriolar material. 
I investigated at the MT-PCM association in greater detail by examining MT 
minus ends and pericentrin in multiple regions of the cell at high magnification. 
Wild-type cells demonstrated a markedly close association of MT ends with 
clearly-defined PCM (Figure 5.4); however, PCM (Figure 5.4, Sections A) was 
on a completely different focal plane to MTs (Figure 5.4, Sections B) in MKS2 
patient cells (at least 1.5 µm apart; n= 20 cells per cell line). This suggests that 
the MT minus ends are not nucleated at or not stably tethered to centriolar 
material, possibly due to centrosomal splitting implied by the multiple pericentrin 
spots (Figure 5.3).  
 
Tyrosination and acetylation of microtubules are altered in MKS patient 
fibroblasts 
 
New MTs are established to be tyrosinated (Barra et al., 1974; Bre et al., 
1987; Gundersen and Bulinski, 1986; Gundersen et al., 1984). Therefore, to test 
whether the multiple MT foci in MKS patient cells represent newly-formed MTs, 
or whether older, more stable MTs are being remodelled differently in these 
cells, I next looked at MT tyrosination and acetylation patterns. 
I demonstrated that tyrosinated MTs typically do not emanate from a single 
focus in MKS patient cells (Figure 5.5), but they do in control cells (red 
arrowheads indicating bright spots of tyrosination, Figure 5.5); instead, 
tyrosination appears to disperse fairly equally along MTs in MKS patient cells, 
with no obvious MT minus ends being visualised. This implies erroneous 
behaviour of new MTs, specifically during assembly; this indicates that at least a 
subset of MTs are being incorrectly nucleated or tethered. 
I next investigated whether stable microtubules appear different in MKS 
patient fibroblasts as this may reveal defects in maintenance, turnover and 
anchoring of MTs. This was achieved by visualising acetylated MTs, a marker of 
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FIGURE 5.3: Multiple pericentrin-rich foci, and multiple MT foci at numerous 
sites are observed.
Microtubules were visualised using anti-α-tubulin (green), and PCM visualised 
using anti-pericentrin (red). Microtubules emanate from a single pericentrin spot 
in wild-type cells, but from multiple pericentrin spots or from no apparent PCM 
(yellow arrowhead) in MKS2 patient cells. Scale bar represents 20 μm.
122
W
ild
-ty
pe
M
K
S2
FIGURE 5.4: Microtubule ends are not markedly associated with centriolar 
material in MKS2 patient cells.
Microtubules were visualised using anti-α-tubulin (green), and PCM visualised 
using anti-pericentrin (red). Two images were captured of each region in MKS2 
patient cells - one of the centrosome (A), and one of the focal plane of the MTs (B). 
A and B images were always >1.5μm apart. Scale bar represents 10 μm.
Region 1 Region 2
Region 3 Region 4
Region 1 Region 2
Region 3 Region 4
A A
B B
A A
B B
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FIGURE 5.5: Tyrosinated microtubules do not emanate from a single focus 
in MKS patient cells.
Tyrosinated MTs were visualised using anti-YL1/2. Tyrosinated MTs emanate 
from single foci less commonly in MKS patient cells than wild-type cells 
(demonstrated at higher magnification in enlarged regions). Scale bar represents 
40 µm.
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stable MTs, using anti-acetylated tubulin. I revealed that acetylated tubulin 
staining was spread further across the cytoplasm in MKS patient cells (Figure 
5.6), suggesting that stable microtubules extend further across these cells. This 
could indicate a defect in microtubule maintenance or turnover. 
It was thus of interest to examine the nucleation of MTs, to determine the 
stage at which MTs display aberrant organisation. Following a 45 minute 
nocodazole treatment, I observed MT regrowth two minutes after washout and 
revealed that MTs are present at non-centrosomal sites in MKS patient cells 
(2 min, Figure 5.7, yellow arrowheads), in addition to radiating from γ-tubulin-
rich regions. However, in control cells, MTs are solely seen associated with 
these presumed centrosomes (2 min, Figure 5.7). MTs, whether centrosomal or 
acentrosomal, were not observed before this washout stage (0 min, Figure 5.7). 
This implies firstly that defects in MT organisation are observed almost 
immediately, and secondly confirms errors in nucleation, stabilisation or 
tethering of these structures at a centrosome. Importantly, these data indicate 
that MT organisational changes in MKS patient cells cannot solely be attributed 
to loss of centrosome integrity, as the centrosome appears intact in these cells. 
 
5.3 Discussion 
 
In the present series of experiments, I endeavoured to ascertain whether 
MKS patient fibroblasts exhibit defects to the MT cytoskeleton, as there is 
evidence of changes to MT anchoring associated with BBS (Kim et al., 2004) 
and to MT acetylation associated with Joubert syndrome (Pintado et al., Cilia 
2014 Conference (unpublished)).  
I observed a disorganised MT cytoskeleton in MKS patient cells, revealing 
errors in localisation of MT ends to a single centrosome or to centriolar material 
in MKS2 fibroblasts. Instead, MTs appear to emanate from multiple foci of 
unknown molecular constitution in MKS2 patient cells. These cells 
demonstrated multiple spots of pericentrin, but MTs were observed on a 
separate focal plane to these. These data indicated that MTs do not have minus 
ends embedded in a centriole in these patient cells; the disorganised MT 
cytoskeleton was concluded to have non-centrosomal origins.  
This is a novel area of research – no studies to date report upon the MT 
cytoskeleton in MKS and a limited number of studies report defects to the 
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FIGURE 5.6: Acetylated MTs are dispersed in MKS patient cells.
Acetylated MTs were visualised using anti-acetylated tubulin (green), shown 
alongside nuclear staining (DAPI, blue). Acetylated MTs are spread further 
through the cytoplasm in MKS patient cells than wild-type cells. Scale bar 
represents 40 µm.
M
K
S3
126
W
ild
-ty
pe
M
K
S2
FIGURE 5.7: MTs are present at acentrosomal sites following nocodazole 
treatment of MKS patient cells.
Microtubules were visualised using anti-α-tubulin. MTs emanate from the 
centrosome (γ-tubulin, red; and inset, red box) in MKS patient cells and control 
cells 2 mins after washout of nocodazole, but are also observed growing at 
acentrosomal sites (yellow arrowheads) in MKS patient cells. MTs are not 
observed in any cell line following this nocodazole treatment. Nuclei were 
visualised using DAPI (blue). Scale bar represents 10 μm.
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cytoplasmic MTs in ciliopathies (Kim et al., 2004; Loktev et al., 2008), with fewer 
still beginning to report post-translational modifications to MTs (Loktev et al., 
2008; Pintado et al., Cilia 2014 Conference (unpublished)).  
I observed differences in the tyrosination and acetylation of cytoplasmic 
MTs in MKS patient cells. Tyrosinated MTs commonly emanated from more 
than one focus, and acetylated microtubules were spread throughout the cell to 
a greater degree. Firstly, the dispersed localisation of tyrosination, a marker of 
newly assembled MTs, implies that MTs are polymerising at more than one 
location. This was supported by my observation that MTs were present at 
multiple locations following nocodazole washout. However, these cells also 
revealed MTs radiating from a single presumed centrosome and, from this, I 
cannot exclude the possibility of MTs being nucleated and stabilised at multiple 
locations throughout the cell. Based on the demonstrable absence of γ-tubulin 
spots and of MT ends at pericentrin spots after this stage, it is more probable 
that MTs are nucleated here and subsequently become untethered (and 
potentially tethered elsewhere), or that they break and disperse throughout the 
cell. 
The prevalence of stable, acetylated microtubules throughout the cytoplasm 
indicates no difficulty of MKS patient cells in nucleating and stabilising 
microtubules. Instead, it appears that MTs are built and stabilised and are 
inappropriately positioned; this could be due to hyperstabilisation of 
microtubules, or tethering of microtubules at multiple subcellular locations. To 
conclude, it appears that MTs are nucleated at the centrosome and at other 
acentrosomal sites, they break or untether, then inappropriately stabilise 
throughout the MKS patient cells. 
This is an important discovery, firstly as MTs effect crucial cellular roles 
and, secondly, as other subcellular defects (such as in the Golgi and in 
ciliogenesis) may be caused by or associated with these MT/centrosome 
phenotypes. As MT defects have not previously been examined in MKS, such 
an association has yet to be investigated, but MT defects may underlie other 
subcellular defects associated with MKS, and possibly even other ciliopathies. 
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Microtubule asymmetry and reorganisation 
 
The organisation and structure of the MT cytoskeleton is extremely 
important for its function. In order to support polarised functions, such as cell 
migration and vesicular trafficking, the MT network must be asymmetric. During 
cell motility, protrusive actin structures may form in the absence of MTs, but 
MTs are required to enable their polarised distribution (Vinogradova et al., 
2009). 
MTs typically radiate from a centrosomal MT organising centre (MTOC), 
with their plus ends at the cell edges. Mesenchymal motile cells such as 
fibroblasts extend their MT array primarily in the direction of movement, 
presumably to direct vesicular trafficking and actin polymerisation here; 
similarly, neurons display distinct MT asymmetry corresponding to their 
necessary vesicular transport functions (Vinogradova et al., 2009).  
By contrast, in the epidermis basal cell MTs emanate from an apical 
centrosome, and suprabasal cell MTs nucleate at cell-cell junctions. Upon 
differentiation of the epithelium, MTs are often (but not always) dissociated from 
the centrosome, which does not lose its ability to nucleate. This allows MTs to 
be arranged in an apical web and longitudinal bundles, with minus ends spread 
over the apical region and plus ends at the basal region (Bacallao et al., 1989; 
Lechler and Fuchs, 2007). 
The centrosome typically nucleates radially symmetric MTs at the cell 
centre (Holy et al., 1997; Salaycik et al., 2005), which are then distributed by a 
number of possible mechanisms if a cell is to create asymmetry. 
 
Alterations to microtubules to generate asymmetry 
  
One such mechanism is spatial regulation of MT stabilisation and 
catastrophe. MTs constantly undergo periods of catastrophe and rescue 
(Kirschner and Mitchison, 1986), which can be performed selectively by the cell 
to generate an asymmetric MT network. Various cellular activities make this 
possible, one being enrichment of MTs in posttranslationally modified tubulin, 
such as detyrosinated tubulin, to create more stable MTs in distinct regions 
(Gundersen and Bulinski, 1988; Salaycik et al., 2005). Focal adhesions - used 
to attach to the extracellular substrate during cell migration and spreading - 
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conversely, act as a common site of catastrophe, with particular frequency at 
the cell rear (Efimov and Kaverina, 2009; Efimov et al., 2008). 
As mentioned, hyperstabilisation of MTs may be responsible for their 
disorganisation in MKS patient cells. Hyperstabilisation may be caused by 
ineffective depolymerisation (e.g. at focal adhesions) or by spatially 
inappropriate posttranslational modification of the MTs; if the cell does not 
effectively polarise, the latter is especially likely as MTs may be ubiquitously 
stabilised regardless of location. 
A study of the BBSome subunit BBIP10 revealed a requirement for this 
protein but no other tested BBS protein (BBS1, BBS12 or PCM-1) in MT 
acetylation (Loktev et al., 2008). This previous study concluded that BBIP10 is 
required to stabilise MTs in vivo, and that the decreased acetylation and density 
of microtubules observed upon BBIP10 depletion result from global MT 
destabilisation. This study also demonstrated multiple foci of pericentrin and γ-
tubulin staining when BBIP10 is absent, resembling the phenotypes I observe in 
MKS patient cells. These split centrioles were, importantly, able to nucleate but 
not to anchor MTs (Loktev et al., 2008). The MT dynamics observed in BBIP10-
depleted cells correlates with the MKS patient cell phenotypes, i.e. MTs appear 
to be nucleated but not anchored at split centrioles, and this is an important 
study as these data indicate partial loss of function of the centrosomes in these 
cells. However, depletion of BBIP10 hindered stabilisation and, separably, 
acetylation of MTs (Loktev et al., 2008), but the opposite appears to be true of 
MKS cells.  
A related mechanism of asymmetric MT array generation is through use of 
MT-binding proteins, such as MAPs, +TIPs, and motors, to move or modify MTs 
in the array. The current hypothesis in the field is that posttranslational 
modifications of tubulin mark subsets of MTs to affect downstream recruitment 
and behaviours of these effector proteins (Verhey and Gaertig, 2007). It 
appears that posttranslational modification can have a stabilising effect, and 
that stabilisation can also result in posttranslational modification (e.g. 
acetylation and detyrosination), but that these can also occur independently 
(Wloga and Gaertig, 2010). 
For example, katanin, a microtubule-severing protein required for motile 
cilia biogenesis, acts as a negative regulator of posttranslational modifications 
in the cell body (Sharma et al., 2007). Polyglutamylation of MTs affects the 
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binding of MAP1A and MAP1B, however; these are proteins thought to be 
involved in MT assembly through tubulin conformational changes (Bonnet et al., 
2001). Tubulin detyrosination impedes association of some +TIPs, plus-end 
tracking proteins, with MTs (Verhey and Gaertig, 2007). Tubulin detyrosination 
and acetylation are also known to decrease binding and motility of kinesin-1 
(Reed et al., 2006), and tubulin acetylation positively regulates dynein binding 
capacity (Dompierre et al., 2007), plus- and minus-end motors (respectively) 
involved in the majority of MT functions.  
With regard to my results, the increased acetylation and more widespread 
tyrosination may therefore impact upon the behaviour of MT-binding proteins 
such as these. For instance, dysregulated motor protein behaviour may result 
from these posttranslational modifications. This could alter extensive cellular 
behaviours such as migration, during which kinesin and dynein function in 
nuclear positioning (Scheffler et al., 2015; Tsai et al., 2010), substrate adhesion 
(Krylyshkina et al., 2002), secretion of matrix proteases (Bachmann and 
Straube, 2015), and delivery of mRNA encoding β-actin and Arp2/3 complex 
components to the leading edge, promoting protrusion (Mingle et al., 2005; 
Oleynikov and Singer, 1998). These are a few of a plethora of other necessary 
roles of MT motor proteins alone, not mentioning other MT-interacting proteins, 
indicating how impactful these posttranslational MT alterations could be. 
Microtubule-binding proteins, such as kinesins, have been thoroughly 
investigated in the ciliopathies during intraflagellar transport (IFT), affecting 
features including cilium length, for instance (Cole et al., 1998; Rosenbaum and 
Witman, 2002). Indeed, proteins perturbed in ciliopathy, such as BBSome 
subunits, are constituents of the mammalian IFT particle (Williams et al., 2014). 
Furthermore, there are numerous links between mutations in IFT components 
and ciliopathy, particularly skeletal ciliopathies; for instance, Jeune syndrome 
and and Mainzer-Saldino syndrome can both be caused by defects in IFT172, 
an IFT-B component (Halbritter et al., 2013). MAP4 has also been associated 
with ciliary and Golgi architecture. In a series of experiments, Zahnleiter et al. 
(2015) reported that patient cells with MAP4 mutations demonstrate cellular 
phenotypes reminiscent of those observed in MKS patient cells, such as 
supernumerary centrosomal spots, decreased percentage of ciliated cells (and 
shorter cilia), and dispersed Golgi. These data imply a focal role of aberrant MT-
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associated functions during the manifestation of these diseases, but are yet to 
elucidate the scope or exact nature of their role. 
In addition to modulating actin cytoskeletal function, the Rho GTPases also 
influence posttranslational modification and stability of MTs, particularly during 
polarisation. ROCK modulates MT acetylation by phosphorylating tubulin 
polymerization promoting protein 1 (TPPP1/p25), which inhibits histone 
deacetylase 6 (HDAC6), an important enzyme in MT acetylation; this process is 
also essential to cell migration, as revealed in a wound closure assay (Schofield 
et al., 2012). Furthermore, Rho and its downstream effector mDia are required 
to selectively generate detyrosinated MTs at a wound edge (Cook et al., 1998; 
Palazzo et al., 2001a), affecting MT stability here to enable polarised migration. 
MT tip proteins enhance cortical capture of MTs using Rho-controlled selective 
stabilisation at a wound edge. This has been demonstrated to occur through 
direct interaction of cortical proteins with MTs and through indirect bridging 
using actin filaments (Gundersen et al., 2004). 
With this evidence in mind, it is apparent that dysregulation of Rho/ROCK 
signalling could be a factor underlying the aberrant posttranslational MT 
modifications observed in MKS patient cells. As these changes to MT structure 
and organisation may be responsible for migration, polarity and a number of 
other cellular defects in MKS, it is possible that Rho/ROCK signalling alterations 
may precede MT defects and may therefore indirectly effect all concomitant 
cellular defects. 
 
Alternative mechanisms for generating MT asymmetry 
 
Another mechanism for generating asymmetry is to nucleate MTs at or 
reassign MTs to a γ-tubulin-rich non-centrosomal site, such as the Golgi (which, 
with the centrosome, reorients to the leading edge) (Efimov et al., 2007; Rivero 
et al., 2009), or an apical membrane (Bellett et al., 2009; Meng et al., 2008; 
Mogensen et al., 2000). 
Golgi dispersal can be caused by MT depolymerisation or inhibition of 
dynein function; centrosomal MTs are responsible for pericentrosomal location 
of the Golgi, whereas Golgi-nucleated MTs maintain Golgi ribbon integrity (Rios, 
2014). It is therefore possible that an altered MT nucleation site or loss of 
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centrosomal anchorage cause Golgi dispersal in MKS patient cells through 
disorganisation of centrosomal MTs.  
Golgi-derived MTs also function in vesicular trafficking, providing tracks 
toward the cell front, and cell polarity (Zhu and Kaverina, 2013). Cells lacking 
Golgi-derived MTs migrate more slowly in wound-healing assay, probably due 
to dysfunctional protein trafficking to the leading edge (Hurtado et al., 2011), 
illustrating the importance of correctly nucleated MTs in directional migration. It 
would therefore be logical that, in MKS patient cells, cytoskeletal defects induce 
Golgi defects, with a number of downstream consequences associated with 
vesicular trafficking. 
As in centrosome-nucleated MTs, dynein is used to anchor Golgi-nucleated 
MTs (Rivero et al., 2009); however, unlike centrosome-nucleated MTs, which 
are radially organised, the Golgi preferentially orients MTs towards the leading 
edge of motile cells to generate asymmetry (Efimov et al., 2007). 
 In polarised cells such as epithelia, MTs are rearranged from a radial, 
centrosomal array into a non-centrosomal array (Bacallao et al., 1989). This 
occurs by centrosomal nucleation of MTs, followed by reassignment of MTOC 
function, which occurs by movement of nucleators such as γ-tubulin (Feldman 
and Priess, 2012) and MT minus-end anchoring proteins such as ninein 
(Mogensen et al., 2000) to the apical membrane. Subsequently, MT plus-ends 
are captured at the adherens junctions and link to cortical dynein to provide the 
mechanical force needed for release and translocation of MTs from 
centrosomes to apical sites (Bellett et al., 2009; Meng et al., 2008). It has been 
proposed that generation of non-centrosomal apico-basal MT arrays in 
polarised epithelia is predominantly through this MT plus- and minus-end 
capture, as opposed to nucleation at these locations (Bellett et al., 2009). 
Removal of MT anchoring protein CAMSAP3 in HeLa cells, a minus-end 
binding protein that stabilises non-centrosomal MTs, leads to an increase in 
centrosomal MTs, which are more detyrosinated than the non-centrosomal 
MTs. In a previous study, depletion of this protein led to upregulation of RhoA, 
and associated actin stress fibre formation due to increased RhoGEF activity, 
which is normally inhibited by MT binding. These data also revealed that non-
centrosomal MTs capture GEF-H1 better than detyrosinated, centrosomal MTs 
(Nagae et al., 2013). This was a critical finding as this indicates that different 
populations of MTs have different interactions with signalling molecules, such 
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as Rho pathway components, meaning that maintaining the correct balance has 
important implications for other cellular structures, and for cellular behaviours. 
This is important when considering the MKS cellular phenotypes; 
posttranslational differences to the MTs may occur upstream of ROCK pathway 
hyperactivation, and thereby actin defects and potentially Golgi defects, or of 
other signalling pathway dysregulation. 
Nucleation and anchoring of MTs at alternate sites and the de-anchoring of 
centrosomal MTs also observed following BBS4 silencing (Kim et al., 2004) may 
be associated with a number of ciliopathy defects. For instance, these may be 
associated with Golgi dispersal as centrosomally-nucleated MTs maintain Golgi 
morphology (Rios, 2014), with directional cell migration and with centriole 
migration defects during ciliogenesis as Golgi-nucleated MTs are required for 
both (Rios, 2014), and with Rho-mediated actin stress fibre formation. From my 
results, I cannot definitively link Rho activity to posttranslational MT 
modifications or to the increased number of MT foci observed in MKS patient 
cells, but these data provide additional evidence that these may be connected. 
Non-centrosomal arrays of MTs are more typically seen in differentiated cell 
types (Bartolini and Gundersen, 2006), perhaps indicating that the MKS patient 
cells may be displaying numerous epithelial-like phenotypes. Relatedly, the MT 
array can be asymmetrically repositioned by subcellular migration of the 
centrosome; MTs anchored to the actin cortex provide the pulling force required 
for this (Tang and Marshall, 2012).  
Centrosomal repositioning occurs during cell division, migration, immune 
synapse formation and ciliogenesis (Tang and Marshall, 2012). It is known that 
Mks1 and -3 siRNA knockdown and mutation of TMEM216 in the current patient 
fibroblasts block centriole migration during ciliogenesis (Dawe et al., 2007; 
Valente et al., 2010) and centrosome orientation during cell migration 
(unpublished data), The disorganised MT cytoskeleton in MKS patient cells may 
therefore be due to misplacement of the centrosomal array of MTs, possibly 
linked to the aberrant actin structures observed in these cells. 
Noncanonical/PCP Wnt signalling through Cdc42/aPKC is responsible for 
centrosome reorientation and the resultant establishment of MT polarity in 
fibroblasts and HeLa cells (Kodani et al., 2009; Palazzo et al., 2001b; 
Schlessinger et al., 2007), processes which are perturbed in MKS cells. The 
present and previous data support failure of the centrosome to correctly polarise 
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as a primary defect in these cells; however, if this were the primary role of MKS 
proteins, it would be hard to explain the altered posttranslational modifications 
and apparent increased number of foci in the MTs of these cells.  
It is far more probable that a Rho signalling defect in MKS precedes failure 
of the centrosome to reorient and, whether dependently or independently of 
this, MT and actin structural and organisational defects. Whether or not Rho 
dysregulation is responsible, appropriately regulated actin and MT networks are 
required to implement directional migration (Magdalena et al., 2003) and these 
are both aberrant in MKS patient cells, meaning that either or both may be 
responsible for migration defects. 
In investigating my hypotheses that MKS patient cells have differently 
organised and structurally altered MTs, I have demonstrated altered sites of MT 
emanation and changes to posttranslational modifications of these, which are 
likely linked. It is unlikely that MKS proteins have independent roles in MT, actin 
and Golgi organisation and Rho signalling in cells; it is more probable that a 
primary defect instigates structural or morphological changes to the cell, or 
signalling cascades, which cause the other defects. I therefore aimed to 
temporally determine the primary cellular defect with the aim of better 
disentangling the molecular aetiology of MKS phenotypes. 
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CHAPTER VI: Microtubule defects temporally precede, but do 
not cause, the other cellular defects 
 
6.1 Introduction 
 
The microtubule (MT) and actin cytoskeleton are established to interact in a 
range of functions, such as mitosis and directional cell migration (Waterman-
Storer and Salmon, 1999), during ciliogenesis (Lemullois et al., 1988; Park et 
al., 2006), and in Golgi positioning and function (Gad et al., 2012; Shen et al., 
2012). It is therefore not illogical to suppose that the observed phenotypic 
defects (i.e. prominent actin bundles, changes to MT foci, Golgi dispersal) may 
be associated with each other, or to a primary defect upstream of these. 
Multiple molecular components are known to be behind MT-actin 
interaction, with Rho pathway components governing a large proportion; for 
instance, microtubule-actin crosslinking factor (MACF) binds actin and stabilises 
MTs (Leung et al., 1999), and has been shown to participate in Wnt/β-catenin 
signal transduction (Chen et al., 2006). MACF1b localises to the Golgi (Lin et 
al., 2005), reflecting a role in regulating the actin and MT cytoskeletons here, 
and of these in regulating Golgi function (Kakinuma et al., 2004). 
A number of other Rho pathway effectors, such as mDia1, are known to be 
MT-actin interactors. This is a formin homology protein which aligns MTs 
parallel to F-actin bundles (Ishizaki et al., 2001), possibly to facilitate cellular 
processes such as cell migration. WHAMM, similarly, is coordinated by RhoD 
and its effectors in Arp2/3- and filamin A-dependent cytoskeletal dynamics, 
effecting such functions as cell adhesion and cell migration (Gad et al., 2012). 
Defects or dysregulation of such integrators of signalling, cytoskeleton and the 
Golgi – which may be the primary function of MKS proteins - is the most 
parsimonious explanation for the defects observed. 
The Golgi is a site of MT nucleation (Efimov et al., 2007), and both actin 
and MTs are used to position the Golgi and enable its function (Egea et al., 
2013). Multiple MT-actin interactors operate at the Golgi, such as WHAMM 
(Campellone et al., 2008; Shen et al., 2012), functionally integrating all three 
subcellular structures. As these are all defective structures in MKS patient cells, 
cytoskeleton-Golgi interactors are of obvious interest.  
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Determining the temporal occurrence of the cytoskeletal and Golgi defects 
may help us to elucidate the primary defect that is causative of the other 
defects. I thus aimed to resolve the temporal order in which the phenotypic 
defects occur, testing the hypothesis that these defects occur in a specific 
order, not simultaneously. Furthermore, I aimed to determine whether a 
connection exists between the MT defects and the Rho signalling pathway, as 
with the association of Rho with the actin defects. 
 
6.2 Results 
 
Microtubule organisational defects are the first to occur in MKS patient 
cells 
 
To examine whether the defects that I have characterised in actin 
organisation (Chapter III), MT post-translational modifications and organisation 
(Chapter V) and Golgi organisation (Chapter IV) occurred simultaneously or 
whether they could be temporally separated, I plated wild-type and MKS patient 
fibroblasts on collagen I-coated coverslips and fixed at 5 minute intervals, using 
immunofluorescence to visualise MT organisation (Figure 6.1), tyrosinated MT 
organisation (Figure 6.2), acetylated MT organisation (Figure 6.3), and Golgi 
complex organisation (Figure 6.4). 
I found that MT defects are apparent 20 minutes after plating (Figure 6.1). 
Within this time, MTs develop multiple, unidentifiable foci of emanation in MKS2 
patient cells, which contrast with the single foci often observed in control and 
MKS3 patient cells (red arrowheads, Figure 6.1). Within the first 20 minutes of 
plating, cells of all cell lines typically display few visible MTs, and thus MT foci 
are rare (Figure 6.1, 10-20 minutes). Following this stage, bright spots of α-
tubulin mark what is presumed to be individual MT foci, a concentrated mass of 
minus ends of MTs (red arrowheads, Figure 6.1). These foci cannot be resolved 
as easily in MKS2 patient cells. At 60 minutes after plating, single foci of MTs 
remain common in WT and MKS3 patient cells (red arrowheads, Figure 6.1), 
but no apparent single MT focus is observed in almost any MKS2 fibroblasts 
(MKS2 20-60 minutes, Figure 6.1). 
The same pattern was also true of tyrosinated MTs – within 20 minutes, 
these emanate from single foci (red arrowheads, Figure 6.2) more commonly in 
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Wild-type MKS2 MKS3
FIGURE 6.1: MKS patient cells develop MT defects within 20 mins.
MTs visualised using anti-α-tubulin. MTs emanating from single foci are marked 
with red arrowheads. Within 20 minutes, MTs emanate from unidentifiable foci 
more commonly in MKS2 patient cells. Scale bar represents 40 μm.
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Wild-type MKS2 MKS3
FIGURE 6.2: MKS patient cells develop differently-patterned tyrosination of 
MTs less than 20 mins after plating.
Tyrosinated MTs visualised using anti-YL1/2. Single foci are indicated with red 
arrowheads. Tyrosinated MTs emanate from an unidentifiable number of foci in 
MKS2 patient cells within 20 mins after plating. Scale bar represents 40 µm.
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control and MKS3 patient cells than in MKS2 patient cells. In MKS2 patient 
cells, MTs frequently have no clear single origin from 20-30 minutes until 60 
minutes following plating – they emanate, instead, from a more widespread, 
cytoplasmic region of immunofluorescence (Figure 6.2). 
To further resolve the differences between control and MKS patient cells, I 
next quantified the percentage of cells demonstrating each of these phenotypic 
defects. Control and MKS patient cells simultaneously generate MTs (0 foci, 
Figure 6.3) and simultaneously tyrosinate MTs (0 foci, Figure 6.4). Differences 
were reported at individual time points between control and MKS3 patient cells 
in the number of cells with MTs emanating from 1 or 2+ foci. Overall, however, 
there is no significant difference between control and MKS3 cell lines in the 
number of MT foci during the first hour after plating (p>0.05, χ2). However, the 
proportion of cells revealing MTs (Figure 6.3) and tyrosinated MTs (Figure 6.4) 
emanating from multiple foci is significantly increased (p<0.001, χ2) in MKS2 
patient cells at all time points (blue bars, Figure 6.3 and 6.4), demonstrating this 
as one of the earliest cellular defects. 
Acetylated microtubules are initially dispersed across the entire cytoplasm 
in control and MKS patient fibroblasts (20 minutes, Figure 6.5), but condense to 
a small, perinuclear region in wild-type cells around 30-40 minutes after plating 
(40 minutes, Figure 6.5). This acetylated MT condensation occurs 50-60 
minutes after plating in MKS2 patient cells, but acetylated tubulin appears to 
remain spread through the cytoplasm to a greater degree in these cells than in 
WT cells (60 minutes, Figure 6.5). 
The Golgi complex remained perinuclear in control and MKS3 patient cells 
over the 60 minute time course, but dispersal throughout the cytoplasm – in 
which sections appeared to “bud” away (red arrowheads, 50 minutes, Figure 
6.6) or extend throughout the cytoplasm (red arrowheads, 60 minutes, Figure 
6.6) - was observed from 40 minutes after plating in MKS2 patient fibroblasts 
(Figure 6.6). 
Quantification of the percentage of cells demonstrating acetylated tubulin 
centralisation indicates that this process begins to occur 15-20 minutes after 
plating in wild-type cells (dotted line, Figure 6.7), but not until later in MKS2 
patient cells. In MKS2 patient cells, this process appears to begin 30 minutes 
after plating, but the rate of centralisation across these cells only increases 
rapidly from 40 minutes after plating (continuous red line, Figure 6.7). 
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FIGURE 6.3: MKS2 patient cells demonstrate an increased number of MT foci. 
Graphs report mean percentage of cells demonstrating the displayed number of foci 
+/- SD. MTs show no site of emanation initially, but gradually MTs emanate from a 
single or multiple sites in roughly equal numbers between wild-type and MKS3 
patient cells, and multiple sites in MKS2 patient cells significantly more frequently 
(p<0.001, χ2).
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FIGURE 6.4: Tyrosinated MTs appear to emanate from an increased number of 
foci in MKS2 patient cells.
Graphs report the mean percentage of cells demonstrating the displayed number of 
foci +/- SD. Tyrosinated MTs show no site of emanation initially, but gradually MTs 
positive for anti-YL1/2 binding emanate from a single or multiple sites in roughly 
equal numbers between wild-type and MKS3 patient cells, and multiple sites in 
MKS2 patient cells significantly more frequently (p<0.001, χ2).
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Wild-type MKS2
FIGURE 6.5: MT acetylation remains dispersed for longer in MKS2 cells.
Acetylated MTs visualised using anti-acetylated tubulin and representative 
images are displayed, along with the percentage of cells demonstrating 
centralised MTs at these time points. Acetylated MT dispersal persists for 50 
minutes in MKS2 patient cells, but condenses 30-40 minutes after plating in 
control cells and, to a lesser extent, in MKS3 patient cells. Scale bar represents 
20 µm.
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Wild-type MKS2 MKS3
FIGURE 6.6: MKS2 patient cells reveal Golgi dispersal 40-50 mins after 
plating.
Golgi was visualised using anti-GM130 (green), and the nucleus using DAPI 
(blue). Golgi disperses in MKS2 patient cells (red arrowheads), but not in 
control or MKS3 patient cells, starting 40 mins after plating. Scale bar 
represents 40 µm.
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FIGURE 6.7: Acetylated tubulin centralises later and to a lesser extent in 
MKS2 patient cells, concurrently with Golgi dispersal.
Graphs report the mean percentage of cells with the relevant phenotype +/- SD. 
The proportion of cells demonstrating centralisation of acetylated tubulin staining in 
the first hour after plating is highly significantly different between control and MKS2 
patient cells (p<0.001, χ2). At an identical time point to centralisation of acetylated 
tubulin staining, the Golgi complex disperses in MKS2 patient cells.
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Centralisation of acetylated tubulin appears to occur concurrently with Golgi 
dispersal in MKS2 patient cells (blue line, Figure 6.7), suggesting that these 
defects may be directly or indirectly connected. 
In Chapter III, I demonstrated that the actin defects occur around 40 
minutes after plating in MKS2 patient cells. The present results therefore 
indicate that the MT defects are the first to occur - differences arise before 20 
minutes for all MTs and tyrosinated microtubules, followed by altered behaviour 
of the Golgi, acetylated microtubules and actin defects (simultaneously). 
These data, together with the data from Chapter V, imply that TMEM216 
mutations (in MKS2 patient cells) first cause MT defects; this may be due to 
aberrant centrosomal nucleation or anchoring of minus ends, or through 
inappropriate breakage or tethering of MTs. Subsequently, this appears to have 
an effect on MT stability, as indicated by the prolonged dispersal of acetylated 
tubulin staining throughout the cytoplasm. How MT defects interacted with Rho 
hyperactivity, or with the actin and Golgi defects (which temporally coincided 
with changes to acetylated tubulin localisation), however, was unclear from 
these data alone. Importantly, these defects occur before a cilium would 
normally develop, which would be observed over a period of hours, as opposed 
to minutes (Seeley and Nachury, 2010). These data are therefore indicative of 
intrinsic defects to cytoskeletal development. 
TMEM67 mutations (in MKS3 patient fibroblasts) did not reveal any of these 
cellular defects within the first hour of plating, but in Chapters III to V, I found 
that these defects are mimicked in these cells. I did not determine a temporal 
order of appearance of actin, MT and Golgi defects in MKS3 cells (other than 
determining that these all occur around 3-4 days following plating), but would 
presume that these followed a similar temporal order. However, the length of 
time taken for these defects to arise means that it is possible that these occur 
downstream of ciliary dysfunction. 
  
Rho pathway components affect microtubule behaviour 
 
I next aimed to test whether the MT foci are altered by manipulation of 
ROCK pathway components, which are implicated in the prominent actin bundle 
formation in Chapter IV, and in previous work (Dawe et al., 2009; Valente et al., 
2010). I transfected control and MKS2 patient cells with constitutively active and 
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dominant negative Rho, and with constitutively active (Δ3) ROCK and examined 
α-tubulin (as a MT marker) and γ-tubulin (as a centrosomal marker). MKS3 
patient fibroblasts were not examined as I had not resolved when changes to 
MT foci appear in these cells 
I demonstrated that transfection with constitutively active Rho (Q63L), 
dominant negative Rho (T19N) (Figure 6.8) and constitutively active ROCK 
(Figure 6.9) lead to MTs emanating from single centrosomal foci in >75% of 
MKS2 patient cells (n= 300 cells across 3 repeats of each experiment). This is 
not observed in any MKS2 patient cells in the absence of these constructs. 
These data imply that, similarly to the actin defects, dysregulation of Rho 
pathway signalling may also be connected to the MT defects in MKS patient 
cells. 
 
Microtubule defects and actin defects occur independently in MKS patient 
cells 
 
To ascertain whether the MT defects influence actin defects (and vice 
versa), I treated wild-type and MKS patient fibroblasts either with taxol (to 
stabilise microtubules) and nocodazole (to disassemble microtubules) – both 5 
minutes after plating (i.e. preceding microtubule defect occurrence) – and 
examined actin filaments an hour after plating. In another experiment, I treated 
cells with jasplakinolide (to stabilise actin filaments) or latrunculin B (to prevent 
actin assembly) – both 30 minutes after plating (i.e. preceding actin defect 
occurrence) - and visualised microtubules, fixing at an hour after plating, as 
cytoskeletal defects have occurred by this point in MKS2 patient cells (n= 3 
experiments under each drug treatment). 
Treating cells with nocodazole or taxol had no effect on the formation of cell 
body actin, but prevented the formation of MKS2-associated prominent actin 
bundles (Figure 6.10). This indicates that MKS-associated actin phenotypes 
likely occur downstream of the MT defects seen in MKS2 patient cells – 
disruption of MT organisation rescues normal actin bundle formation. 
Treatment with jasplakinolide and latrunculin B had equivalent effects on 
the MT cytoskeleton of all three fibroblast lines. Jasplakinolide caused MTs to 
elongate and tubulin staining to condense around the cell centre, with no 
identifiable focus of emanation in any cell line (Figure 6.11). Latrunculin B, 
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Q63L T19N
FIGURE 6.8: Dominant negative and constitutively active Rho decrease the 
number of MT foci in MKS2 patient cells.
MTs visualised using anti-α-tubulin (green), centrosomes visualised using 
anti-γ-tubulin (red and white arrowheads) and nucleus visualised using DAPI 
(blue). Electroporation with Q63L (constitutively active) and T19N (dominant 
negative) Rho generates MTs emanating from single foci more frequently in 
MKS2 patient cells, but electroporation with these constructs has no effect on 
control cells. Scale bar represents 40 μm.                                             
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FIGURE 6.9: Constitutively active ROCK affects the number of MT foci 
in MKS2 patient cells.
MTs visualised using anti-α-tubulin (green), centrosomes visualised using 
anti-γ-tubulin (red) and nucleus visualised using DAPI (blue). MTs emanated 
from single foci in MKS2 patient cells more frequently following transfection 
with constitutively active ROCK. Scale bar represents 40 μm.
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Taxol Nocodazole
FIGURE 6.10: MT disassembly and stabilising drug treatments cause 
MKS-associated prominent actin bundles to disassemble, but have no 
effect on normal intracellular actin structures.
Cells were plated for 5 mins, drug-treated with taxol to stabilise microtubules or 
nocodazole to disassemble microtubules, then actin was fixed and visualised 
using fluorescently-labelled phalloidin 1 hour after plating. Taxol and nocodazole 
both cause the MKS2 prominent actin filaments observed following DMSO control 
treatment (red arrowheads) to disassemble, but other actin structures remain 
intact. Scale bar represents 40 µm or 20 µm for DMSO control.
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Jasplakinolide Latrunculin B
FIGURE 6.11: Actin drug treatments alter MT organisation similarly in all 
cell lines. 
Cells were plated for 30 minutes prior to addition of jasplakinolide (to stabilise 
actin filaments) or latrunculin B (to prevent actin assembly), then fixed 1 hour after 
plating, using immunofluorescence to visualise microtubules (anti-α-tubulin). 
Compared with the DMSO control, both drugs caused disruption to the MT 
cytoskeleton. However, MKS2 patient cells appeared different to control cells 
following either drug treatment. Scale bars represent 40 μm.
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similarly, caused rounding of the cell body and elongated protrusive MT 
structures to form in all cell lines, with no identifiable focus of MT emanation 
(Figure 6.11). Neither of these drug treatments appeared to alter the number of 
MT foci present in MKS2 any more than in the other cell lines; actin-dependent 
cell shape changes are likely behind this, so I can come to no conclusions as to 
the dependency of the MT defects on the actin defects. 
 
Defects are expected to occur independently of ciliogenesis 
 
It could be argued that many of these defects are merely a downstream 
consequence of ciliogenesis failure. To test this, I plated wild-type cells in either 
the serum-containing medium used throughout all of the experiments or serum-
free medium. A low proportion of cells were ciliated under serum-containing 
conditions when compared to serum-free conditions (between 6-10% of 300 
cells examined across 3 experiments) (Figure 6.12). This indicates that, even if 
MKS patient cells are attempting ciliogenesis, very few would be doing so under 
experimental conditions. 
 
6.3 Discussion 
 
In the present chapter, I aimed to question the temporal relationships 
between the actin, MT and Golgi defects in MKS patient cells in order to 
elucidate a primary cause, or at least an order of phenotypes to infer a causal 
relationship. 
I found that defects in the MTs are the first to occur. These defects took as 
little as 10 minutes to become established, in the case of tyrosinated and total 
tubulin, in which MTs were observed emanating from multiple or no obvious foci 
in MKS2 patient cells. Actin defects and Golgi defects then occurred around 30-
40 minutes following plating and appeared to temporally coincide with the 
condensation of acetylated microtubules to the cell centre, i.e. the stabilisation 
of microtubules at the cell centre. These three phenotypes appear concomitant, 
but I cannot conclude from the current data whether alterations to actin, MTs, or 
a source upstream of these, are responsible for the Golgi defects. 
The number of MT foci appear reduced to a single focus in MKS2 patient 
cells upon ROCK signalling pathway activation or inactivation, implicating 
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FIGURE 6.12: A low percentage of wild-type cells are ciliated under 
experimental conditions when compared with serum starvation conditions.
Cilia visualised using anti-acetylated-tubulin (green), centrosomes visualised 
using anti-γ-tubulin (red) and nucleus visualised using DAPI (blue). Cilia in 
serum-containing conditions indicated with white arrowheads. Few cilia are 
present in control cells in serum-containing, experimental conditions. Scale bars 
represent 40 μm.
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dysregulation of this pathway as a causative agent of the increase in number of 
MT foci in MKS. When paired with the likely ties with the actin defects, these 
data strongly implicate Rho signalling in generating MKS phenotypes. 
Reinforcing this, the MT and actin defects were found to occur independently of 
each other. 
Besides being the first instance of MT defects being reported in MKS, these 
results are, furthermore, the first to connect the previously described 
dysregulation of Rho signalling (Adams et al., 2011; Dawe et al., 2009; Valente 
et al., 2010) to this phenotype, and to identify changes to the actin and MT 
cytoskeleton as temporally separable phenotypes in this disease. This is 
important as it enables us to begin to construct an order of defects, providing 
clues as to the primary role of MKS proteins. 
 
Microtubule-actin interactors have important cellular functions 
 
To effect capricious cellular function, such as motility, the cytoskeleton must 
remain adaptable; for this, correctly organised and structurally functional MTs 
and actin must interact. A variety of structures and proteins enable their 
cooperation, such as focal adhesions, motor proteins (e.g. myosin and kinesin), 
MT-actin crosslinking factor (MACF) and formins. Based on the results reported 
in this thesis, MKS proteins TMEM216 and TMEM67 may function in a similar 
role, or may be constituents of such structures or proteins.  
Focal adhesions, actin-linked structures involved in cell locomotion through 
extracellular matrix attachment, are built and become contractile in a Rho-
regulated process, also serving as sites of signal transduction (Burridge and 
Chrzanowska-Wodnicka, 1996). MTs also interact with these structures in order 
to establish cell polarity, which has a dual role. Firstly, focal adhesions stabilise 
the MT (Kaverina et al., 1998), which explains how MTs specifically stabilise at 
the leading edge; secondly, MTs deliver localised doses of relaxing signals to 
the focal contact to stimulate disassembly as the focal adhesion moves 
rearward with respect to the moving cell (Kaverina et al., 1999). By this method, 
MTs are able to modulate the behaviour of the actin cytoskeleton.  
Focal contact formation and maturation is controlled by a complex interplay 
of the effects of Rho GTPases on cell contractility and MT stability (Ng et al., 
2014). Alterations are reported in focal adhesion structure or function in a 
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number of ciliopathies, indicating that such MT-actin crosstalk may be a topic of 
interest for subsequent study in the ciliopathies. RPGR-deficient cells, a model 
with reduced number of cilia, demonstrate focal adhesion kinase dysregulation 
and impaired attachment to fibronectin (Gakovic et al., 2011). Similarly, 
inversin/nephrocystin-2-null MEFs have diffuse focal adhesion distribution and 
impaired directional cell migration (Veland et al., 2013). Furthermore, Bbs4-, 6- 
and 8-deficient cells demonstrate overabundant focal adhesions, which are 
associated with increased levels of active RhoA (Hernandez-Hernandez et al., 
2013). Finally, a number of nephrocystins are known to constitute part of the 
focal adhesion kinase complex (Simms et al., 2009). It is of note that we also 
observe alterations to focal adhesion morphology in MKS patient cells on 
certain substrates (Meadows and Dawe, unpublished). These alterations may 
occur up- or downstream of alterations to actomyosin contractility and/or 
alterations to MT organisation and stability in these cells, which remains to be 
determined. 
Evidence indicates that motor proteins may be crucial to MT-actin 
interactions; for instance, myosin IIB and V (the actin-based motors) localise to 
MTs (Kelley et al., 1996; Waterman-Storer and Salmon, 1999). Myosin IIB is of 
particular interest as it localises to MT ends in the leading lamellipodia of 
migrating cells (Kelley et al., 1996), which may be associated with the altered 
MT foci in MKS patient cells; here it is thought that myosin IIB provides 
retrograde flow of actin or vesicles along MTs from the leading edge (Kelley et 
al., 1996; Waterman-Storer and Salmon, 1999). Myosin IIB is also required for 
centriole migration during ciliogenesis (Hong et al., 2015) and coordinates actin 
dynamics and MT acetylation to effect biogenesis of the primary cilium (Rao et 
al., 2014). When actin assembly is blocked in migrating cells, MTs extend into 
the lamellipodium without undergoing catastrophe, reinforcing their functional 
connection (Waterman-Storer and Salmon, 1999). Furthermore, kinesin, the MT 
plus end-directed motor protein, localises to stress fibres upon MT 
depolymerisation (Okuhara et al., 1989). Association between these 
cytoskeletal components is complex, and is crucial for appropriate cellular 
movement. 
In Chapter IV, I reported differences in myosin and phosphomyosin 
localisation in MKS2 patient fibroblasts. If MKS proteins function in myosin-
dependent actin-MT interactions, this provides a possible explanation as to why 
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MT minus end placement is altered. However, it is more probable that altered 
myosin and phosphomyosin localisation is a downstream consequence of 
forming prominent actin bundles. 
MACF co-localises with actin stress fibres and ruffles, and with 
detyrosinated MTs, stabilising them and tethering them to actin (Leung et al., 
1999). MACF1, alongside ELMO (engulfment and motility) proteins, is also 
implicated in the formation and persistence of Rac-induced actin protrusions, 
essential structures for directed cell migration, through its interaction with actin 
and with MTs (Margaron et al., 2013). MACF1-deficient keratinocytes fail to 
efficiently migrate due to the transience of the polarised membrane; MTs at the 
plasma membrane in these cells do not undergo typical pause and catastrophe, 
nor tethering to the actin cytoskeleton. This occurred downstream of mDia 
activation and was also paired with failure of the MTOC and Golgi to reorient 
(Kodama et al., 2003), reminiscent of MKS phenotypes. Such a correlation is 
indicative of how intertwined these cellular features are, and illustrating the 
complexity of deducing the underlying function of MKS proteins. 
Formins are another example of MT-actin interactors that may be of interest 
to study in the context of MKS proteins. These nucleate actin filament formation 
from the barbed end, and the best studied of which are Rho GTPase effectors 
mDia1, -2, and -3 (Goode and Eck, 2007). Formins such as mDia1 and -2 are, 
independently of their actin-based functions, tasked with stabilisation of MTs 
oriented towards the leading edge (Bartolini et al., 2008; Ishizaki et al., 2001; 
Palazzo et al., 2001), regulating integrin signalling here (Palazzo et al., 2004). 
These are posited to contribute to cell polarity through their involvement in 
vesicular trafficking and/or effects on the cytoskeleton at the cell front (Bartolini 
et al., 2008; Lin et al., 2002).  
Two formins, DIA1 (human mDia1 orthologue) and FMNL1, are required for 
MTOC reorientation in T cells (Gomez et al., 2007), a process perturbed in 
MKS. This MTOC reorientation is Cdc42- and Rac1-dependent (Gomez et al., 
2007; Stowers et al., 1995), and requires appropriate MT dynamics (Li and 
Gundersen, 2008), providing support for a Rho-associated cause of this 
phenotype in MKS.  
Inverted formins (INF) -1 and -2 are of particular interest to us as they 
display a number of features associated with MKS. INF1 associates with MTs 
and, when its expression is induced in fibroblasts, prompts actin stress fibre 
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formation, the acetylation of MTs (features observed in MKS patient fibroblasts), 
and MT-actin coalignment (Young et al., 2008). INF2 associates with Cdc42 
and Rac1, regulates vesicular transport and mediates the detyrosination of MTs 
that is necessary for MTOC reorientation, all independently of its actin 
polymerisation and depolymerisation activities (Andres-Delgado et al., 2010; 
Madrid et al., 2010). Furthermore, MT acetylation capacity has been reported to 
be a function of the FH2 domain, meaning this is likely a general function of 
formins (Thurston et al., 2012).  
Formins are effectors and modulators of Rho GTPase signalling; when Rho 
GTPases bind their N-terminal Rho GTPase-binding domain, autoinhibition of 
the diaphanous-related formins is alleviated, allowing the FH2 domain to 
nucleate actin filament polymerisation, but the activated formin can recruit Rho 
GTPase components. For instance, it is thought that RhoA activates FH1/FH2 
domain-containing protein 1 (FHOD1) through ROCK, following which FHOD1 
is hypothesised to associate with Rac to inhibit lamellipodium generation 
(Gasteier et al., 2003; Young and Copeland, 2010). In addition to actin stress 
fibre production, RhoA may induce MT stabilisation (Cook et al., 1998); this 
would promote MT growth towards the leading edge, stimulating Rac1 activity, 
and thus additional actin protrusions to form. 
The actin structure generated upon formin activation (and thus the cellular 
function) is dependent on a number of factors, such as the associated GTPase, 
the formin activated and the cellular context (Young and Copeland, 2010). For 
example, RhoB induces mDia1 or -2-instigated endosome association with actin 
filaments, which impedes their motility (Fernandez-Borja et al., 2005; Wallar et 
al., 2007). 
These previous data indicate a role of these actin-MT interactors in 
posttranslational modification of MTs, and their involvement with Rho signal 
transduction. These data reveal formins as potential proteins of interest in study 
of the aetiology of MKS. It is possible that MKS proteins have a similar role to 
formins, or possibly even interact, whether directly or indirectly, with formins. 
Multiple MT-actin interactors function in stress fibre and actin ruffle formation, 
MT stabilisation, canonical and non-canonical Wnt signalling, MTOC 
reorientation, cell polarity and directed cell migration. These are all features with 
reported defects in MKS and the other ciliopathies, meaning that MKS proteins 
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having a role in MT-actin interaction may prove the most parsimonious 
explanation for all of these observed defects.  
This hypothesis is supported in study of other ciliopathies; polycystic kidney 
disease protein PKD2 interacts with mDia1 (Rundle et al., 2004). However, this 
has not yet been demonstrated in MKS, and is not a topic of active study as 
evidence of cytoskeletal involvement in ciliopathy is a novel area of research. 
This role of MKS proteins could, however, also explain failures in ciliogenesis; 
MTs are the major axonemal component and involved in ciliary vesicle 
trafficking (Sorokin, 1962; Sorokin, 1968; Sotelo and Trujillo-Cenoz, 1958). 
Furthermore, centriole migration is actin- and MT-dependent (Boisvieux-Ulrich 
et al., 1987; Boisvieux-Ulrich et al., 1990; Burakov et al., 2003), so dysfunction 
of a component involved in cytoskeletal interaction could have widespread 
effects. 
 
Microtubule-actin interactors at the Golgi 
 
A number of the aforementioned MT-actin interactors, in addition to a 
plethora of other proteins, have a functional role at the Golgi complex. If MKS 
mutations do represent an alteration to these, this may explain the Golgi 
dispersal occurring subsequently to the MT defects, and in conjunction with the 
actin defects. 
MACF1 is one such protein: it interacts with p230 to achieve transport of 
GPI-anchored proteins from the TGN to the plasma membrane, along the MT 
and actin cytoskeleton (Kakinuma et al., 2004). MACF1 exists in multiple 
isoforms; MACF1b is predominantly localised to the Golgi, where it maintains 
Golgi structure; siRNA against MACF1 induced Golgi dispersal (Lin et al., 2005) 
similar to that seen in MKS patient cells.  
WHAMM is a protein with similar function; this is Golgi-associated, with MT-
binding and Arp2/3-mediated actin nucleation capabilities that occur 
independently of each other. Vesicles are recruited by WHAMM and remodelled 
into tubules, with WHAMM proposed to act as a physical link to the MTs 
(orchestrating membrane tubulation) and actin (promoting tubule elongation) 
(Campellone et al., 2008; Shen et al., 2012). RhoD is also implicated here, 
binding WHAMM to effect changes in cell attachment and actin dynamics, and 
thus cell migration (Gad et al., 2012). RhoD also localises to early endosomes 
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and the Golgi and – as the binding partner of WHAMM – is similarly vital to 
anterograde vesicular trafficking from the ER to the plasma membrane (Blom et 
al., 2015). We cannot resolve the exact details of the Golgi dispersal observed 
in MKS, but these data indicate that the MKS proteins may, therefore, have 
additional, undiscovered functions that are analogous to those of such MT-actin 
binding proteins. 
It should be noted that, although MTOC and Golgi positioning events are 
evidently connected by their links to the cytoskeleton and Rho signalling (e.g. 
ROCK inhibition accelerates cell migration but inhibits MTOC and Golgi 
positioning), they are separately controlled. Disruption of MTs inhibits MTOC 
polarity, whereas Golgi polarisation is actin- and ABP-dependent (specifically 
upon Arp2/3, WASP and the FH2 domain of mDia1), but not vice versa 
(Magdalena et al., 2003), concomitant with my observation of independent MT 
and actin defects. Additionally, Rho stimulation of MT stability is independent of 
actin stress fibre formation (Cook et al., 1998), all supporting a conclusion that 
MKS proteins operate upstream of cytoskeletal defects.  
A role of MKS proteins in tethering the cytoskeleton to membranes is a 
reasonable hypothesis. If these were acting as membrane-cytoskeleton tethers, 
responsible for the dynamics of both, perturbation would result in a number of 
the changes observed in the cell, such as alteration of post-translational 
modifications to and site(s) of nucleation of the MT cytoskeleton, actin stress 
fibre development, aberrant ciliogenesis and, downstream of these, Golgi 
dispersal. 
Evidence in support of this hypothesised role of ciliopathy proteins is 
beginning to accumulate. CEP290 is thought to be a key Y-link constituent, 
binding the ciliary membrane and MTs (Craige et al., 2010; Drivas et al., 2013); 
TMEM67, associated with filamin A, binds along basolateral actin fibres (Adams 
et al., 2011); and numerous other MKS proteins are known to associate with 
post-Golgi vesicles along MTs, in addition to localising to many other 
membranous structures (Collado-Hilly et al., Cilia 2014 Conference 
(unpublished); Lee et al., 2012). 
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Rho pathway involvement in MT-actin interaction 
 
RhoA and Rac1 induce generation of various actin structures, and certain 
phases of MT dynamic instability can effect activation of these proteins. For 
instance, RhoG-activated MT growth in fibroblasts (but not the presence of MT 
polymer alone) causes Rac1 activation, leading to actin polymerisation and 
actin protrusive structure formation at the leading edge (Gauthier-Rouviere et 
al., 1998; Waterman-Storer and Salmon, 1999).  
Taken with my phenotypic observations and the data suggesting RhoA 
hyperactivation in the current patient cells, it is reasonable to alternatively posit 
a role of MKS proteins upstream of cytoskeletal defects and of Rho signal 
transduction. It may be that inappropriate activation of certain Rho signalling 
pathways causes these phenotypes; RhoD, for instance, is a WHAMM binding 
partner (Gad et al., 2012), together playing a key role in actin and MT functions, 
e.g. adhesion and migration. 
Currently there is no data implicating ciliopathy proteins either as a tether, 
or functioning upstream of Rho to cause these phenotypes, but the data from 
my study, combined with the literature, provide insight as to how either of these 
may be the primary function of MKS proteins. 
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CHAPTER VII: GENERAL DISCUSSION 
 
7.1 The roles of MKS proteins 
 
Within this thesis I have attempted to establish the extra-ciliary roles of the 
MKS proteins, in order to deduce a model for how these proteins might function 
in a cell. 
I have shown an involvement of MKS proteins in the regulation and 
organisation of the actin and microtubule (MT) cytoskeleton, in addition to 
affecting the structure of the Golgi apparatus. In agreement with my 
hypotheses, I revealed that alterations to the cytoskeleton, including prominent 
actin bundle formation, occur in a temporally-dependent manner, which was a 
novel finding. Furthermore, I described novel evidence of changes to the 
number of MT foci and defective post-translational modifications to the MT 
cytoskeleton (which coincided with Golgi dispersal) in MKS patient cells. In 
addition, I found that these defects appeared to occur downstream of ROCK 
pathway dysregulation. I have, therefore, demonstrated unreported extra-ciliary 
functions of the MKS proteins and begun an investigation into the signalling 
pathways underlying these functions. 
From these data, and based upon evidence from current ciliopathy 
research, I therefore postulate three possible roles for MKS proteins within the 
cell, as follows. 
 
MKS proteins are centrosome cohesion molecules 
 
It is possible that the MKS proteins maintain centrosome integrity. I 
revealed that MKS2 patient cells displayed numerous foci of pericentrin 
staining, but that the disorganised MTs of these cells observed to emanate from 
multiple foci did not appear to emanate from these pericentrin-containing points. 
If MKS2 mutations lead to dissolution of the centrosome, loss of centrosome 
integrity may be the factor precluding MT emanation from a single centrosome.  
This would lead to MT disorganisation. A fragmented centrosome could 
cause mechanical breakage of the MTs, leading to multiple MT networks across 
the cell, an observed phenotype. Such activity would make the MT network 
more dynamic in these cells as the number of MT ends would increase, which 
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allows more rapid polymerisation and catastrophe (Keating and Borisy, 1999; 
Yu et al., 1994). However, the acetylated tubulin staining, a marker of stabilised 
tubulin, indicated the converse to be true – tubulin appeared to be stabilised 
throughout the cell. 
Alternatively, increased tethering of MT plus- or minus-ends at these 
regions of dispersed fragmented pericentriolar material may occur, increasing 
the stability of the MTs. It may be that PCM components are mislocalised, i.e. 
not forming an intact centrosome by surrounding the centrioles, and spread 
through the cell in MKS. These would be observed as acentrosomal sites of MT 
origin.  This hypothesis is supported by observations of acetylated tubulin 
dispersal and multiple acentrosomal foci in the MKS2 patient cells. This 
scenario is possible; ninein, a PCM component, is frequently observed 
stabilising free MT minus ends in epithelial cells, resulting in numerous 
acentrosomal foci (Bartolini and Gundersen, 2006; Mogensen et al., 2000). 
Furthermore, handover of MTOC function to acentrosomal sites is a common 
feature in epithelial polarisation, which features Par protein-dependent 
movement of nucleators, such as PCM components, away from the centrosome 
to an apical surface (Feldman and Priess, 2012).  
In additional support, a previous study using live imaging of MTs 
demonstrated that split centrioles in cells depleted of BBIP10, a subunit of the 
BBSome (a ciliary structure, components of which are often associated with 
BBS), could nucleate but not anchor MTs (Loktev et al., 2008). Similarly, BBS4 
silencing induced PCM1 mislocalisation and associated deanchoring of 
centrosomal MTs (Kim et al., 2004), supporting the possibility of tethering as a 
role of centrosomal components such as MKS protein complexes. 
However, the nocodazole washout demonstrated that MTs nucleate at 
multiple subcellular locations in MKS2 patient cell. This means that aberrant 
nucleation – MTs nucleating from, not tethering at, acentrosomal sites or 
pericentriolar components besides pericentrin - appears to be the most 
probable cause of centrosome-dependent MT disorganisation in MKS2 patient 
cells. Furthermore, it is of note that this defect occurs on such short time-scales 
that this is highly unlikely to be cilium-dependent. Nonetheless, it is possible 
that, subsequent to centrosome splitting, increased MT breakage and tethering 
may follow aberrant nucleation.  
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Similar defects in centrosome integrity or number have been observed in 
conjunction with a number of ciliopathies, including MKS models. A study of 
kidney tissue and cells from MKS1 and MKS3 patients, in addition to shRNA 
knockdown of Mks1 and Mks3 in IMCD3 cells, reported over-duplication of 
centrosomes and cilia in these. This implicates MKS1 and MKS3 in centrosome 
duplication although, notably, this paper defined multiple centrosomes based on 
γ-tubulin staining, without confirming these were intact or functional 
(Tammachote et al., 2009); it is therefore possible that these cells also 
demonstrated split centrosomes. Importantly, the current results also imply that 
multiple ‘centrosomal’ nexuses may be functional in nucleating or tethering MTs 
in MKS2 patient cells. 
Nek5, a kinase involved in primary cilium functioning, has previously been 
reported to promote centrosome integrity through pericentriolar material 
recruitment, and to enhance the MT nucleation involved during mitotic 
centrosome separation (Prosser et al., 2015), further coupling centrosome 
cohesion behaviour, the cilium and MT dynamics. 
Depletion of BBS8 and BBIP10 in human RPE cells leads to increased 
centrosome splitting, which appears remarkably similar to the pericentrin 
staining that I observed in MKS2 cells. BBS8 depletion, additionally, caused a 
reduction in pericentin levels, but cells were still able to generate cilia (Loktev et 
al., 2008).  
BBIP10 depletion also led to a BBSome-independent reduction in MT 
polymerisation and stabilisation, as demonstrated by a reduction in cytoplasmic 
MT density and, indirectly, also in acetylation. BBIP10 overexpression 
concordantly increased MT acetylation, despite no direct interaction with MTs; 
this was proposed to occur through BBIP10 inhibition of HDAC6 (Loktev et al., 
2008). SAS-1, a protein related to C2CD3 (which is affected in OFD syndrome), 
is critical in maintaining centriole integrity and can also bind and stabilise MTs, 
as indicated by acetylated tubulin staining, in C. elegans (von Tobel et al., 
2014). 
This has implications for my data; we can establish from the above 
evidence that constituents of the centrosome responsible for its integrity can 
also nucleate and tether MTs elsewhere in the cell, and can implement the 
stabilisation of MTs. If MKS proteins have similar roles, whether individually or 
as a complex, mutations may cause not only loss of centriole integrity, but also 
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errors in anchoring and stabilising MTs. It also provokes question as to the 
activity of enzymes that may be interacting with MKS proteins – could an 
interacting enzyme be responsible for MT dynamics and/or post-translational 
modification? 
Erroneous centrosome amplification is observed in polycystic kidney 
disease mouse models. Polycystin-1 (Pkd1) knockouts abrogate centrosome 
amplification (Battini et al., 2008), and polycystin-2 (Pkd2) overexpression in a 
mouse transgenic line results in supernumerary centrosomes due to 
centrosome overduplication (Burtey et al., 2008), although it is unlikely that this 
would be caused by similar pathways to centrosomal splitting.  
Interestingly, SIRT2, a nicotinamide adenine dinucleotide-dependent 
deacetylase that mediates deacetylation of α-tubulin, is upregulated in Pkd1 
mutant and knockdown cells; overexpression of SIRT2 in IMCD3 cells leads to 
aberrant centrosome amplification, and depletion prevents centrosome 
amplification associated with polycystin-1 loss (Zhou et al., 2014). This 
potentially provides an aetiological link from the increased numbers of 
“centrosomal protein” foci to enzyme-mediated changes in MT stability.  
MAP4, a MT-associated protein that bundles and stabilises MTs (Olson et 
al., 1995) and binds septin-2 within the ciliary axoneme, regulating ciliary length 
(Ghossoub et al., 2013), is mutated in a few uncommon ciliopathic diseases 
characterised by short stature and microcephaly. The mutations in these 
diseases were also associated with centrosome amplifications, MT-dependent 
dispersal of the Golgi apparatus and shortened cilia (Zahnleiter et al., 2015). 
These cellular phenotypes, particularly aberrant MT stability and concomitant 
Golgi dispersal, resemble the temporal correlation I reported between 
acetylated tubulin restriction to the cell centre and Golgi dispersal, making this 
result of interest. 
A hypothetical role of MKS proteins in centrosome integrity is therefore 
supported by the current and previous data. Loss of these, or a functionally-
similar centriolar protein or enzyme, may increase the centriole number or, 
alternatively, may tear apart current centrosomes. The latter seems more likely 
in the context of the current results as the pericentrin spots seem to display too 
much variation in size to constitute entire centrosomes. MKS proteins may fulfil 
such a cohesive function. Downstream of this, loss of such a protein would 
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affect MT stability, ciliogenesis and, potentially, Golgi organisation, structure 
and function. 
 
MKS proteins tether the cytoskeleton to membranes 
 
Another possibility is that MKS proteins act as cytoskeleton-membrane 
linkers. This is supported by evidence that MKS1-silenced Paramecium cells 
demonstrate detachment of the cortical cytoskeleton from the plasma 
membrane (Campillo et al., 2012). Moreover, as transmembrane proteins, 
TMEM216 and meckelin predictably localise to membranous structures, such as 
the Golgi apparatus, including the vesicles surrounding the ciliary base, ciliary 
membrane, nuclear envelope, cell-cell junctions and apical membrane in 
polarised cells; however, they also bind along basolateral actin fibres, with 
filamin A, the actin crosslinking protein, and with post-Golgi vesicles along MTs 
(Adams et al., 2011; Collado-Hilly et al., Cilia 2014 Conference (unpublished); 
Dawe et al., 2009; Lee et al., 2012). These proteins are not the only ciliary 
proteins that localise to the cytoskeleton; Bbs8 and Ift20, for instance, localise 
to both F-actin and MTs (May-Simera et al., 2015). However, it is not known 
whether these proteins interact with the cytoskeleton independently or as a 
complex. 
Unpublished work has recently demonstrated that RNAi of MKS1 leads to 
defective vesicular transport, plasma membrane distension, epithelial 
differentiation and impairment of ciliary sensory function. Crucially, this also 
leads to disruption of the actin cytoskeleton, particularly at cell-cell and cell-
matrix adhesion sites, implicating MKS1 as an intermediate protein linking the 
actin cytoskeleton and membranes [Collado-Hilly et al., Cilia 2014 Conference 
(unpublished)].  
 In my experiments, I demonstrated multiple cytoskeletal defects in MKS 
patient cells, and these appeared to be connected to a previously undescribed 
Golgi defect. Indeed, coronin 7, an actin-Golgi interactor with roles in promoting 
actin polymerisation and post-Golgi trafficking (Rybakin et al., 2008; Rybakin et 
al., 2004; Yuan et al., 2014) was transcriptionally downregulated. This indicates 
that aberrant coronin 7 transcription occurs alongside MKS mutations, and may 
be associated with the Golgi morphology defects observed. It is also possible 
that this occurs upstream of vesicular trafficking defects to cause aberrant 
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ciliogenesis; however, additional study is required to investigate the effects and 
the causes of alterations to coronin 7 transcription. 
 Indeed, defects in vesicular trafficking of TMEM138 and of MKS4-encoded 
CEP290, which would typically occur along TMEM216-linked post-Golgi 
vesicles associated with MTs, and concomitant shortened cilia, have been 
reported following TMEM216 knockdown in fibroblasts (Lee et al., 2012). This 
indicates that TMEM216 or MKS complexes may effect their function in post-
Golgi transport to the ciliary base by linking membranous structures to the 
cytoskeleton during directional protein transport. Moreover, this also supports 
the possibility that these defects precede cilium-associated defects, as failures 
in Golgi transport of ciliary components would interfere with ciliogenesis.  
Vesicular transport is necessary not only during ciliogenesis, but also during 
cell migration, which is also disrupted in MKS patient cells. It is also of note that 
vesicular trafficking defects have a central role in BBS (Blacque et al., 2004; 
Nachury et al., 2007), although much research has investigated vesicular 
trafficking solely in regard to IFT. It is possible that these protein complexes 
function beyond the cilium, including during vesicular trafficking.  
 Numerous MT-actin interactors function at the Golgi, such as MACF1, 
which is responsible for protein transport from the TGN along the MT and actin 
cytoskeleton to the cell periphery (Kakinuma et al., 2004), co-localising with 
stress fibres and stabilising MTs (Leung et al., 1999). MKS proteins could 
feasibly have a similar function. 
 This hypothesis – MKS proteins as a cytoskeleton-membrane tether – 
makes sense with regard to a key role of MKS proteins in the base of the cilium 
or ciliary membrane. TMEM216 and meckelin co-localise at, and have a 
necessary function at the transition zone (Dawe et al., 2007b; Valente et al., 
2010), and in ciliogenesis. Reduction of meckelin, for instance, causes the 
basal body orientation to be lost, in which the actin cytoskeleton is heavily 
implicated (Abdelhamed et al., 2015; Boisvieux-Ulrich et al., 1987; Boisvieux-
Ulrich et al., 1990; Dawe et al., 2007a; Dawe et al., 2007b; Lemullois et al., 
1987; Picariello et al., 2014). Further to this, CEP290 has been implicated as a 
key structural component of the Y-links (Craige et al., 2010; Drivas et al., 2013), 
binding both the ciliary membrane and MTs (Drivas et al., 2013). However, the 
other MKS module proteins are thought to have a less essential, more 
regulatory role in the transition zone complex; these are hypothesised to 
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cooperate to bind the ciliary membrane to axonemal MTs, and knockout of both 
an MKS module and NPHP module component are required for Y-link disruption 
in C. elegans [Blacque et al., Cilia 2014 conference (unpublished)]. This may, 
therefore, not be the most crucial role of TMEM216 and meckelin. 
 MKS protein function at cell-cell junctions, the apical membrane of 
polarised cells and the nuclear envelope in linking to cytoskeletal components 
would also be logical in the context of the observed phenotypes. These are 
sites of MT capture prior to their organisation (Bellett et al., 2009; Lechler and 
Fuchs, 2007; Meng et al., 2008) or downstream function, such as centrosome 
reorientation (Salpingidou et al., 2007), and sites of actin polymerisation or 
contractility, such as in nuclear movement (Starr and Fridolfsson, 2010), 
protrusion formation, and focal adhesions, all of which have observed defects 
(in published and unpublished work). Notably, recent unpublished work from our 
group (Meadows and Dawe) has established that meckelin is a novel focal 
adhesion component. These reports of TMEM216 and meckelin localising to 
cytoskeleton- and membrane-associated sites throughout the cells provides the 
most marked evidence for the hypothesis of MKS proteins as cytoskeleton-
membrane linker proteins or protein complexes. 
However, it is yet to be revealed how, as a cytoskeleton-membrane linker, 
MKS proteins would cause changes to MT stability, number of MT foci or the 
apparent centrosome fragmentation, which is perhaps generated by alternate 
membranous sites of MT nucleation and tethering, or why the numerous 
observed cellular phenotypes would appear to be ROCK-dependent. 
 
MKS proteins are signalling molecules upstream of ROCK 
 
Accumulating evidence indicates that the ciliopathy proteins have key 
functions within the non-canonical Wnt/PCP pathway, whether acting from the 
cilium or otherwise; indeed, numerous developmental phenotypes may be 
attributed to dysregulated Wnt signalling (both canonical and non-canonical), 
particularly renal cysts (Pinson et al., 2000; Saadi-Kheddouci et al., 2001). 
However, it is hard to explain mouse models of MKS1, TMEM67, CEP290, and 
RPGRIP1L that do not show alterations to Wnt signalling within the context of 
this theory (Abdelhamed et al., 2013; Lancaster et al., 2011; Mahuzier et al., 
2012; Wheway et al., 2013). 
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 Throughout this thesis, I have demonstrated a number of cellular 
phenotypes which appear Rho/ROCK pathway-dependent, inclusive of the 
previously-observed prominent actin bundles, which are abrogated in the 
presence of pathway inhibitors and upon the introduction of dominant negative 
Rho, and mimicked by introduction of constitutively active members of this 
pathway.  
This is accompanied by evidence suggesting that the increased number of 
MT foci observed in MKS2 patient cells can be attenuated by manipulation of 
this pathway, suggesting that dysregulation of the ROCK pathway in these cells 
may be responsible for a number of cellular phenotypes. Furthermore, 
constitutively active ROCK induces Golgi dispersal in wild-type cells analogous 
to that seen in MKS patient cells, but has no effect in MKS cells, implying that 
the cellular results induced by active ROCK have already been maximally 
effected. These findings, that Rho inhibitory drugs can reverse many of the 
cellular defects, are important evidence in addressing my aim to advise future 
therapeutics for the milder ciliopathies. 
Mutations in MKS2 and loss of meckelin have both been reported to cause 
RhoA and Dishevelled hyperactivation, seemingly causing prominent actin 
bundles to develop (Valente et al., 2010). I can confirm from my results that, 
downstream of this, ROCK levels are increased in MKS3 patient cells, indicating 
that the pathway is hyperactivated. Myosin levels appeared unchanged, but 
localisation appeared to change; phosphomyosin and myosin were presumably 
localising to the actin bundles.  
As supporting evidence of a role of these proteins in, more broadly, 
Wnt/PCP signal transduction pathways, meckelin is known to interact with 
Dishevelled at the basal body where Rpgrip1l, the MKS5 protein product, 
stabilises it (Mahuzier et al., 2012). Rpgrip1l, tmem67 and mks1 morphant 
zebrafish all display convergent extension defects (Leightner et al., 2013; Leitch 
et al., 2008; Mahuzier et al., 2012) and impaired laterality (Mahuzier et al., 
2012), which is typically associated with Wnt/PCP signalling dysregulation. 
Furthermore, meckelin phosphorylates ROR2, thereby acting as a non-
canonical Wnt5a receptor, mediating downstream canonical and Shh pathway 
inhibition and RhoA activation, and playing a crucial role in all three signalling 
cascades (Abdelhamed et al., 2015; Abdelhamed et al., 2013). ROR2 is 
reported to form a complex with Vangl2, another PCP component, upon 
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stimulation with Wnt5a (Gao et al., 2011). Mutations in genes encoding Wnt5a, 
ROR2 and Vangl2 have been linked to spina bifida and limb bud development 
(Gao et al., 2011), indicating that the transduction of Wnt5a signalling via ROR2 
may underlie a number of the developmental defects associated with MKS.  
It is currently impossible to resolve whether the defects associated with 
MKS occur due to dysregulation of Wnt/PCP and/or canonical Wnt signalling, or 
have another role that impacts Rho components downstream of this. Cystic 
MKS3 phenotypes have been attributed to elevated proliferation resulting from 
canonical Wnt dysregulation in restricted regions (Leightner et al., 2013); it may 
be that this is the case, and that the relative importance of Wnt5a pathway 
transduction is tissue-specific. It is of note that different mutations in TMEM67 
induce different severity of canonical and non-canonical Wnt pathway 
dysregulation (Abdelhamed et al., 2013). This evidence may resolve why 
certain mouse models demonstrate no obvious alterations to Wnt signalling – in 
certain tissues, upon incurring specific mutations, meckelin may not have an 
essential signal transduction role. Meckelin does, however, appear to be crucial 
in a signal transduction role in at least a number of instances. 
In alternative explanation, it is established that inversin, an NPHP-causative 
gene, acts as a molecular switch between the Wnt signalling pathways through 
its actions on Dishevelled in different cellular contexts; its upregulation 
constrains canonical Wnt signalling by the proteasomal targeting of Dishevelled 
and promotes PCP signalling, and its inhibition attenuates this downregulation 
of canonical signalling (Simons et al., 2005). Concomitantly, inversin-null MEFs 
demonstrate elevated β-catenin and reduced Rho GTPase activity (Veland et 
al., 2013). Mks1 null MEFs also show high levels of canonical Wnt/β-catenin 
signalling (and heightened proliferation not reported in other ciliopathies), 
indicating there may be a negative regulatory role of MKS proteins in canonical 
Wnt signalling (Wheway et al., 2013). Notably, loss of TMEM216 increases 
Dishevelled phosphorylation, modulating hyper-responsiveness of Rho 
signalling pathways (Valente et al., 2010). It is therefore possible that these 
MKS proteins have a similar role to inversin, as a molecular switch, or are 
involved in this process as part of a complex, such as those at the transition 
zone. In support of this hypothesis, nphp-3, an MKS7-causative gene (in 
addition to a number of other NPHP genes) genetically interacts with 
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nphp-2/inversin, in addition to having an essential role in convergent extension 
movements (Bergmann et al., 2008; Zhou et al., 2010). 
Concordantly with this concept, these are not the only ciliopathy proteins 
proposed to function in Wnt signalling; BBS genes interact with Vangl2 (Ross et 
al., 2005), bbs1, -4 and -6 interact with wnt11 and wnt5b, suppression of which 
leads to β-catenin stabilisation (Gerdes et al., 2007), and RhoA is highly 
upregulated in the absence of BBS4, -6 and -8 proteins (Hernandez-Hernandez 
et al., 2013). This indicates that a number of the transition zone-associated 
proteins participate in various branches of Wnt signalling. However, it should be 
noted that Jouberin (a ciliopathy protein encoded for by Ahi1) facilitates β-
catenin nuclear translocation to upregulate canonical Wnt signalling but, 
through spatial constraint of Jouberin and β-catenin, this function is partially 
repressed by the cilium (Lancaster et al., 2011), i.e. the cilium may act as a 
reservoir to maintain Wnt signalling within a reduced range. 
The Wnt signalling pathway also impacts on ciliogenesis. Wnt/PCP 
components have multiple essential functions during ciliogenesis; for instance, 
PCP effectors such as Dvl and Inturned regulate basal body docking and 
orientation, governing Rho-mediated actin reorganisation and vesicular 
trafficking (Park et al., 2008), and Fuz is central to membrane trafficking during 
ciliogenesis (Gray et al., 2009). It is also postulated that presence of a cilium 
constrains canonical Wnt signalling (Corbit et al., 2008) but the importance of 
an intact, functional cilium (as opposed to just the basal body), and of “ciliary” 
proteins, within this process is unknown. 
If MKS proteins (particularly meckelin), or an MKS protein complex, were to 
participate in Wnt/PCP (specifically Rho/ROCK) signal transduction, this could 
explain a number of phenotypes observed. This could even occur from a 
location within the basal body. In example, p160ROCK, a Rho pathway 
component, maintains centriole integrity as an intercentriolar linker (Chevrier et 
al., 2002), and MKS/NPHP protein complexes may act analogously to this, as is 
discussed within the next section.  
Alterations to Rho/ROCK signalling can explain a number of the observed 
phenotypes. For instance, Rho maintains MT stability in the trailing edge of 
migrating cells and is involved in stable MT generation at the leading edge 
(Cook et al., 1998; Salaycik et al., 2005); also, ROCK phosphorylation of 
TPPP1 increases HDAC6 activity, thereby reducing acetylation and impacting 
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upon cell migration (Schofield et al., 2012). Hyperactivated Rho could thus 
result in ubiquitous cytoplasmic MT stabilisation and migratory defects. 
Changes in MT stability and actin structures would understandably also have 
dramatic effects on centriole migration, and on Golgi organisation and 
trafficking.  
If MKS proteins function as Rho pathway effectors solely at the cilium, 
changes to nucleation and tethering of MTs and centrosome splitting are harder 
to explain. Furthermore, MKS proteins evolved prior to developmental signalling 
– Wnt and Hh signalling are restricted predominantly to metazoan organisms, 
but TZ complex proteins are reported throughout eukaryotes – implying that this 
was not the initial function of TZ complex proteins, and thus is unlikely to be 
their sole function now (Barker et al., 2014).  
Resultantly, I postulate that MKS proteins act within a complex, that this 
complex has more than one role, and that these proteins act synergistically to 
enable these structural and functional roles. 
 
7.2 Is there more than one role of MKS proteins? 
 
Although less parsimonious than a single role, evidence indicates that there 
are multiple roles of MKS proteins, likely as part of a complex that is analogous 
to the focal adhesions, which have both a structural and signalling role. I 
propose that this complex is formed at different locations throughout the cell, 
possibly with variable components to enable different binding partners at each 
location of action. 
This is supported by evidence of MKS proteins having interaction partners 
outside of the TZ complexes, including filamin A on basolateral actin cables 
(Adams et al., 2011), nesprin 2 at the nuclear envelope (Dawe et al., 2009) and 
RanGAP, a GTPase activating Ran, a GTP-binding protein involved in nuclear 
transport (Picariello et al., 2014). An MKS/ciliopathy protein complex may have 
the same or different roles at different locations, which may be dependent on 
the isoforms used; unpublished work from our group suggests that multiple 
isoforms of MKS3 transcript exist, which may explain variability of effects in 
mouse models. 
The model I hypothesise is displayed in Figure 7.1. I propose that the MKS 
protein module, whether in conjunction with the NPHP module and BBSome, or 
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FIGURE 7.1: Model to show MKS proteins acting in a complex as Rho 
effectors and cytoskeleton-membrane linkers. 
MKS proteins interact with nuclear envelope proteins, actin-binding proteins 
(white objects), the Golgi apparatus, focal adhesion complexes, cell-cell 
junctions, and the ciliary transition zone. I postulate that MKS protein complexes 
act as Rho effectors at these locations, simultaneously interacting with other 
complexes (such as focal adhesion complex proteins, or centrosomal proteins) to 
maintain the integrity of these structures. Further, I propose that these actions 
affect cytoskeletal dynamics, having downstream consequences on actin 
networks, microtubule stability, and membranous structures. Consequently, MKS 
mutation has observed effects on cell migration, polarity, cell spreading, vesicular 
trafficking and ciliogenesis.
Migrating 
fibroblasts
Epithelial cells
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without, functions in both a structural capacity, and as a Rho pathway effector at 
multiple membranous locations throughout the cell.  
From the evidence presented in this thesis, I have suggested an increase in 
the subcellular locations of these complexes from those indicated at the end of 
the introduction (Figure 1.5) to additional MT-associated locations, including the 
centrosome and cell-cell junctions. Furthermore, I also propose a structural and 
Rho signal transduction role of these complexes at these locations. 
I propose that this complex affects local cytoskeletal dynamics via indirect 
binding to actin fibres, using influential intermediates such as crosslinking 
protein filamin A. Furthermore, I suggest that through enzymatic action or 
another protein intermediate, this complex acts upon MT nucleators and/or 
tethers (e.g. through modulation of p160ROCK activation at the centrosome, or 
maintaining PCM integrity) to recruit and stabilise or destabilise MTs. Finally, I 
postulate that this complex has a necessary structural role, maintaining the 
integrity of a functioning transition zone. I suggest that loss of polarity, 
centrosome positioning, Golgi dispersal, and defects in vesicular trafficking 
observed in conjunction with ciliopathy occur downstream of ROCK-dependent 
cytoskeletal changes and loss of centrosome/basal body integrity. 
Evidence would indicate that such activity may occur at the focal adhesions, 
for instance; MKS proteins localise here, where they are probably situated on 
the plasma membrane (Meadows and Dawe, unpublished), and likely induce 
Rho-associated actin changes during locomotion.  
A dual signalling and structural role is plausible. Knockdown of RPGR, a 
protein causative of retinal dystrophy – a ciliopathy – leads to more prominent 
actin filaments and reduction in β1-integrin receptors at the cell surface, in 
addition to basal dysregulation of a number of signalling pathways, including 
Akt, Erk1/2, focal adhesion kinase and Src (Gakovic et al., 2011). Focal 
adhesion components, including FAK, paxillin and vinculin, also associate with 
basal bodies to anchor them to the actin cytoskeleton (Antoniades et al., 2014). 
It would follow that an association between signalling and basal body 
components could potentially occur at additional subcellular locations beyond 
the focal adhesions, interacting with the cytoskeleton at these locations. 
Coronin 7 transcript downregulation may occur downstream of Rho pathway 
hyperactivation and contribute to vesicular trafficking defects. No evidence 
presently exists as to how coronin 7 is regulated, but nuclear expression of its 
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C. elegans equivalent, Pod1, is regulated by ROCK (Plotkin and Mudunuri, 
2008). As ROCK appears upregulated in MKS patient cells, this appears an 
obvious underlying cause of transcriptional changes to coronin 7, although this 
remains to be determined. siRNA against Pod1 also inhibits gene expression of 
fibronectin, an extracellular matrix component, and secretion of MMP inhibitors, 
enzymes involved in degrading ECM (Plotkin and Mudunuri, 2008). As we 
observe reduced ECM presence in the MKS patient cells (Meadows and Dawe, 
unpublished), it is possible that coronin 7 regulates ECM production, 
downstream of ROCK hyperactivation. 
It is probable that TMEM216 and meckelin have distinct roles within this 
proposed MKS protein complex, as implied by the different effects when these 
are mutated or knocked down in cells. MKS2 has more marked, immediate 
effects on cell behaviour; this may indicate a more crucial role of TMEM216 
than meckelin, either in the structure or function of an MKS protein complex, or 
independently of this protein complex. However, we are only beginning to 
resolve the precise function of the transition zone complexes as entities, and it 
would be harder still to estimate the roles of the MKS proteins independently of 
each other.  
 
7.3  What does this mean for other ciliopathies? 
 
A dual structural and signalling role of other ciliopathy complexes, such as 
the NPHP complex and the BBSome – functioning either with or without the 
MKS protein complex – would explain why multiple ciliopathies have defects in 
the same cellular processes. Joubert syndrome, Bardet Biedl Syndrome and 
nephronophthisis, amongst multiple other ciliopathies are allelic with MKS (Arts 
et al., 2007; Baala et al., 2007; Brancati et al., 2009; Delous et al., 2007; den 
Hollander et al., 2006; Doherty et al., 2010; Edvardson et al., 2010; Gorden et 
al., 2008; Leitch et al., 2008; Noor et al., 2008; Otto et al., 2009; Sayer et al., 
2006; Srour et al., 2012; Valente et al., 2010; Valente et al., 2006), and can 
have an epistatic effect on other ciliopathy loci (Leitch et al., 2008); considering 
this, it is highly likely that disruption of one component would affect the activity 
of others.  
Disruption of ciliopathy complexes with such a role could easily explain all 
of the reported cellular defects associated with ciliopathy, including aberrant 
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ciliogenesis and centriole movement and integrity, changes to cytoskeletal 
organisation and stability, altered focal adhesions, vesicular trafficking defects 
and dysregulated Wnt and Hh signalling. 
As an effector of the Wnt/PCP pathway (whether far upstream or just of 
Rho/ROCK) and a cytoskeleton-membrane tether, ciliopathy protein complex 
components could effect changes to the actin and MT cytoskeleton through 
both Rho GTPase signal transduction [affecting the stability and associated 
function of both (Bishop and Hall, 2000; Ellenbroek and Collard, 2007; Ridley, 
2006)] and through cytoskeletal recruitment and anchoring at specific 
membranous locations, such as the leading edge (e.g. at focal adhesions) of a 
migrating cell, the Golgi, ciliary vesicles associated with a centriole or the ciliary 
membrane. 
Simultaneous structural and signalling behaviour is observed in other 
centrosomal proteins, such as Talpid3, defects in which cause Hedgehog 
signalling defects. These proteins generate cytoskeletal reorganisation which 
mechanistically precedes a number of ciliogenesis defects, such as actin-
mediated basal body positioning and axonemal extension (Stephen et al., 2013; 
Yin et al., 2009). Subsequent defects observed in Hh signalling are therefore 
likely to be cilium-dependent (Davey et al., 2007; Davey et al., 2006). 
Other ciliopathy proteins, such as Kif7, also appear to perform such an 
impactful role. Kif7 co-precipitates with NPHP1 (Dafinger et al., 2011), and it 
localises to the cilium tip, where it regulates growth and catastrophe of the 
axonemal MT plus ends. Kif7 is also a known regulator of the Hh pathway, 
creating a cilium tip compartment in which Gli activity can be regulated (He et 
al., 2014). Lending support for this hypothesis, Kif7 also localises to multiple 
other subcellular sites beyond the cilium and is involved in maintaining 
structural integrity of the centrosome and the Golgi (Dafinger et al., 2011).  
Failure of ciliopathy protein complexes to perform either a structural or 
signalling role would have drastic consequences on the cell which correspond 
to those observed in patient cells, such as defects in migration speed and 
directionality (Barker and Dawe, unpublished). These may occur downstream of 
alterations to Rho/ROCK signal transduction, as similar defects to polarised 
migration are observed in inversin mutants. As mentioned, inversin is the gene 
product of NPHP2 and a protein thought to act as a molecular switch between 
Wnt signalling pathways (Veland et al., 2013), a function also described of 
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BBS4 (Gerdes et al., 2007). However, inv-null  mutants also display cytoskeletal 
rearrangements (Werner et al., 2013) and altered focal adhesion distribution 
(Veland et al., 2013), which may the primary cause of defective migration. 
Concluding that these complexes may have a structural and signalling role 
beyond the cilium is not a radical conclusion as IFT proteins, such as IFT20, 
IFT57 and IFT88 (Finetti et al., 2009), are already known to be used in 
trafficking throughout the cell; additionally, IFT88 has recently been revealed to 
influence MT organisation, cell migration and polarity, irrespective of cilia 
(Boehlke et al., 2015). Furthermore, inhibition of Rab8 activity (part of the 
vesicular trafficking machinery) leads to BBS-like phenotypes (Nachury et al., 
2007). 
In addressing my primary aim, to discover the extra-ciliary roles of the MKS 
proteins TMEM216 and TMEM67, I have revealed that many of these roles 
appear to be cilium-independent. This is hard to conclusively prove, due to an 
absence of an appropriate cilium-free model; however, the rapid development of 
a number of these defects and the low rates of ciliogenesis under the serum-
containing conditions used throughout these experiments indicate that the 
observed defects are not likely to result from the absence of a cilium. It is of 
further note that a recent RNAi screen of ciliary proteins in non-ciliated 
Drosophila cells uncovered a cilium-independent function of a number of these 
proteins in canonical Wnt signalling, supporting the present hypothesis (Balmer 
et al., 2015). This is important for future treatment of the problem; if the 
ciliogenesis defect is the primary defect in the ciliopathies, it is most worthwhile 
to address this avenue of research. However, if another of these defects occurs 
upstream of this and the others, this becomes an obvious therapeutic target. 
Ciliogenesis failure does not explain the hepatic anomalies in MKS, a key 
pathogenic feature of this and a number of the other ciliopathies, as these 
precede ciliogenesis (Clotman et al., 2008), so it is worthwhile investigating the 
extra-ciliary roles of the “ciliopathy” proteins to determine the most effective 
therapeutic targets. 
 
7.4 Conclusions & future perspectives 
 
It is possible for an MKS complex functioning as a Rho effector and a 
structural, cytoskeleton-membrane linker to be active at all of the locations that 
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MKS is observed in, including the focal adhesions (performing vital actions 
during motility), the Golgi apparatus (functioning in cytoskeleton-dependent 
vesicular trafficking, also impacting on ciliogenesis), cell-cell junctions 
(mediating MT capture), the nucleus (controlling positioning through modulation 
of cytoskeletal dynamics) and, of course, the transition zone (Figure 7.1).  
At the transition zone, their best-studied role, MKS proteins are likely 
important regulators of ciliary membrane composition, thereby controlling Shh 
signalling. However, they may also interact with and influence canonical and 
non-canonical Wnt signalling components, such as Dvl and Inturned. However, 
in contrast to the prevailing view in the ciliopathy field, I believe that a diffusion 
barrier at the transition zone is not the primary role of MKS proteins, validated 
by my use of serum in my experiments, in contrast to much of the current 
research – control cells do not typically form many cilia under these conditions. 
Together, these data imply that MKS proteins perform the roles described in this 
thesis independently of ciliary signalling defects. 
The prominence of the other ciliary proteins, such as BBS proteins, in many 
of these examples implies that MKS proteins would not function alone in these 
roles and that these “ciliopathy protein” complexes may cooperate to form 
structures tasked with signal transduction at multiple subcellular locations. This 
thesis therefore advances knowledge about the roles of MKS proteins, but may 
also inform research into the wider spectrum of ciliopathies, if the proteins 
involved do, in fact, interact to perform similar functions. This research topic 
therefore has vital implications in the genetic diagnosis and prognosis of this 
diverse group of disorders. 
Future research should establish the nature of these complexes at other 
subcellular locations – are the same isoforms of all the proteins used throughout 
the cell? Do the molecular constituents of the ciliopathy protein complexes vary 
across subcellular locations? Which proteins are vital to the the balance and 
components of Wnt/PCP and canonical Wnt signalling throughout the cell? How 
much redundancy is there in the transition zone complex proteins at other 
locations? If we can ascertain the biochemical composition and activity of these 
ciliopathy complexes throughout the cell, therapeutic potential may be possible. 
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APPENDIX 1: Centrosome positioning in non-dividing cells 
The following paper was written during the course of my PhD, co-first 
authored with Dr Amy Barker, and additionally authored by Dr Helen Dawe. This 
is a review describing centrosome movement in contexts outside of cell division. 
This paper has been appended as it provides a more detailed insight into 
centrosome movement during ciliogenesis and in relation to the Golgi and the 
nucleus, as covered more briefly in the introduction to this thesis. It also further 
describes centrosome movement during cell migration. 
This paper has been removed from the current version for copyright reasons. 
The final publication is available at:
link.springer.com/article/10.1007%2Fs00709-015-0883-5
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